COHR_AR2012_print.indd 1
1/15/13 1:01 PM
COHR_AR2012_print.indd 2
1/15/13 1:01 PM
COHR_AR2012_print.indd 3
1/15/13 1:01 PM
COHR_AR2012_print.indd 4
1/15/13 1:01 PM
amplifiers. Innolight brought microchip oscillators
that can be combined with different amplifiers.
Lumera brings a high-power platform for more
demanding applications. We envision being able to
mix-and-match the various components to deliver
configurable solutions with unrivaled performance,
reliability, efficiency, size and cost to a broad set of
applications.
Coherent continued its practice of returning cash to
shareholders during fiscal 2012 through the repur-
chase of $25 million dollars of stock (approximately
543 thousand shares), bringing our four-year total
to $395.5 million dollars (approximately 11.8 mil-
lion shares). These purchases completed previous
repurchase authorizations and our board approved
a new $25 million authorization. At the end of
calendar 2012, fiscal cliff discussions dominated the
U.S. news. There was a substantial amount of un-
certainty as to how the situation would be resolved
including what future tax rates would be on capital
gains and dividends. We concluded that an extraor-
dinary dividend would boost calendar 2012 returns
for our shareholders at prevailing advantageous tax
rates. A special dividend of $1/share was paid in the
first fiscal quarter of 2013 (December 2012) at a total
cost of approximately $24.0 million dollars.
We would like to thank you for your continued
support and confidence. We believe our product,
channel and investment strategies will keep our
company well-positioned as a world leader in the
laser industry.
Very truly yours,
John R. Ambroseo,
President and
Chief Executive Officer
Garry W. Rogerson,
Chairman of the Board
COHR_AR2012_finalRevA.indd 5
1/18/13 8:37 AM
(Th is page intentionally left blank.)
Notice of Annual Meeting
of Stockholders
February 27, 2013
8:30 a.m.
Silicon Valley Capital Club, 50 West San Fernando, San Jose, California 95113
MATTERS TO BE VOTED ON:
1. To elect the seven directors named in the proxy statement;
2. To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered
public accounting fi rm for the fi scal year ending September 28, 2013;
3. Advisory vote to approve executive offi cer compensation; and
4. To transact such other business as may properly be brought before the meeting and any
adjournment(s) thereof.
Th e foregoing items of business are more fully described in the Proxy Statement accompanying this Notice.
Stockholders of record at the close of business on January 9, 2013, are entitled to notice of and to vote at the meeting and
at any adjournments or postponements thereof.
All stockholders are cordially invited to attend the meeting. However, to assure your representation at the meeting, you are
urged to mark, sign, date and return the enclosed proxy card as promptly as possible in the postage-prepaid envelope enclosed
for that purpose or follow the instructions on the enclosed proxy card to vote by telephone or via the Internet. Any stockholder
of record attending the meeting may vote in person even if he or she has returned a proxy. Please note, however, that if your
shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy
issued in your name from that record holder.
Santa Clara, California
January 25, 2013
Sincerely,
John R. Ambroseo
President and Chief Executive Offi cer
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held
on February 27, 2013
Th e proxy statement and annual report to stockholders are available at www.proxyvote.com.
YOUR VOTE IS IMPORTANT
In order to assure your representation at the meeting, you are requested to complete, sign and date the enclosed proxy card as
promptly as possible and return it in the enclosed envelope or follow the instructions on the enclosed proxy card to vote by
telephone or via the Internet. Any stockholder attending the Annual Meeting may vote in person even if he or she returned a
proxy card.
Table of Contents
GENERAL INFORMATION ABOUT THE MEETING
PROPOSAL ONE
Election of Directors
PROPOSAL TWO
Ratifi cation of the Appointment of Deloitte & Touche LLP
as Independent Registered Public Accounting Firm
PROPOSAL THREE
Advisory Vote to Approve Executive Compensation
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
OUR EXECUTIVE OFFICERS
COMPENSATION DISCUSSION AND ANALYSIS
SUMMARY COMPENSATION AND EQUITY TABLE S
EQUITY COMPENSATION PLAN INFORMATION
CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
OTHER MATTERS
3
6
13
14
14
16
17
26
32
32
33
34
PROXY STATEMENT
General Information About the Meeting
General
Th e enclosed Proxy is solicited on behalf of the Board of Directors
(the “Board”) of Coherent, Inc. for use at the Annual Meeting of
Stockholders (the “Annual Meeting” or “meeting”) to be held at
8:30 a.m., local time, on February 27, 2013 at the Silicon Valley
Capital Club, 50 West San Fernando, San Jose, California 95113, and
at any adjournment(s) thereof, for the purposes set forth herein and
in the accompanying Notice of Annual Meeting of Stockholders. Our
telephone number is (408) 764-4000. Th ese proxy solicitation materials
were fi rst mailed on or about January 25, 2013 to all stockholders
entitled to vote at the Annual Meeting.
Who May Vote at the Meeting?
You are entitled to vote at the Annual Meeting if our records show that you held your shares as of the close of business of our record date, January 9,
2013 (the “Record Date”). On the Record Date, 24,042,471 shares of our common stock, $0.01 par value, were issued and outstanding.
What Does Each Share of Common Stock I Own Represent?
On all matters, each share has one vote, unless, with respect to Proposal 1 regarding the election of directors, cumulative voting is in eff ect. See
“Election of Directors—Vote Required” for a description of cumulative voting rights with respect to the election of directors.
How Does a Stockholder Vote?
Whether or not you plan to attend the Annual Meeting, we urge you
to vote by proxy to ensure your vote is counted. If you are entitled to
vote, you may do so as follows:
• Th rough your broker: If your shares are held through a broker, bank
or other nominee (commonly referred to as held in “street name”),
you will receive instructions from them that you must follow to have
your shares voted. If you want to vote in person, you will need to
obtain a legal proxy from your broker, bank or other nominee and
bring it to the meeting.
• In person: Attend the Annual Meeting and, if you request, we will give
you a ballot at the time of voting. If you have previously submitted
a proxy card, you must notify us at the Annual Meeting that you
intend to cancel your prior proxy and vote by ballot at the meeting.
• Returning a Proxy Card: Simply complete, sign and date the enclosed
proxy card and return it promptly in the envelope provided. If your
signed proxy card is received before the Annual Meeting, the designated
proxies will vote your shares as you direct.
• Using the Telephone: Dial toll-free 1-800-690-6903 using a touch-
tone phone and follow the recorded instructions. You will be asked
to provide the control number from the enclosed proxy card.
• Th rough the Internet: go to www.proxyvote.com to complete an
electronic proxy card. You will be asked to provide the control number
from the enclosed proxy card.
For telephone or Internet use, your vote must be received by 11:59 P.M.
Eastern Time on February 26, 2013 to be counted.
If you return a signed and dated proxy card without marking any
voting directions, your shares will be voted “for” the election of all
seven nominees for director and “for” all other proposals.
Matters to be Presented at the Meeting
We are not aware of any matters to be presented at the meeting other
than those described in this proxy statement. If any other matter is
properly presented at the Annual Meeting, your proxy holders (one of
the individuals named on your proxy card) will vote your shares in their
discretion. Th e cost of this solicitation will be borne by us. We may
reimburse brokerage fi rms and other persons representing benefi cial
owners of shares for their expenses in forwarding solicitation material to
such benefi cial owners. In addition, proxies may be solicited by certain
of our directors, offi cers and regular employees, without additional
compensation, personally or by telephone or facsimile.
COHERENT, INC. - 2012 Proxy Statement
3
GENERAL INFORMATION
Revoking Your Proxy
If you hold your shares in street name, you must follow the instructions
of your broker, bank or other nominee to revoke your voting instructions.
If you are a holder of record and wish to revoke your proxy instructions,
you must (i) advise the Corporate Secretary in writing at 5100 Patrick
Henry Dr., Santa Clara, California 95054 before the proxies vote your
shares at the meeting, (ii) timely deliver later-dated proxy instructions
or (iii) attend the meeting and vote your shares in person.
Attendance at the Annual Meeting
All stockholders of record as of the Record Date may attend the Annual
Meeting. Please note that cameras, recording devices and similar electronic
devices will not be permitted at the Annual Meeting. No items will
be allowed into the Annual Meeting that might pose a concern for
the safety of those attending. Additionally, to attend the meeting you
will need to bring identifi cation and proof suffi cient to us that you
were a stockholder of record as of the Record Date or that you are a
representative of a stockholder of record as of the Record Date for a
stockholder of record that is not a natural person. For directions to
attend the Annual Meeting or other questions, please contact Investor
Relations by telephone at (408) 764-4110 no later than 5:00 p.m.
(California time) on February 26, 2013.
Quorum; Abstentions; Broker Non-Votes
Our bylaws provide that stockholders holding a majority of the shares
of common stock issued and outstanding and entitled to vote on the
Record Date constitute a quorum at meetings of stockholders. Votes
will be counted by the inspector of election appointed for the Annual
Meeting, who will separately count “For” and (with respect to proposals
other than the election of directors) “Against” votes, abstentions and
broker non-votes.
A “broker non-vote” occurs when a nominee holding shares for a
benefi cial owner does not vote because the nominee does not have
discretionary voting power with respect to the proposal and has not
Deadline for Receipt of Stockholder Proposals
In order to submit stockholder proposals for the fi scal 2013 annual
meeting for inclusion in the Company’s proxy statement pursuant to
Rule 14a-8 of the Securities Exchange Act of 1934, as amended (“SEC
Rule 14a-8”), written materials must be received by the Corporate
Secretary at the Company’s principal offi ce in Santa Clara, California
no later than September 27, 2013.
Stockholder proposals must otherwise comply with the requirements
of SEC Rule 14a-8.
Proposals must be addressed to: Bret DiMarco, Corporate Secretary,
Coherent, Inc., 5100 Patrick Henry Dr., Santa Clara, California 95054.
Simply submitting a proposal does not guarantee its inclusion.
Section 2.15 of the Company’s bylaws also establishes an advance
notice procedure with regards to director nominations and stockholder
proposals that are not submitted for inclusion in the proxy statement,
but that a stockholder instead wishes to present directly from the
fl oor at any Annual Meeting. To be properly brought before the fi scal
2013 Annual Meeting, a notice of the nomination or the matter the
stockholder wishes to present at the meeting must be delivered to the
Corporate Secretary (see above), no later than the close of business on
the 45th day (December 11, 2013), nor earlier than the close of business
on the 75th day (November 11, 2013), prior to the one year anniversary
of the date these proxy materials were fi rst mailed by us unless the
annual meeting of stockholders is held prior to January 28, 2014 or
4
COHERENT, INC. - 2012 Proxy Statement
received instructions with respect to the proposal from the benefi cial
owner. Abstentions and broker non-votes represented by submitted
proxies will not be taken into account in determining the outcome of
the election of directors. Abstentions will not be taken into account
in determining the outcome of Proposal One and will have the same
eff ect as votes against Proposals Two and Th ree. We intend to separately
report abstentions and our Compensation and HR Committee will
generally view abstentions as neutral when considering the results of
Proposal Th ree. Broker non-votes represented by submitted proxies will
not be taken into account in determining the outcome of any proposal.
after April 28, 2014, in which case, the proposal must be received by us
not earlier than the 120th day prior to the annual meeting and not later
than the later of the 90th day prior to the annual meeting and the tenth
day following public announcement of the date the annual meeting
will be held and must otherwise be in compliance with applicable laws
and regulations in order to be considered for inclusion in the proxy
statement and form of proxy relating to that meeting.
If a stockholder who has notifi ed us of his or her intention to present
a proposal at an Annual Meeting does not appear to present his or her
proposal at such meeting, we need not present the proposal for vote at
such meeting. Th e Chair of the Annual Meeting has the fi nal discretion
whether or not to allow any matter to be considered at the meeting
which did not timely comply with all applicable notice requirements.
If a stockholder wishes only to recommend a candidate for consideration
by the Governance and Nominating Committee as a potential nominee
for the Company’s Board, see the procedures discussed in “Proposal
One — Election of Directors — Board Meetings and Committees
— Process for Recommending Candidates for Election to the Board
of Directors.”
Th e attached proxy card grants to the proxyholders discretionary
authority to vote on any matter raised at the Annual Meeting, including
proposals which are timely raised at the meeting, but did not meet the
deadline for inclusion in this proxy statement.
Eliminating Duplicative Proxy Materials
To reduce the expense of delivering duplicate voting materials to our
stockholders who may hold shares of Coherent common stock in more
than one stock account, we are delivering only one set of the proxy
solicitation materials to certain stockholders who share an address,
unless otherwise requested. A separate proxy card is included in the
voting materials for each of these stockholders.
We will promptly deliver, upon written or oral request, a separate copy
of the annual report or this proxy statement to a stockholder at a shared
address to which a single copy of the documents was delivered. To obtain
an additional copy, you may write us at 5100 Patrick Henry Drive,
Santa Clara, California 95054, Attn: Investor Relations, or contact
our Investor Relations department by telephone at (408) 764-4110.
Electronic Delivery of Proxy Materials
GENERAL INFORMATION
Similarly, if you share an address with another stockholder and have
received multiple copies of our proxy materials, you may contact us
at the address or telephone number specifi ed above to request that
only a single copy of these materials be delivered to your address in
the future. Stockholders sharing a single address may revoke their
consent to receive a single copy of our proxy materials in the future
at any time by contacting our distribution agent, Broadridge, either
by calling toll-free at 1-800-542-1061, or by writing to Broadridge,
Householding Department, 51 Mercedes Way, Edgewood, NY 11717.
Broadridge will remove such stockholder from the Householding program
within 30 days of receipt of such written notice, after which each such
stockholder will receive an individual copy of our proxy materials.
In an eff ort to reduce paper mailed to your home and help lower printing and postage costs, we are off ering stockholders the convenience of
viewing online proxy statements, annual reports and related materials. With your consent, we can stop sending future paper copies of these
documents. To participate during the voting season, registered stockholders may follow the instructions when voting online.
Incorporation by Reference
To the extent that this proxy statement has been or will be specifi cally
incorporated by reference into any other fi ling of Coherent with the
SEC, the sections of this proxy statement entitled “Report of the Audit
Committee of the Board of Directors” (to the extent permitted by
the rules of the SEC) and “Compensation Discussion and Analysis”
shall not be deemed to be so incorporated, unless specifi cally provided
otherwise in such fi ling.
FURTHER INFORMATION
We will provide without charge to each stockholder solicited by these proxy solicitation materials a copy of our annual report on Form 10-K for
the fi scal year ended September 29, 2012 without exhibits and any amendments thereto on Form 10-K/A upon request of such stockholder made
in writing to Coherent, Inc., 5100 Patrick Henry Drive, Santa Clara, California 95054, Attn: Investor Relations. We will also furnish any exhibit
to the annual report on Form 10-K if specifi cally requested in writing. You can also access our Securities and Exchange Commission (“SEC”)
fi lings, including our annual reports on Form 10-K, and all amendments thereto fi led on Form 10 K/A, on the SEC website at www.sec.gov.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING
TO BE HELD ON FEBRUARY 27, 2013:
Th e proxy statement and annual report to stockholders are available at www.proxyvote.com.
Stockholder List
A list of stockholders entitled to vote at the Annual Meeting will be available for examination by stockholders of record at the Annual Meeting.
COHERENT, INC. - 2012 Proxy Statement
5
PROPOSAL ONE ELECTION OF DIRECTORS
Nominees
Seven (7) members of our Board of Directors are to be elected at the
Annual Meeting. Unless otherwise instructed, the proxy holders will
vote the proxies received by them for the nominees named below.
Each nominee has consented to be named a nominee in the proxy
statement and to continue to serve as a director if elected. If any
nominee becomes unable or declines to serve as a director, if additional
persons are nominated at the meeting or if stockholders are entitled to
cumulate votes, the proxy holders intend to vote all proxies received
by them in such a manner (in accordance with cumulative voting) as
will ensure the election of as many of the nominees listed below as
possible, and the specifi c nominees to be voted for will be determined
by the proxy holders.
We are not aware of any reason that any nominee will be unable or
will decline to serve as a director. Th e term of offi ce of each person
elected as a director will continue until the next Annual Meeting of
Stockholders or until a successor has been elected and qualifi ed or until
his or her earlier resignation or removal. Th ere are no arrangements
or understandings between any director or executive offi cer and any
other person pursuant to which he or she is or was to be selected as a
director or offi cer.
Th e names of the nominees, all of whom are currently directors standing
for re-election, and certain information about them as of December 31,
2012 are set forth below. All of the nominees have been unanimously
recommended for nomination by the Board acting on the unanimous
recommendation of the Governance and Nominating Committee of
the Board. Th e committee consists solely of independent members
of the Board. Th ere are no family relationships among directors or
executive offi cers of Coherent.
Name
John R. Ambroseo
Jay T. Flatley(3)
Susan M. James(1)(2)
L. William Krause(2)(3)
Age Director Since
2002
51
2011
60
2008
66
2009
70
Principal Occupation
President and Chief Executive Offi cer
President and Chief Executive Offi cer of Illumina, Inc.
Retired Audit Partner, Ernst & Young
President of LWK Ventures
Garry W. Rogerson(1)(2)
Lawrence Tomlinson(1)
Sandeep Vij(3)
(1) Member of the Audit Committee.
(2) Member of the Governance and Nominating Committee.
(3) Member of the Compensation and H.R. Committee.
60
72
47
2004
2003
2004
Chief Executive Offi cer of Advanced Energy Industries, Inc.
Retired Senior Vice President and Treasurer of Hewlett-Packard Co.
President and Chief Executive Offi cer of MIPS Technologies, Inc.
Except as set forth below, each of our directors has been engaged in
his or her principal occupation set forth above during the past fi ve
years. Th ere is no family relationship between any of our directors or
executive offi cers.
John R. Ambroseo. Mr. Ambroseo has served as our President and
Chief Executive Offi cer as well as a member of the Board since
October 2002. Mr. Ambroseo served as our Chief Operating Offi cer
from June 2001 through September 2002. Mr. Ambroseo served as
our Executive Vice President and as President and General Manager of
the Coherent Photonics Group from September 2000 to June 2001.
From September 1997 to September 2000, Mr. Ambroseo served as
our Executive Vice President and as President and General Manager
of the Coherent Laser Group. From March 1997 to September 1997,
Mr. Ambroseo served as our Scientifi c Business Unit Manager. From
August 1988, when Mr. Ambroseo joined us, until March 1997, he
served as a Sales Engineer, Product Marketing Manager, National
Sales Manager and Director of European Operations. Mr. Ambroseo
received a Bachelor degree from SUNY-College at Purchase and a PhD
in Chemistry from the University of Pennsylvania.
Jay T. Flatley. Since 1999 Mr. Flatley has served as President, Chief
Executive Offi cer and a member of the Board of Directors of Illumina,
Inc., a leading developer, manufacturer and marketer of life science tools
and integrated systems for the analysis of genetic variation and function.
Prior to joining Illumina, Mr. Flatley was co-founder, President, Chief
Executive Offi cer, and a member of the Board of Directors of Molecular
Dynamics, Inc., a NASDAQ-listed life sciences company focused on
genetic discovery and analysis, from 1994 until its sale to Amersham
Pharmacia Biotech Inc. in 1998. He served in various other positions
with that company from 1987 to 1994. From 1985 to 1987, he was
Vice President of Engineering and Vice President of Strategic Planning
at Plexus Computers, a UNIX computer company. Mr. Flatley holds a
B.A. in Economics from Claremont McKenna College and a B.S. and
M.S. in Industrial Engineering from Stanford University.
Mr. Flatley’s years of executive and management experience in the high
technology industry, including serving as the chief executive offi cer of several
public companies, his service on the board of another publicly held company,
and his service as a director of Coherent make him an invaluable member
of our Board of Directors.
Mr. Ambroseo’s status as our Chief Executive Offi cer, his 24 year tenure
with Coherent, his extensive knowledge of our products, technologies and
end markets and his over a decade of service as a director of Coherent make
him an invaluable member of our Board of Directors.
Susan M. James. Ms. James originally joined Ernst & Young, a global
leader in professional services, in 1975, serving as a partner from 1987
until her retirement in June 2006, and as a consultant from June 2006
to December 2009. During her tenure with Ernst & Young, she was
6
COHERENT, INC. - 2012 Proxy Statement
the lead partner or partner-in-charge for the audit work for a signifi cant
number of technology companies, including Intel Corporation, Sun
Microsystems, Amazon.com, Autodesk, Inc. and the Hewlett-Packard
Company, as well as for the Ernst & Young North America Global
Account Network. She also served on the Ernst & Young Americas
Executive Board of Directors from January 2002 through June 2006.
She is a certifi ed public accountant (inactive) and a member of the
American Institute of Certifi ed Public Accountants. Ms. James also serves
on the boards of directors of Applied Materials, Inc., a manufacturing
equipment, services and software company, Yahoo! Inc., an Internet
technology company, and Tri-Valley Animal Rescue, a non-profi t
corporation dedicated to providing homes for homeless pets. Ms. James
holds Bachelor’s degrees in Mathematics from Hunter College and
Accounting from San Jose State University.
Ms. James’ years in the public accounting industry, her service on the boards
and committees of a number of other publicly held companies and her fi ve
years of service as a director of Coherent make her an invaluable member
of our Board of Directors.
L. William Krause. Mr. Krause has been President of LWK Ventures, a
private investment fi rm, since 1991. In addition, Mr. Krause served as
Chairman of the Board of Caspian Networks, Inc., an IP networking
systems provider, from April 2002 to September 2006 and as Chief
Executive Offi cer from April 2002 until June 2004. From September 2001
to February 2002, Mr. Krause was Chairman and Chief Executive
Offi cer of Exodus Communications, Inc. He also served as President
and Chief Executive Offi cer of 3Com Corporation, a global data
networking company, from 1981 to 1990 and as its Chairman from
1987 to 1993 when he retired. Mr. Krause currently serves as a director
of Brocade Communications Systems, Inc., a networking solutions
and services company, CommScope Inc., a networking infrastructure
company and Core-Mark Holdings, Inc., a distributor of packaged
consumer goods. Mr. Krause previously served as a director for the
following public companies: Packeteer, Inc., Sybase, Inc. and TriZetto
Group, Inc. Mr. Krause holds a B.S. degree in electrical engineering
and received an honorary Doctorate of Science from Th e Citadel.
Mr. Krause’s years of executive and management experience in the high
technology industry, including serving as the chief executive offi cer of
several companies, his service on the boards and committees of a number
of other publicly held companies, and his four years of service as a director
of Coherent make him an invaluable member of our Board of Directors.
Garry W. Rogerson. Mr. Rogerson has served as our Chairman of the
Board since June 2007. Since August 2011, Mr. Rogerson has been
Chief Executive Offi cer and a member of the Board of Directors of
Advanced Energy Industries, Inc., a provider of power and control
technologies for thin-fi lm manufacturing and solar-power generation.
He was Chairman and Chief Executive Offi cer of Varian, Inc., a
major supplier of scientifi c instruments and consumable laboratory
supplies, vacuum products and services, from February 2009 and 2004,
respectively until the purchase of Varian by Agilent Technologies, Inc.
Director Independence
PROPOSAL ONE ELECTION OF DIRECTORS
in May 2010. Mr. Rogerson served as Varian’s Chief Operating Offi cer
from 2002 to 2004, as Senior Vice President, Scientifi c Instruments
from 2001 to 2002, and as Vice President, Analytical Instruments from
1999 to 2001. Mr. Rogerson received an honours degree and Ph.D. in
biochemistry from the University of Kent at Canterbury.
Mr. Rogerson’s years of executive and management experience in the high
technology industry, his service including serving as the chief executive offi cer
of several public companies, his service on the board of another publicly
held company, and his nine years of service as a director of Coherent make
him an invaluable member of our Board of Directors.
Lawrence Tomlinson. Mr. Tomlinson retired from Hewlett-
Packard Company, a global technology company, in June 2003.
Prior to retiring from Hewlett-Packard, from 1993 to June 2003
Mr. Tomlinson served as its Treasurer, from 1996 to 2002 he was
also a Vice President and from 2002 to June 2003 was also a Senior
Vice President. Mr. Tomlinson is a member of the board of directors
of Salesforce.com, Inc., a customer relationship management service
provider. Mr. Tomlinson previously served as a director of Th erma-
Wave, Inc. Mr. Tomlinson received a B.S. degree in accounting from
Rutgers University and an M.B.A. from Santa Clara University.
Mr. Tomlinson’s years of executive and management experience in the high
technology industry, his experience in the fi nance and accounting industry,
his service on the boards and committees of a number of other publicly
held companies and his decade of service as a director of Coherent make
him an invaluable member of our Board of Directors.
Sandeep Vij. Mr. Vij has held the position of President and Chief
Executive Offi cer of MIPS Technologies, Inc., a leading provider of
processor architectures and cores, since January 2010. Previously,
Mr. Vij had been the Vice President and General Manager of the
Broadband and Consumer Division of Cavium Networks, Inc., a
provider of highly integrated semiconductor products from May 2008
to January 2010. Prior to that he held the position of Vice President of
Worldwide Marketing, Services and Support for Xilinx Inc., a digital
programmable logic device provider, from 2007 to April 2008. From
2001 to 2006, he held the position of Vice President of Worldwide
Marketing at Xilinx. From 1997 to 2001, he served as Vice President
and General Manager of the General Products Division at Xilinx.
Mr. Vij joined Xilinx in 1996 as Director of FPGA Marketing. Mr. Vij
is a member of the board of directors of MIPS Technologies, Inc.
He is a graduate of General Electric’s Edison Engineering Program
and Advanced Courses in Engineering. He holds a Masters degree in
electrical engineering from Stanford University and a B.S. degree in
electrical engineering from San Jose State University.
Mr. Vij’s years of executive and management experience in the high technology
industry, including serving as the chief executive offi cer of another public
company, his service on the board of another publicly held company, and
his nine years of service as a director of Coherent make him an invaluable
member of our Board of Directors.
Th e Board has determined that, with the exception of Mr. Ambroseo, all of its current members and all of the nominees for director are “independent
directors” as that term is defi ned in the marketplace rules of the Nasdaq Stock Market.
COHERENT, INC. - 2012 Proxy Statement
7
PROPOSAL ONE ELECTION OF DIRECTORS
Board Meetings and Committees
Th e Board held a total of three (3) meetings during fi scal 2012. During fi scal
2012, the Board had three standing committees: the Audit Committee; the
Compensation and H.R. Committee; and the Governance and Nominating
Committee. From time to time, the Board may create limited ad hoc
committees, service on which does not provide additional compensation.
In the past, the Board has also established special committees. No director
serving during fi scal 2012 attended fewer than 75% of the aggregate of
all meetings of the Board and the committees of the Board upon which
such director served. All of the members of each standing committee are
“independent” as defi ned under the applicable rules established by the
Nasdaq Stock Market.
Audit Committee
Th e Audit Committee, which has been established in accordance with
Section 3(a)(58)(A) of the Exchange Act, consists of directors James,
Rogerson, and Tomlinson. Th e Audit Committee held eleven (11) meetings
during fi scal 2012. Th e Board has determined that directors James,
Rogerson and Tomlinson are “audit committee fi nancial experts” as that
term is defi ned in the rules of the SEC. Among other things, the Audit
Committee has the sole authority for appointing and supervising our
independent registered public accounting fi rm and is primarily responsible
for approving the services performed by our independent registered public
accounting fi rm and for reviewing and evaluating our accounting principles
and our system of internal accounting controls.
Compensation and H.R. Committee
Th e Compensation and H.R. Committee of the Board consists of directors
Krause, Flatley, Tomlinson and Vij. In December 2011, Mr. Flatley replaced
Mr. Rogerson on the committee. All of the members of the Compensation
and H.R. Committee are “independent” as defi ned under the marketplace
rules of the Nasdaq Stock Market. Th e Compensation and H.R. Committee
held eight (8) meetings during fi scal 2012. As part of an eff ort to balance
committee memberships, Mr. Tomlinson ceased serving on the committee
eff ective January 1, 2013, resulting in each of our standing committees
having three members. Th e Compensation and H.R. Committee, among
other things, reviews and approves our executive compensation policies
and programs, and makes equity grants to our employees, including
offi cers, pursuant to our stock option plans. Th is committee has the sole
authority delegated to it by the Board to make employee equity grants,
which must be done at a meeting rather than by written consent. For
additional information about the committee’s processes and procedures
for the consideration and determination of executive compensation, see
“Compensation Discussion and Analysis”.
Governance and Nominating Committee
Th e Governance and Nominating Committee consists of directors
James, Krause and Rogerson. Th e Governance and Nominating
Committee held three (3) meetings during fi scal 2012. Th e Governance
and Nominating Committee, among other things, assists the Board
by making recommendations to the Board on matters concerning
director nominations and elections, board committees and corporate
governance and compensation for directors. For fi scal 2012, the
committee retained an independent compensation consultant to advise
it on Board compensation.
Copies of the charters for each of our committees may be found on
our website at www.coherent.com under “Investor Relations.”
Attendance at Annual Meeting of Stockholders by the members of the Board of Directors
All directors are encouraged, but not required to attend our annual meeting of stockholders. At our annual meeting held on February 28, 2012,
all members of the Board attended in person other than Mr. Vij, who attended by telephone due to a prior international travel commitment.
Process for Stockholders to Recommend Candidates for Election to the Board of Directors
Th e Governance and Nominating Committee will consider nominees
properly recommended by stockholders. A stockholder that desires
to recommend a candidate for election to the Board must direct the
recommendation in writing to us at our principal offi ces (Attention: Bret
DiMarco, Corporate Secretary) and must include the candidate’s name,
age, home and business contact information, principal occupation or
employment, the number of shares benefi cially owned by the nominee,
whether any hedging transactions have been entered into by the nominee
or on his or her behalf, information regarding any arrangements or
understandings between the nominee and the stockholder nominating
the nominee or any other persons relating to the nomination, a written
statement by the nominee acknowledging that the nominee will owe a
fi duciary duty to Coherent if elected, a written statement of the nominee
that such nominee, if elected, intends to tender, promptly following such
nominee’s election or re-election, an irrevocable resignation eff ective
upon such nominee’s failure to receive the required vote for re-election
at the next meeting at which such nominee would face re-election
and upon acceptance of such resignation by the board of directors, in
accordance with the corporation’s guidelines or policies, and any other
information required to be disclosed about the nominee if proxies were
to be solicited to elect the nominee as a director.
For a stockholder recommendation to be considered by the Governance
and Nominating Committee as a potential candidate at an annual
meeting, nominations must be received on or before the deadline
for receipt of stockholder proposals for such meeting. In the event a
stockholder decides to nominate a candidate for director and solicits
proxies for such candidate, the stockholder will need to follow the
rules set forth by the SEC and in our bylaws. See “General Information
About Th e Meeting—Deadline for Receipt of Stockholder Proposals.”
Th e Governance and Nominating Committee’s criteria and process for
evaluating and identifying the candidates that it approves as director
nominees are as follows:
• the Governance and Nominating Committee regularly reviews the
current composition and size of the Board;
8
COHERENT, INC. - 2012 Proxy Statement
PROPOSAL ONE ELECTION OF DIRECTORS
• the Governance and Nominating Committee reviews the qualifi cations of
any candidates who have been properly recommended by a stockholder,
as well as those candidates who have been identifi ed by management,
individual members of the Board or, if the Governance and Nominating
Committee determines, a search fi rm. Such review may, in the Governance
and Nominating Committee’s discretion, include a review solely of
information provided to the Governance and Nominating Committee
or may also include discussions with persons familiar with the candidate,
an interview with the candidate or other actions that the committee
deems proper;
• the Governance and Nominating Committee evaluates the performance
of the Board as a whole and evaluates the qualifi cations of individual
members of the Board eligible for re-election at the annual meeting
of stockholders;
• the Governance and Nominating Committee considers the suitability
of each candidate, including the current members of the Board, in
light of the current size and composition of the Board. Except as may
be required by rules promulgated by the Nasdaq Stock Market or
the SEC, it is the current belief of the Governance and Nominating
Committee that there are no specifi c, minimum qualifi cations that
must be met by any candidate for the Board, nor are there specifi c
qualities or skills that are necessary for one or more of the members of
the Board to possess. In evaluating the qualifi cations of the candidates,
the Governance and Nominating Committee considers many factors,
including, issues of character, judgment, independence, age, expertise,
diversity of experience, length of service, other commitments and the
like. While Coherent does not have a formal policy with regard to the
consideration of diversity in identifying director nominees, as noted
above, diversity is one of many factors that the committee considers.
Th e Governance and Nominating Committee evaluates such factors,
among others, and does not assign any particular weighting or priority
to any of these factors. Th e Governance and Nominating Committee
considers each individual candidate in the context of the current perceived
needs of the Board as a whole. While the Governance and Nominating
Committee has not established specifi c minimum qualifi cations
for director candidates, the committee believes that candidates and
nominees must refl ect a Board that is comprised of directors who
(i) are predominantly independent, (ii) are of high integrity, (iii) have
qualifi cations that will increase the overall eff ectiveness of the Board,
and (iv) meet other requirements as may be required by applicable
rules, such as fi nancial literacy or fi nancial expertise with respect to
audit committee members;
• in evaluating and identifying candidates, the Governance and Nominating
Committee has the authority to retain and terminate any third party
search fi rm that is used to identify director candidates and has the
authority to approve the fees and retention terms of any search fi rm; and
• after such review and consideration, the Governance and Nominating
Committee recommends the slate of director nominees to the full
Board for its approval.
Th e Governance and Nominating Committee will endeavor to notify, or
cause to be notifi ed, all director candidates, including those recommended
by a stockholder, of its decision as to whether to nominate such individual
for election to the Board.
Our corporate governance guidelines require that upon a member of
the Board turning 72 years old, he or she shall submit a conditional
resignation to the Governance and Nominating Committee eff ective
upon the next annual meeting of stockholders. Th e committee then
determines whether to recommend to the Board to accept such resignation.
Mr. Tomlinson submitted such conditional resignation following his
72nd birthday and the committee and Board unanimously determined
not to accept the resignation. Given Mr. Tomlinson’s years of service to
Coherent and fi nance expertise, the Board re-nominated Mr. Tomlinson
as part of the slate of directors for consideration by the stockholders at
the annual meeting.
Majority Voting and Conditional Resignations from the Board of Directors
In December 2012, upon the recommendation of the Governance and
Nominating Committee the Board of Directors amended our bylaws,
eff ective December 1, 2013, to change the voting standard for the election
of directors that are not Contested Elections (as defi ned below) from
a plurality to a majority of the votes cast. A majority of the votes cast
means the number of votes cast “for” a director’s election exceeds the
number of votes cast against that director’s election (with “abstentions”
and “broker non-votes” not counted as a vote cast either “for” or “against”
that director’s election). However, if the number of nominees exceeds the
number of directors to be elected (a “Contested Election”), the directors
shall be elected by a plurality of the votes cast.
In connection with the amendment to the Bylaws establishing a majority
vote standard for the election of directors in elections that are not Contested
Elections, the Board also adopted a director election policy to (i) establish
procedures under which any incumbent director who fails to receive a
majority of the votes cast in an election that is not a Contested Election
shall tender his or her resignation to the Governance and Nominating
Committee for consideration; and (ii) provide that the Governance
and Nominating Committee will make recommendations to the Board
regarding the actions to be taken with respect to all such off ers to resign.
Th e Board shall act on the resignation within ninety (90) days following
certifi cation of the election results. In the event that the Board does not
accept such resignation, then such director shall continue to serve until
such time as his or her successor is elected.
Stockholder Communication with the Board of Directors
While the Board believes that management speaks for Coherent, any
stockholder may contact any of our directors by writing to them by
mail c/o Bret DiMarco, Corporate Secretary, at our principal executive
offi ces, the address of which appears on the inside back cover of this
proxy statement.
Any stockholder may report to us any complaints regarding accounting,
internal accounting controls, or auditing matters. Any stockholder
who wishes to so contact us should send such complaints to the Audit
Committee c/o Bret DiMarco, Corporate Secretary, at our principal
executive offi ces, the address of which appears on the inside back cover
of this proxy statement.
COHERENT, INC. - 2012 Proxy Statement
9
PROPOSAL ONE ELECTION OF DIRECTORS
Any stockholder communications that the Board is to receive will fi rst
go to our Corporate Secretary, who will log the date of receipt of the
communication as well as the identity and contact information of the
correspondent in our stockholder communications log.
Our Corporate Secretary will review, summarize and, if appropriate,
investigate the complaint under the direction of the appropriate committee
of the Board in a timely manner. In the case of accounting or auditing
related matters, a member of the Audit Committee, or the Audit Committee
as a whole, will then review the summary of the communication, the
results of the investigation, if any, and, if appropriate, the draft response.
Th e summary and response will be in the form of a memo, which will
become part of the stockholder communications log that the Corporate
Secretary maintains with respect to all stockholder communications.
Independent Chair and Board Leadership
Our Board leadership structure consists of an independent Chairman,
who is elected by the independent directors, and independent committee
chairs. We separate the positions of Chief Executive Offi cer and Chairman
in recognition of the diff erences between the two roles. Th e Board believes
this structure provides independent Board leadership and engagement.
Given that our Chairman is an independent director, the Board does
not feel the need for a separate “lead independent director,” as our
independent Chairman performs that function. Th e Board takes its
independence seriously and reinforces this standard with six of its seven
members being independent.
Th e role of the Board and its Committees in Risk Oversight
Th e Board oversees Coherent’s risk profi le and management’s processes
for assessing and managing risk, both as a whole Board and through its
committees, with our Governance and Nominating Committee delegated
the responsibility for assigning oversight responsibilities to each committee
and the Board as a whole. Our senior executive team provides regular
updates to the Board and each committee regarding our strategies and
objectives and the risks inherent with them.
Each regular meeting of the Board includes a discussion of risks related
to the Company’s fi nancial results and operations and each committee
schedules risk-related presentations regularly throughout the year. In
addition our directors have access to our management to discuss any
matters of interest, including those related to risk. Th ose members
of management most knowledgeable of the issues attend Board and
committee meetings to provide additional insight on the matters being
discussed, including risk exposures. Our Chief Financial Offi cer and
General Counsel both report directly to our Chief Executive Offi cer,
providing him with further visibility to our risk profi le. A Vice President,
Finance is the designated offi cer overseeing our enterprise risk management
program and works closely with both our Chief Financial Offi cer and
General Counsel on these matters.
Th ese regular meetings also provide our Board members the opportunity
to discuss issues of concern directly with management. In general the
Board and its committees oversee the following risk categories:
• Th e Board oversees generally the Company’s overall enterprise risk
management process and specifi cally with regards to the areas of
strategy, mergers and acquisitions, communications and operations;
• Th e Audit Committee generally oversees risks primarily related to
fi nancial controls, accounting, tax, treasury, capital, legal, regulatory
and compliance;
• Th e Compensation and H.R. Committee generally oversees our
compensation programs so that they do not incentivize excessive risk
taking as well as overseeing human resources related risks; and
• Th e Governance and Nominating Committee oversees the assignment
of risk oversight categories by each particular committee and/or the
Board as a whole as well as those risks related to compensation of
members of the Board, succession planning for the Board and chief
executive offi cer.
In the fall of 2012, management presented an assessment of the risks
associated with the Company’s compensation plans. Th e Committee
agreed with the conclusion that the risks were within our ability to
eff ectively monitor and manage and that these risks are not reasonably
likely to have a material adverse eff ect on the Company.
Fiscal 2012 Director Compensation
During fi scal 2012, we paid our non-employee directors an annual retainer (depending upon position) and for service on the Board as follows:
Position
Board Member
Board Chair
Audit Committee Chair
Compensation and H.R. Comm. Chair
Governance & Nominating Comm. Chair
Audit Committee member (non-Chair)
Compensation and H.R. Committee member (non-Chair)
Governance and Nominating Committee member (non-Chair)
10
COHERENT, INC. - 2012 Proxy Statement
Annual Retainer
40,000
16,000
34,000
16,000
10,750
12,500
8,500
6,500
$
$
$
$
$
$
$
$
PROPOSAL ONE ELECTION OF DIRECTORS
Beginning in the second quarter of fi scal year 2013, the annual retainer
for the Board Chair was increased to $40,000. Th e increase was approved
by the Governance and Nominating Committee after a review of the
compensation of the Board of Directors by the committee’s independent
compensation consultant, Compensia. In particular, Compensia noted
that the Chair annual retainer was signifi cantly below the median
compensation measured against the Company’s peer group (which
was the same group used for comparing compensation for the named
executive offi cers).
Th e chart below summarizes the gross cash amounts earned by non-employee directors for service during fi scal 2012 on the Board and its
committees (all amounts in dollars):
Name
Jay T. Flatley
Susan M. James
L. William Krause
Garry W. Rogerson
Lawrence Tomlinson
Sandeep Vij
(1) Includes Mr. Rogerson’s service as Chairman of the Board.
(2) Reflects a pro rata amount for service on the committee.
$
$
$
$
$
$
Annual Board
Service
40,000
40,000
40,000
56,000(1) $
$
40,000
40,000
$
Audit
Committee
Compensation
and H.R.
Committee
Nominating
and Governance
Committee
— $
34,000
— $
12,500 $
12,500 $
— $
7,083(2)
$
—
8,500
$
1,417(2) $
8,500
16,000
— $
6,500 $
6,500 $
10,750 $
— $
— $
Total
47,083
80,500
55,000
80,667
61,000
56,000
Th e chart below summarizes the amounts earned by non-employee directors for service (including both Board and, where applicable, committee
service) during fi scal 2012:
Name
Total ($)
Jay T. Flatley
247,248
Susan M. James
280,665
L. William Krause
255,165
Garry W. Rogerson
280,832
Lawrence Tomlinson
261,165
256,165
Sandeep Vij
(1) These amounts do not reflect compensation actually received. Rather, these amounts represent the aggregate grant date fair value computed in accordance with ASC 718,
for restricted stock units (“RSUs”) and stock options which were granted in fiscal 2012. The assumptions used to calculate the value of these stock units and stock options
are set forth in Note 12. “Employee Stock Option and Benefit Plans” of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the
year ended September 29, 2012.
Option Awards
($)(1)(2)
—
—
—
—
—
—
Stock Awards
($)(1)(2)
200,165
200,165
200,165
200,165
200,165
200,165
Fees Paid in
Cash ($)
47,083
80,500
55,000
80,667
61,000
56,000
(2) The directors’ aggregate holdings of RSUs as of September 29, 2012 were as follows:
Name
Jay T. Flatley
Susan M. James
L. William Krause
Garry W. Rogerson
Lawrence Tomlinson
Sandeep Vij
(1) The shares underlying the RSUs will vest to the extent an individual is a member of the Board of Directors on the applicable vesting date.
(2) 3,500 shares vest on February 15, 2013 and 2,000 shares vest on September 20, 2014.
(3) 3,500 shares vest on February 15, 2013 and 2,000 shares vest on April 1, 2013.
Th e directors’ aggregate holdings of stock option awards (both vested and unvested) as of September 29, 2012 were as follows:
Name
Jay T. Flatley
Susan M. James
L. William Krause
Garry W. Rogerson
Lawrence Tomlinson
Sandeep Vij
Shares(1)
5,500(2)
5,500(3)
5,500(3)
5,500(3)
5,500(3)
5,500(3)
Shares
24,000
18,000
30,000
6,000
18,000
—
COHERENT, INC. - 2012 Proxy Statement
11
PROPOSAL ONE ELECTION OF DIRECTORS
Th e following table shows equity grants received by non-employee directors in fi scal 2012:
Name
Jay T. Flatley
Susan M. James
L. William Krause
Garry W. Rogerson
Lawrence Tomlinson
Sandeep Vij
Restricted Stock Units
Granted in Fiscal 2012
(# shares)
3,500
3,500
3,500
3,500
3,500
3,500
Our stockholders approved the adoption of our 2011 Equity Incentive
Plan in March 2011 (the “2011 Plan”).
Th e Board has adopted resolutions automatically granting under the
2011 Plan each non-employee member of the Board of Directors
3,500 RSUs upon such member’s reelection to the Board, with vesting
on February 15 of the following year. Eff ective in December 2011,
the Board determined that upon the initial appointment of a non-
employee member to the Board, such new director will receive a
grant of 3,500 RSUs, which vest over two years (fi fty percent on each
anniversary of grant).
For option grants held by a director who retires after at least eight
years of service on the Board which are outstanding under the 1998
Director Plan, such grants will fully vest and the director will have
the right to exercise his or her option as to both vested and unvested
shares as of such date. Th e option will remain exercisable for the lesser
of (i) two (2) years following the date of such director’s retirement or
(ii) the expiration of the option’s original term. Th is provision was not
adopted for option grants under the 2011 Plan.
With the adoption of our 2011 Plan, the 1998 Director Plan has
been terminated other than for outstanding historical grants made
thereunder. As of September 29, 2012, 441,000 shares have been
issued upon the exercise of options and the vesting of RSUs under
the 1998 Director Plan.
Option Exercises and Stock Vested at 2012 Fiscal Year-End
Th e table below sets forth certain information for each non-employee director regarding the exercise of options and the vesting of stock awards
during the year ended September 29, 2012, including the aggregate value realized upon such exercise or vesting.
Name
Jay T. Flatley
Susan M. James
L. William Krause
Garry W. Rogerson
Lawrence Tomlinson
Sandeep Vij
Vote Required
Option Awards
Stock Awards
Number of Shares
Acquired on
Exercise
(#)
—
—
—
30,000
—
15,000
Value Realized
on Exercise
($)
—
—
—
626,580
—
273,960
Number of Shares
Acquired on
Vesting
(#)
—
5,500
5,500
5,500
5,500
5,500
Value Realized
on Vesting
($)
—
305,055
276,675
305,055
305,055
305,055
Every stockholder voting for the election of directors may cumulate such
stockholder’s votes and give one candidate a number of votes equal to the
number of directors to be elected multiplied by the number of votes to
which the stockholder’s shares are entitled. Alternatively, a stockholder
may distribute his or her votes on the same principle among as many
candidates as the stockholder thinks fi t, provided that votes cannot be
cast for more than seven (7) candidates. However, no stockholder will
be entitled to cumulate votes for a candidate unless (i) such candidate’s
name has been properly placed in nomination for election at the
Annual Meeting prior to the voting and (ii) the stockholder, or any
other stockholder, has given notice at the meeting prior to the voting
of the intention to cumulate the stockholder’s votes. If cumulative
voting occurs at the meeting and you do not specify how to distribute
your votes, your proxy holders (the individuals named on your proxy
card) will cumulate votes in such a manner as will ensure the election
of as many of the nominees listed above as possible, and the specifi c
nominees to be voted for will be determined by the proxy holders.
If a quorum is present, the seven (7) nominees receiving the highest
number of votes will be elected to the Board. See “Information
Concerning Solicitation and Voting—Quorum; Abstentions; Broker
Non-Votes.”
Th e Board recommends that Stockholders vote “FOR”
the seven nominees presented herein.
12
COHERENT, INC. - 2012 Proxy Statement
PROPOSAL TWO
RATIFICATION OF
THE APPOINTMENT
OF DELOITTE & TOUCHE LLP
AS INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
Th e Audit Committee of the Board has selected Deloitte & Touche
LLP, an independent registered public accounting fi rm, to audit our
fi nancial statements for the fi scal year ending September 28, 2013, and
recommends that stockholders vote for ratifi cation of such appointment.
Deloitte & Touche LLP has audited our fi nancial statements since
the fi scal year ended September 25, 1976. Although ratifi cation
by stockholders is not required by law, the Audit Committee has
determined that it is desirable to request ratifi cation of this selection by
the stockholders as a matter of good corporate practice. Notwithstanding
its selection, the Audit Committee, in its discretion, may appoint a new
independent registered public accounting fi rm at any time during the
year if the Audit Committee believes that such a change would be in
the best interest of Coherent and its stockholders. If the stockholders
do not ratify the appointment of Deloitte & Touche LLP, the Audit
Committee may reconsider its selection. Th e Audit Committee selected
Deloitte & Touche LLP to audit our fi nancial statements for the fi scal
year ended September 29, 2012, which was ratifi ed by our stockholders.
Representatives of Deloitte & Touche LLP are expected to be present at
the meeting and will be aff orded the opportunity to make a statement
if they desire to do so. Th e representatives of Deloitte & Touche LLP
are also expected to be available to respond to appropriate questions.
Principal Accounting Fees and Services
Th e following table sets forth fees for services provided by Deloitte & Touche LLP, the member fi rms of Deloitte Touche Tohmatsu, and their
respective affi liates (collectively, “Deloitte”) during fi scal years 2012 and 2011:
2011
Audit fees(1)
1,665,000
Audit-related fees(2)
—
—
Tax fees
All other fees(3)
2,000
TOTAL
1,667,000
(1) Represents fees for professional services provided in connection with the integrated audit of our annual financial statements and internal control over financial reporting
and review of our quarterly financial statements, advice on accounting matters that arose during the audit and audit services provided in connection with other statutory or
regulatory filings.
2012
1,725,000 $
172,632
—
2,200
1,899,832 $
$
$
(2) Represents $146,874 in fees for due diligence associated with our acquisition activities in fiscal 2012 and $25,578 for services related to the review of our XBRL filings
(3) Represents the annual subscription for access to the Deloitte Accounting Research Tool, which is a searchable on-line accounting database.
Pre-Approval of Audit and Non-Audit Services
Th e Audit Committee has determined that the provision of non-
audit services by Deloitte is compatible with maintaining Deloitte’s
independence. In accordance with its charter, the Audit Committee
approves in advance all audit and non-audit services to be provided
by Deloitte. In other cases, the Chairman of the Audit Committee has
the delegated authority from the Committee to pre-approve certain
additional services, and such pre-approvals are communicated to the
full Committee at its next meeting. During fi scal years 2012 and 2011,
100% of the services were pre-approved by the Audit Committee in
accordance with this policy.
Vote Required
Th e affi rmative vote of a majority of the votes cast will be required to ratify
the selection of Deloitte & Touche LLP as our independent registered
public accounting fi rm for the fi scal year ending September 28, 2013.
Th e Audit Committee and the Board recommends
that Stockholders vote “FOR” the ratifi cation of
the appointment of Deloitte & Touche LLP as our
Independent Registered Public Accounting Firm
for the fi scal year ending September 28, 2013.
COHERENT, INC. - 2012 Proxy Statement
13
PROPOSAL THREE
ADVISORY VOTE
TO APPROVE EXECUTIVE
COMPENSATION
At our Annual Meeting in March 2011, our stockholders indicated
that they would like to have an annual advisory vote on executive
compensation. Accordingly, our Board of Directors proposes
that stockholders provide advisory (non-binding) approval of the
compensation of our named executive offi cers, as disclosed pursuant to the
compensation disclosure rules of the SEC, including the Compensation
Discussion and Analysis, the Fiscal 2012 Summary Compensation
Table and related tables and disclosure.
As described in our Compensation Discussion and Analysis, we have
adopted an executive compensation philosophy designed to provide
alignment between executive pay and performance and to focus
executives on making decisions that enhance our stockholder value in
both the short and long term. Executives are compensated in a manner
consistent with Coherent’s strategy, competitive practices, stockholder
interest alignment, and evolving compensation governance standards.
Th e committee positions the midpoint of our target compensation ranges
near the 50th percentile of our peers, with actual compensation falling
above or below depending upon the Company’s fi nancial performance.
Vote Required
Under our bylaws the affi rmative vote of the holders of a majority of
the votes cast is required to approve the compensation of our named
executive offi cers disclosed in this proxy statement. Th e vote is an
advisory vote, and therefore not binding. Our Board of Directors
values the opinions of our stockholders and to the extent there is any
signifi cant vote against the named executive offi cer compensation as
disclosed in this proxy statement, we will consider our stockholders’
concerns and the Compensation and H.R. Committee will evaluate
whether any actions are necessary to address those concerns.
Recommendation
Th e Board of Directors unanimously recommends that Stockholders vote “FOR” the approval of our named
Executive Offi cer Compensation disclosed in this proxy statement.
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
Security Ownership of Certain Benefi cial Owners and Management
Th e following table sets forth, as of December 31, 2012, certain
information with respect to the benefi cial ownership of common
stock by (i) any person (including any “group” as that term is used in
Section 13(d)(3) of the Exchange Act known by us to be the benefi cial
owner of more than 5% of our voting securities, (ii) each director and
each nominee for director, (iii) each of the executive offi cers named in the
Summary Compensation Table appearing herein, and (iv) all executive
offi cers and directors as a group, based on information available to the
Company as of fi ling this proxy statement. We do not know of any
arrangements, including any pledge by any person of our securities,
the operation of which may at a subsequent date result in a change of
control. Unless otherwise indicated, the address of each stockholder
in the table below is c/o Coherent, Inc., 5100 Patrick Henry Drive,
Santa Clara, California 95054.
14
COHERENT, INC. - 2012 Proxy Statement
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Number
of Shares
Percent of
Total(1)
2,420,217
10.07%
1,655,562
6.89%
1,393,750
5.80%
1,353,095
5.63%
1,276,122
359,303
5.31%
1.48%
65,694
65,248
15,757
14,529
11,500
24,000
39,000
14,000
6,700
5,900
*
*
*
*
*
*
*
*
*
*
Name and Address
Eagle Asset Management, Inc.(2)
880 Carillon Parkway
St. Petersburg, FL 33716
Wellington Management Co. LLP(2)
280 Congress Street
Boston, MA 02210
Royce & Associates LLC(2)
745 Fifth Ave.
New York, NY 10151
Dimensional Fund Advisors(2)
1299 Ocean Ave.,
11th Floor Santa Monica,
CA 90401
Vanguard Group Inc.(2)
P.O. Box 2600
Valley Forge, PA 19482.
John R. Ambroseo(3)
Helene Simonet(4)
Paul Sechrist(5)
Bret DiMarco(6)
Mark S. Sobey(7)
Jay T. Flatley(8)
Susan M. James(9)
L. William Krause(10)
Garry W. Rogerson(11)
Lawrence Tomlinson(12)
Sandeep Vij(13)
All directors and executive offi cers as a group
(11 persons)(14)
* Represents less than 1%.
(1) Based upon 24,041,471 shares of Coherent common stock outstanding as of December 31, 2012. Beneficial ownership is determined in accordance with the rules of the
SEC and generally includes voting or investment power with respect to the securities. In computing the number of shares beneficially owned by a person and the percentage
ownership of that person, each share of Coherent common stock subject to options held by that person that are currently exercisable or will be exercisable within 60 days of
December 31, 2012 and all RSUs which will vest within 60 days of December 31, 2012, are deemed outstanding. In addition, such shares, are not deemed outstanding for
the purpose of computing the percentage ownership of any other person.
621,631
2.55%
(2) Based on the institutional holding report provided by NASDAQ, which reflects the most recent Schedule 13D, 13F or 13G (or amendments thereto) filed by such person
with the SEC, or a Schedule 13D, 13F or 13G filing made after our receipt of this report.
(3) Includes 222,053 shares issuable upon exercise of options held by Mr. Ambroseo which were exercisable or would become exercisable within 60 days of December 31, 2012.
(4) Includes 27,651 shares issuable upon exercise of options held by Ms. Simonet which were exercisable or would become exercisable within 60 days of December 31, 2012.
(5) Includes 44,500 shares issuable upon exercise of options held by Mr. Sechrist which were exercisable or would become exercisable within 60 days of December 31, 2012.
(6) Includes 7,000 shares issuable upon exercise of options held by Mr. DiMarco which were exercisable within 60 days of December 31, 2012.
(7) Includes 8,000 shares issuable upon exercise of options held by Mr. Sobey which were exercisable within 60 days of December 31, 2012.
(8) Includes 8,000 shares issuable upon exercise of options held by Mr. Flatley which were exercisable and 3,500 shares issuable upon vesting of RSUs within 60 days of
December 31, 2012.
(9) Includes 18,000 shares issuable upon exercise of options held by Ms. James which were exercisable and 3,500 shares issuable upon vesting of RSUs within 60 days of
December 31, 2012.
(10) Includes 30,000 shares issuable upon exercise of options held by Mr. Krause which were exercisable and 3,500 shares issuable upon vesting of RSUs within 60 days of
December 31, 2012.
(11) Includes 3,500 shares issuable upon vesting of RSUs within 60 days of December 31, 2012 held by Mr. Rogerson.
(12) Includes 3,500 shares issuable upon vesting of RSUs within 60 days of December 31, 2012 held by Mr. Tomlinson.
(13) Includes 3,500 shares issuable upon vesting of RSUs within 60 days of December 31, 2012 held by Mr. Vij.
(14) Includes an aggregate of 365,204 options and 21,000 shares issuable upon vesting of RSU’s which were exercisable or would become exercisable or vested, as the case may
be, within 60 days of December 31, 2012.
COHERENT, INC. - 2012 Proxy Statement
15
OUR EXECUTIVE OFFICERS
Section 16(a) Benefi cial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange
Act”) requires our offi cers and directors, and persons who own more
than ten percent of a registered class of our equity securities to fi le
reports of ownership and changes in ownership with the SEC. Such
offi cers, directors and ten-percent stockholders are also required by SEC
rules to furnish us with copies of all forms that they fi le pursuant to
Section 16(a). Based solely on our review of the copies of such forms
received by us, and on written representations from certain reporting
persons that no other reports were required for such persons, we believe
that, during fi scal 2012, our offi cers, directors and, to our knowledge,
greater than ten percent stockholders complied with all applicable
Section 16(a) fi ling requirements other than the Form 4 fi lings for our
independent director annual grants (Messrs. Flatley, Krause, Rogerson,
Tomlinson and Vij and Ms. James) for our February 2012 annual meeting
and one sale transaction for Ms. James in February 2012. Th e delayed
reporting was caused by administrative error and promptly corrected.
OUR EXECUTIVE OFFICERS
Th e name, age, position and a brief account of the business experience of our chief executive offi cer and each of our other executive offi cers as
of December 31, 2012 are set forth below:
Name
John R. Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
Age
51
60
52
53
44
Offi ce Held
President and Chief Executive Offi cer
Executive Vice President and Chief Financial Offi cer
Executive Vice President and General Manager, Specialty Laser Systems
Executive Vice President Worldwide Sales, Service and Marketing
Executive Vice President, General Counsel and Corporate Secretary
Please see “Nominees” above for Mr. Ambroseo’s biographical
information.
Helene Simonet. Ms. Simonet has served as our Executive Vice President
and Chief Financial Offi cer since April 2002. Ms. Simonet served as
Vice President of Finance of our former Medical Group and Vice
President of Finance, Photonics Division from December 1999 to
April 2002. Prior to joining Coherent, she spent over twenty years
in senior fi nance positions at Raychem Corporation’s Division and
Corporate organizations, including Vice President of Finance of the
Raynet Corporation. Ms. Simonet has both Master’s and Bachelor
degrees from the University of Leuven, Belgium.
Mark Sobey. Mr. Sobey has served as our Executive Vice President and
General Manager of Specialty Laser Systems (SLS) since April 2010.
Mr. Sobey served as Senior Vice President and General Manager for
the SLS Business Group, which primarily serves the Microelectronics
and Research markets from July 2007 until April 2010. Prior to
Coherent, Mr. Sobey has spent over 20 years in the Laser and Fiber
Optics Telecommunications industries, including roles as Senior Vice
President Product Management at Cymer from January 2006 through
June 2007 and previously as Senior Vice President Global Sales at JDS
Uniphase through October 2005. He received his PhD in Engineering
and BSc in Physics, both from the University of Strathclyde in Scotland.
Paul Sechrist. Mr. Sechrist has served as our Executive Vice President,
Worldwide Sales and Service in March 2011. He has over 28 years
of experience with Coherent, including as Senior Vice President and
General Manager of Commercial Lasers and Components Business
Group from October 2008 to March 2011, Vice President and General
Manager of Specialty Laser Systems Business Group, Santa Clara from
March 2008 to October 2008, and Vice President for Components
from April 2005 to October 2008. Prior to this, Mr. Sechrist also held
roles in Sales Management, Sales, Applications and Manufacturing.
Mr. Sechrist received an AA degree from San Jose City College, with
Physics studies at California State University, Hayward.
Bret DiMarco. Mr. DiMarco has served as our Executive Vice President
and General Counsel since June 2006 and our Corporate Secretary since
February 2007. From February 2003 until May 2006, Mr. DiMarco was
a member and from October 1995 until January 2003 was an associate
at Wilson Sonsini Goodrich & Rosati, P.C., a law fi rm. Mr. DiMarco
received a Bachelor degree from the University of California at Irvine
and a Juris Doctorate degree from the Law Center at the University
of Southern California. He is also an adjunct professor of law at the
University of California Hastings College of the Law, teaching corporate
law and mergers and acquisitions.
16
COHERENT, INC. - 2012 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS
Compensation Discussion and Analysis
Introduction
Set forth below are tables refl ecting several performance metrics from
the last three fi scal years.
In this section, we describe the material components of our executive
compensation program for our “Named Executive Offi cers” or “NEOs”:
Our revenue grew 33% from fi scal 2010 to fi scal 2011 and decreased
4% from fi scal 2011 to fi scal 2012 (dollars in millions):
Name
John R. Ambroseo
Helene Simonet
Mark S. Sobey
Paul Sechrist
Bret DiMarco
Title
President and Chief Executive Offi cer
Executive Vice President and Chief Financial Offi cer
Executive Vice President and General Manager,
Specialty Laser Systems
Executive Vice President, Worldwide Sales
and Service
Executive Vice President, General Counsel
and Corporate Secretary
We also provide an overview of our executive compensation philosophy,
principal compensation policies and practices by which the Compensation
and H.R. Committee arrives at its decisions regarding NEO compensation.
$900
$800
$700
$600
$500
$400
$300
$200
$100
$0
$803
$769
$605
FY2010
FY2011
FY2012
Stockholder Feedback
Our pro forma EBITDA% increased from 17% to 19.5% from fi scal
2010 to fi scal 2011 and decreased to 18.4% in fi scal 2012:
Th e committee carefully considers feedback from our stockholders
regarding our executive compensation program, including the results
of our annual advisory vote on executive compensation, which (as seen
below) has been strongly supported by our stockholders. Stockholders
are invited to express their views to the committee as described in this
proxy under the heading “Stockholder Communication with the Board of
Directors.” We strongly urge our stockholders to read this Compensation
Discussion and Analysis in conjunction with the advisory vote under
Proposal Th ree.
20
15
10
5
0
17.0%
19.5%
18.4%
FY2010
FY2011
FY2012
Executive Summary
Our Business
Founded in 1966, we are a world leader in providing photonics based
solutions to the commercial and scientifi c research markets. Our common
stock is listed on the NASDAQ Global Select Market and is part of the
Russell 2000 and Standard & Poor’s SmallCap 600 Index. For more
information about our business, please read “Business” and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”
sections in our Annual Report on Form 10-K fi led with the Securities
and Exchange Commission on November 28, 2012.
Selected Business Highlights
Fiscal 2012 saw Coherent maintain a strong fi nancial performance.
However, we did not match the prior year’s level of growth, especially when
measured against the multiple fi nancial performance records seen in fi scal
2011, including annual revenue, pro forma EBITDA percentage and pro
forma earnings per share. Our continued strong fi nancial performance
allowed us to continue to invest in the development of new technologies
and to prudently return money to our stockholders through our stock
repurchase programs. Th ese results did not fully meet the performance
requirements under our executive compensation programs and you will
see in the coming pages that our executive variable cash compensation
program had a signifi cantly lower payout than targeted.
* Pro forma EBITDA% is defined as operating income adjusted for deprecia-
tion, amortization, stock compensation expenses, major restructuring costs
and certain other non-operating income and expense items.
Our non-GAAP earnings per share grew 80% from fi scal 2010 to fi scal
2011 and declined 11% in fi scal 2012:
$4.0
$3.5
$3.0
$2.5
$2.0
$1.5
$1.0
$0.5
$0.0
$3.46
$3.09
$1.92
FY2010
FY2011
FY2012
* Non-GAAP earnings per share is defined as earnings per share excluding
certain recurring and non-recurring items.
For a reconciliation table of earnings per share on a GAAP basis and
EBITDA % to net income as a percentage of revenue , please refer to
the “Reconciliation Table” at the end of this section.
COHERENT, INC. - 2012 Proxy Statement
17
COMPENSATION DISCUSSION AND ANALYSIS
Compensation Overview
Compensation Philosophy. Our approach to compensating our executives
is to tie total compensation to stockholder value by our results of
operations and our stock price. Th is approach provides strong alignment
between executive pay and performance and focuses executives on
making decisions that enhance our stockholder value in both the short
and long-term. We design our executive compensation program to
achieve the following goals:
• Pay for Performance, with both short and long-term
measurements—A signifi cant portion of the annual compensation
of our executives is designed to vary with annual business performance
and a comparative achievement to stockholder return by a comparison
to the Russell 2000 Index.
• Tie compensation to performance of the core business—Our
fi scal 2012 annual cash bonus plan was dependent upon Coherent’s
achievement against two thresholds: adjusted EBITDA dollars and
net sales. Th e committee felt these were the most eff ective metrics
for tying management’s compensation directly to Coherent’s core
operating results.
• Retain and Hire Talented Executives—Executives should have
base salaries and employee benefi ts that are market competitive and
the committee positions the midpoint of our target compensation
ranges near the 50th percentile of our peer group (as noted below),
with actual compensation falling above or below depending upon
Coherent’s fi nancial performance.
• Align compensation with stockholder interests—Our stockholders
benefi t from continued strong operating performance by the Company
and the committee believes that having a signifi cant portion of
compensation tied to equity with both time and performance-based
vesting requirements directly aligns management to stockholder
returns. Grants of performance-based RSUs in fi scal 2012 have a
single vesting date three years from grant solely dependent upon the
performance of Coherent’s common stock price measured against the
Russell 2000 Index. For each 1% Coherent’s common stock exceeds the
performance of the Russell 2000 Index for the trailing ninety trading
days from the vesting measurement date against the comparable period
from the date of grant, the grant recipient will get a 2% increase in
the number of shares above target (up to a maximum cap), and for
each 1% below the Russell 2000 Index’s performance, a 2% decrease
in the number of shares (down to zero). Th e maximum achievable
amounts under the performance-based RSUs make up the largest
potential portion of the equity grants for our chief executive offi cer.
Elements of Executive Compensation. During fi scal 2012, the compensation
of our NEOs primarily consisted of (A) base salary, (B) participation
in our annual variable cash incentive plan (referred to below as our
“cash bonus plan” or “VCP”), and (C) long-term equity incentive
awards divided between time-based RSUs and performance-based
RSUs. For fi scal 2012, on average, approximately 80% of our NEO’s
target compensation and approximately 88% of our CEO’s target
compensation was delivered in the form of variable annual cash bonus
plan and long-term equity incentives.
18
COHERENT, INC. - 2012 Proxy Statement
As a demonstration of how closely executive compensation is tied to
company performance, the cash pay mix for our chief executive offi cer
during fi scal 2012 at target, maximum and actual can be illustrated
as follows (*) (dollars in thousands):
$2,000
$1,800
$1,600
$1,400
$1,200
$1,000
$800
$600
$400
$200
$
Target
Maximum
Actual
Fixed
Variable
* Note: This chart reflects base salary and cash bonus for Fiscal Year 2012.
This chart does not include other benefits.
Compensation Governance. “Pay for performance” has been and remains
at the core of Coherent’s executive compensation. We accomplish this
primarily by (i) having a majority of the NEOs’ potential compensation
being “at risk” through a combination of a fi scal year variable cash bonus
program tied to achievement of operating metrics and (ii) equity grant
vesting tied to achievement of a performance metric. In addition to
this core philosophy, the committee monitors and considers evolving
governance approaches and standards in executive compensation. As
more fully discussed below, recent examples of how this philosophy is
applied and changes made pursuant to compensation practices, include:
• As a result of the performance criteria of our annual cash bonus plan,
in fi scal 2012 the payouts to our NEOs were approximately 19.9%
as compared to target, including no payout in the second half of the
year due to a failure to meet the threshold conditions;
• We have a claw-back policy for our chief executive offi cer and chief
fi nancial offi cer in certain circumstances;
• We have minimum share ownership requirements for our chief
executive offi cer;
• Our change-of-control plan provides for payment only in “double-
trigger” circumstances—namely a change-of-control coupled with a
termination of employment; and
• Aside from our change-of-control plan, our executive offi cers do not
have employment or severance contracts.
COMPENSATION DISCUSSION AND ANALYSIS
Our stockholders recognized our corporate governance and executive
compensation structure by overwhelmingly approving our “say on
pay” advisory votes in each of the last two years:
In 2011, voting 19,684,002 shares (92%) in favor compared to
only 591,602 shares (3%) against, with 1,204,275 shares (5%)
abstaining;
In 2012, voting 20,764,535 shares (99%) in favor compared to only
187,670 shares (1%) against, with 24,577 shares (0*%) abstaining.
* Percentages are of votes cast and do not include “broker non-votes”
Role of Management
Th e committee regularly meets with Mr. Ambroseo, our chief executive
offi cer, to obtain recommendations with respect to the compensation
programs, practices and packages for our Named Executive Offi cers
other than Mr. Ambroseo. Additionally, Ms. Simonet, our executive
vice president and chief fi nancial offi cer, Mr. DiMarco, our executive
vice president and general counsel and members of our human resources
department are regularly invited to meetings of the committee or otherwise
asked to assist the committee.
Th e assistance of these individuals include providing fi nancial information
and analysis for the committee and its compensation consultant, taking
minutes of the meeting or providing legal advice, developing compensation
proposals for consideration, and providing insights regarding our employees
(executive and otherwise) and the business context for the committee’s
decisions. Named Executive Offi cers will attend portions of committee
meetings when requested, but leave the meetings when matters potentially
aff ecting them are discussed.
Th e committee makes decisions regarding Mr. Ambroseo’s compensation
without him present.
Role of the Committee’s Compensation Consultant
Th e committee is committed to utilizing the services of an independent
compensation consultant and in fi scal 2012, engaged Compensia as
its independent compensation consultant. Compensia assisted the
committee by:
• Reviewing and analyzing our executive compensation program; and
• Providing market data and ranges for fi scal 2012 compensation.
Additionally, in fi scal 2012, Compensia was retained by the Governance
and Nominating Committee to review, analyze and make recommendations
regarding compensation for service on the Board of Directors and its
committees.
Th e independent compensation consultant serves at the discretion of the
committee and is not permitted to do other work for Coherent unless
expressly authorized by the committee. Since retention, Compensia
has not performed any work for Coherent other than its work with the
committee, the Board of Directors or other committees of the Board of
Directors. Th e committee is focused on maintaining the independence of
its compensation consultant and, accordingly, does not anticipate having
its consultant perform any other work for the Company in addition to
its direct work for the committee or the Board.
We also participate in and maintain a subscription to the Radford
Global Technology Survey. Th is survey provides benchmark data and
compensation practices reports to assist us with regards to employee
compensation generally.
Pay Positioning Strategy and Benchmarking of Compensation
We have striven to position the midpoint of our target compensation
ranges near the 50th percentile of our peers, resulting in targeted total
compensation that is competitive within our labor market for performance
that meets the objectives established by the committee. A Named Executive
Offi cer’s actual salary, cash incentive compensation opportunity and equity
compensation may fall below or above the target position based on the
individual’s experience, seniority, skills, knowledge, performance and
contributions. Th ese factors are weighed individually by the committee
in its judgment, and no single factor takes precedence over others nor
is any formula used in making these decisions.
Th e chief executive offi cer’s review of the performance of the other
Named Executive Offi cers is considered by the committee in making
individual pay decisions. With respect to the chief executive offi cer,
the committee additionally considered the performance of Coherent
as a whole and the views of the Board of Directors regarding the chief
executive offi cer’s performance. Actual realized pay is higher or lower
than the targeted amounts for each individual based primarily on the
Company’s performance.
In analyzing our executive compensation program relative to this target
market positioning, the committee reviews information provided by its
independent compensation consultant, which includes an analysis of
data from peer companies’ proxy fi lings with respect to similarly situated
individuals at the peer companies and the Radford Global Technology
Survey, which is a broad cross-section of technology companies of similar
size to Coherent.
For pay decisions made in fi scal 2012, after consulting with our independent compensation consultant, the committee determined that the
following companies comprise the peer group for fi scal 2012:
Cabet Microelectronics
Infi nera
Cymer Inc.
Emulex
Entegris
FEI
Finisar
FLIR Systems
Harmonic
Integrated Device Tech.
JDS Uniphase
MKS Instruments
National Instruments
Newport
Novellus Systems
Opnext
Polycom
Plantronics
PMC-Sierra
Trimble Navigation
COHERENT, INC. - 2012 Proxy Statement
19
COMPENSATION DISCUSSION AND ANALYSIS
Th e committee made the following changes to the group of peer
companies from fi scal 2011 primarily as a result of fi ltering such
companies through the selection criteria noted below:
Removed: Altera, Linear Technology, Opnext, Varian Semiconductor
and Veeco Instruments.
Added: Cabot Microelectronics, Emulex, Entegris, Harmonic, MKS
Instruments, National Instruments, Novellus Systems and Polycom.
Several factors are considered in selecting the peer group, the most
important of which are:
Primary Criteria
• Industry (primarily companies in the Electronic Equipment and
Semiconductor sub-industry classifi cations defi ned by the Global
Industry Classifi cation Standard (GICS) system);
• Revenue level (primarily companies with annual revenues between
0.5x-2.0x that of Coherent);
Secondary Criteria
• Annual revenue growth of greater than 5%;
• Market capitalization between 0.5 and 2.0x of Coherent; and
• Market capitalization as a multiple of revenues of greater than 1.5x.
Th e committee annually reviews the composition of the peer group to
ensure it is the most relevant set of companies to use for comparison
purposes.
Components of Our Executive Compensation Program
Th e principal components of our executive offi cer compensation and
employment arrangements during fi scal 2012 included:
• Base salary;
• Variable cash bonus program;
• Equity awards; and
• Other benefi ts.
Th ese components were selected because the committee believes that a
combination of salary, incentive pay and benefi ts is necessary to help
us attract and retain the executive talent on which Coherent’s success
depends. Th e following table shows at target the components of total
direct compensation for our named executive offi cers as a group for
fi scal 2012.
NAMED EXECUTIVE OFFICERS
FY 2012 TOTAL DIRECT COMPENSATION AT TARGET
20%
14%
66%
Long-Term Equity Compensation
Annual Incentive
Base Salary
Base Salary
Base salary is the foundation to providing an appropriate total direct
compensation package. We use base salary to fairly and competitively
compensate our executives for the jobs we ask them to perform. Th is
is the most stable component of our executive compensation program,
as this amount is not at risk. Th e committee reviewed market data
information provided by Compensia with respect to similarly situated
individuals to assist it in determining the base salary for each Named
Executive Offi cer, depending upon the particular executive’s experience
and historical performance. Th ere were no increases to salary in fi scal
2012 for any of our Named Executive Offi cers.
Variable Cash Incentive Compensation
A substantial portion of each individual’s potential short-term
compensation is in the form of variable incentive pay tied to committee-
established goals. In fi scal 2012, Coherent maintained one incentive
cash program under which executive offi cers were eligible to receive
bonuses, the 2012 Variable Compensation Plan (“2012 VCP”).
20
COHERENT, INC. - 2012 Proxy Statement
2012 VCP
Th e 2012 VCP was designed as an “at risk” bonus compensation program
to promote a focus on the growth and profi tability of Coherent. It provided
incentive compensation opportunity in line with targeted market rates to
our Named Executive Offi cers. Under the 2012 VCP, participants were
eligible to receive bi-annual bonuses (with measurement periods for the fi rst
half and the second half of the 2012 fi scal year). In setting the performance
goals, the committee assessed the anticipated diffi culty and importance to
the success of Coherent of achieving the performance goals.
COMPENSATION DISCUSSION AND ANALYSIS
Th e actual awards (if any) payable for each semi-annual period varied
depending on the extent to which actual performance met, exceeded
or fell short of the goals approved by the committee, which are set
at the beginning of the fi scal year. Th e 2012 VCP goals were tied to
Coherent achieving varying levels of adjusted EBITDA dollars (“adjusted
EBITDA $”), with a requirement of achieving two thresholds for
each payment period: (1) at least 80% of the Board-approved budgeted
revenue and (2) a minimum of a certain adjusted EBITDA $, without
giving eff ect to any 2012 VCP payments. Adjusted EBITDA was defi ned
as earnings before interest, taxes, depreciation, amortization and certain
other non-operating income and expense items and other items, such as
the fi scal impact of stock option expensing under Financial Accounting
Standards Board, or FASB, Accounting Standards Codifi cation, or
ASC 718, 2012 VCP earned, impairment or restructuring charges,
and the impact of acquisitions made during the fi scal year.
Each measurement period had the same range of between zero and
200%, with target at 100% of the executive’s participation rate.
Consistent with its analysis of whether compensation programs create
risk, the committee reduced the maximum percentage which could
be earned under the annual cash bonus program with the 2012 fi scal
year from 300% to 200%.
Fiscal 2012 Variable Compensation Plan Scale for Named Executive Offi cers
Adjusted EBITDA$ Achievement for First Half FY 2012 w as $72.1 M,
with a C orresponding P ayout of A pproximately 39.9% of T arget
First Half of Fiscal Year 2012
First Half FY 2012 VCP Scale
Adjusted EBITDA $ (in millions)
$65.6 (threshold)
$73.8
$82.0
$88.2
$94.4 (and above)
Revenue Th reshold $325.3 million
Payout
0%
50%
100%
150%
200%
Named
Executive
Offi cer
John Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
Target
Percentage
of Salary
100%
70%
60%
50%
50%
Payout
Percentage
Actual
Range of
Award
($)(1)
Salary
0-200% 124,629
0-140% 56,532
0-120% 43,071
0-100% 32,403
0-100% 33,400
Actual
Award
Percentage
of Salary(2)
39.9%
39.9%
39.9%
39.9%
39.9%
Adjusted EBITDA$ Achievement for Second Half FY 2012 w as $70.6M,
R esulting in N o P ayout
Second Half of Fiscal Year 2012
Second Half FY 2012 VCP Scale
Adjusted EBITDA $ (in millions)
$83.0 (threshold)
$93.4
$103.7
$109.9
$116.1
Revenue Th reshold $362.8 million
Payout
0%
50%
100%
150%
200%
Th e tables below describe for each Named Executive Offi cer under
the 2012 Variable Compensation Plan (i) the target percentage of base
salary, (ii) the potential award range as a percentage of base salary, and
(iii) the actual award earned for the measurement period in fi scal 2012.
Equity Awards
Target
Percentage
of Salary
Actual
Award
Percentage
of Salary(2)
Named
Executive
Offi cer
John Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
(1) Reflects amounts earned during the applicable half of fiscal 2012.
(2) This reflects the aggregate bonuses earned by the Named Executive Officers
Actual
Award
($)(1)
0
0
0
0
0
Payout
Percentage
Range of
Salary
0-200%
0-140%
0-120%
0-100%
0-100%
100%
70%
60%
50%
50%
0%
0%
0%
0%
0%
for the applicable half of fiscal 2012 under the 2012 VCP.
We believe that equity awards provide a strong alignment between the
interests of our executives and our stockholders. We seek to provide equity
award opportunities that are consistent with our targeted market median,
with the potential for increase for exceptional fi nancial performance,
consistent with the reasonable management of overall equity compensation
expense and stockholder dilution. Finally, we believe that long-term
equity awards are an essential tool in promoting executive retention.
For fi scal 2012, our long-term incentive program included the grant
of time-based RSUs and performance-based RSUs. Th ese components
provide a reward for past corporate and individual performance and as
an incentive for future performance.
When making its compensation decisions, the committee reviews a
compensation overview prepared by its independent compensation
consultant which refl ects potential realizable value under current short and
long-term compensation arrangements for each Named Executive Offi cer.
Fiscal 2012 Equity Grants
For fi scal 2012, the committee determined to base the equity program
on a combination of time-based and performance-based RSUs. In
particular, the committee determined to measure achievement for the
performance grants by the relative performance of Coherent’s total
COHERENT, INC. - 2012 Proxy Statement
21
COMPENSATION DISCUSSION AND ANALYSIS
shareholder return against that of the Russell 2000 Index. Th e committee
believed that using the Russell 2000 Index (in which Coherent is a
member) as a proxy of total stockholder return directly aligns executive
compensation with stockholder interest. Th e committee determined
that both the performance-based and time-based RSU grants provide
a further retention tool in that the time-based grants vest over two
years with one-year annual cliff vesting and, for the performance-based
grants, a single measurement period three years from the date of grant.
In fi scal 2012 the committee transitioned to a performance-based
program whereby there is only a single measurement period at the end
of three years rather than individual one-year tranches. Accordingly,
it set target achievement for all Named Executive Offi cers (other
than the chief executive offi cer) to receive an equity distribution of
approximately 2/3rds time-based and 1/3rd performance-based equity
award payouts at target, with a 50/50 distribution in the event of
maximum achievement.
For our chief executive offi cer, our goal is that at the end of three
years, our chief executive offi cer will receive greater than half of his
total equity awards in performance-based equity awards at target
achievement. Accordingly, for our chief executive offi cer, at target,
approximately 60% of his equity awards are performance-based and at
maximum achievement that percentage increases to approximately 75%.
In the event of a change of control of the Company, the performance-
based grants will be measured, with respect to performance periods
not yet completed, by the relative total shareholder return of Coherent
against the Russell 2000 Index through the date of the change of control
and such performance-based shares would then convert to time-based
vesting with a single vesting date at the three year anniversary of the grant.
Th e following chart shows the aggregate composition of equity grants
for fi scal 2012 to our chief executive offi cer assuming the maximum
achievement under the performance-based grants:
FY 2012 CEO EQUITY GRANT COMPONENTS
AT MAXIMUM ACHIEVEMENT
25%
Th e following tables refl ects the equity grants to the Named Executive
Offi cers during the fi rst quarter of fi scal 2012:
Named Executive Offi cer
John Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
Named Executive Offi cer
John Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
Time-Based
RSU Grants
24,000
10,050
9,380
8,040
6,700
Performance-Based
RSU Grants Range
(issuance dependent
upon achievement)
0 – 72,000
0 – 9,900
0 – 9,240
0 – 7,920
0 – 6,600
Performance-
Based RSU Grants
at Target
36,000
4,950
4,620
3,960
3,300
Equity Award Practices
Equity grants to our employees are driven by our annual review
process. Grant guidelines are based on competitive market practices.
Typically, an eligible employee is granted equity at the fi rst committee
meeting after beginning employment and may be eligible for periodic
grants thereafter. Eligibility for and the size of grants are infl uenced by
the then-current guidelines for non-executive offi cer grants and the
individual’s performance or particular requirements at the time of hire.
In fi scal 2012, the committee granted an aggregate of 397,861 shares
subject to time-based and performance-based restricted stock units
(at maximum), representing approximately 1.68% of Coherent’s
outstanding common stock as of September 30, 2012 (excluding
automatic and initial grants to directors). Th e committee did not grant
any stock options during fi scal 2012 to employees. With the assistance
of Compensia, the committee has reviewed this burn rate relative to
peer practices and guidance from Institutional Shareholder Services
(ISS) and found that the total dilution was consistent with the median
of peer practices and complied with ISS guidelines.
75%
During fi scal 2012 equity grants were only made at meetings of the
committee.
Chief Executive Offi cer Minimum Stock
Ownership Guidelines
During fi scal 2012, the committee adopted mandatory stock ownership
guidelines for our chief executive offi cer. Our guidelines require that the
chief executive offi cer hold shares with a value of at least three times base
salary, without counting vested or unvested option grants or unvested
grants of RSUs. Compliance is measured as of the date of each year’s
annual meeting based on the stock price of the shares as of the date
of their acquisition. In the event that our chief executive offi cer does
not satisfy the minimum requirements, then 25% of the net after-tax
shares (e.g. exercised options/shares received on the vesting of RSUs)
must be held until the guidelines are met. As of December 31, 2012,
Mr. Ambroseo held stock worth approximately eleven times his base
salary and, accordingly, signifi cantly exceeded the minimum stock
ownership guideline.
Performance Based RSUs
Time Based RSUs
22
COHERENT, INC. - 2012 Proxy Statement
Other Benefi ts
Retirement Plans
Executive offi cers are eligible to participate in our 401(k) Retirement
Plan on the same terms as all other U.S. employees, including a 4%
Company matching contribution. Our 401(k) Retirement Plan is a
tax-qualifi ed plan and therefore is subject to certain Internal Revenue
Code limitations on the dollar amounts of deferrals and Company
contributions that can be made to plan accounts. Th ese limitations
apply to our more highly-compensated employees (including the
Named Executive Offi cers).
We maintain a Deferred Compensation Plan for certain employees and
members of the Board. Th e Deferred Compensation Plan permits eligible
participants to defer receipt of compensation pursuant to the terms
of the plan. Th e Deferred Compensation Plan permits participants to
contribute, on a pre-tax basis, up to 75% of their base salary earnings,
up to 100% of their bonus pay and commissions and up to 100%
of directors’ annual retainer earned in the upcoming plan year. Plan
participants may invest deferrals in a variety of diff erent deemed
investment options. To preserve the tax-deferred status of deferred
compensation plans, the IRS requires that the available investment
alternatives be “deemed investments.” Participants do not have an
ownership interest in the funds they select; the funds are only used
to measure the gains or losses that are attributed to the participant’s
deferral account over time.
Th e committee considers the Deferred Compensation Plan to be a
reasonable and appropriate program because it promotes executive offi cer
retention by off ering a deferred compensation plan that is comparable
to and competitive with what is off ered by our peer group of companies.
Employee Stock Purchase Plan
Our stockholders have approved an employee stock purchase plan
whereby employees can purchase shares for a discount, subject to
various participation limitations. As employees, our Named Executive
Offi cers are eligible to participate in this plan.
Severance and Change of Control Arrangements
We have adopted our Change of Control Severance Plan (the “Change of
Control Plan”) which provides certain benefi ts in the event of a change
of control of Coherent for certain executives, including each of our
Named Executive Offi cers. Benefi ts are provided if there is a change
in ownership of Coherent, a change in eff ective control of Coherent,
or a change in ownership of a substantial portion of Coherent’s assets
COMPENSATION DISCUSSION AND ANALYSIS
(in each case as construed under Section 409A of the Internal Revenue
Code and the regulations thereunder)(a “change of control”) and
within two years thereafter (or within two months prior thereto) the
participant’s employment is terminated without cause or is voluntarily
terminated following a constructive termination. Th e committee believes
the Change of Control Plan serves as an important retention tool in
the event of a pending change of control transaction.
Th e Change of Control Plan was amended and restated in the fi rst
quarter of fi scal 2013. Among the amendments made to the plan in
fi scal 2013 were: eliminating outplacement assistance and adding a
time-limited protection against terminations made in anticipation of a
change of control as well as changes to the defi nition of “Good Reason.”
Th e committee reviews the provisions of the Change of Control Plan at
a minimum every two years at or immediately prior to the termination
of the plan. Th e committee believes that reviewing the Change of
Control Plan every two years allows for the right balance in providing
certainty for the participants while providing the committee with the
opportunity to revise the plan consistent with corporate governance
best practices, evolving peer group practices and regulatory changes.
Th e committee does not consider the potential payments and benefi ts
under these arrangements when making compensation decisions for
our NEOs. Th ese arrangements serve specifi c purposes unrelated to the
determination of the NEOs’ total direct compensation for a specifi c year.
Executive Perquisites and Other Personal Benefi ts
In the fi rst quarter of fi scal 2011, the committee determined, upon
recommendation from management and in consultation with Compensia,
to eliminate and phase-out executive perquisites eff ective January 1,
2011. Th e use of leased vehicles by executives was terminated for
Ms. Simonet and Mr. DiMarco in October 2011 and in April 2012
for Mr. Ambroseo.
Automobile Benefi t. During fi scal 2012 prior to the termination of
vehicle leases, Mr. Ambroseo, Ms. Simonet and Mr. DiMarco utilized
vehicles leased by Coherent. Th e leased automobiles were administered
by a third party fi nancing agency and Coherent paid the monthly lease
amount. Executive offi cers were either reimbursed for or provided
gas, oil, maintenance and insurance for automobiles leased under this
program. Participants in the automobile program incurred annual
imputed income on the personal use of any vehicles under the program,
including fuel and miles, as determined using the Internal Revenue
Code rules.
Tax and Accounting Considerations
• Accounting for Stock-Based Compensation—We account for stock-based
compensation in accordance with the requirements of ASC 718. We
also take into consideration ASC 718 and other generally accepted
accounting principles in determining changes to policies and practices
for our stock-based compensation programs.
• Section 162(m) of the Internal Revenue Code—Th is section limits the
deductibility of compensation for our chief executive offi cer and our
other most highly compensated Named Executive Offi cers (other
than our chief fi nancial offi cer) unless the compensation is less than
$1 million during any fi scal year or is “performance-based” under
COHERENT, INC. - 2012 Proxy Statement
23
COMPENSATION DISCUSSION AND ANALYSIS
Section 162(m). Our 2001 Stock Plan and 2011 Plan are designed so
that option grants and certain performance-based full value awards
thereunder are fully tax-deductible. Cash compensation (including both
base salary and payments under our 2012 VCP) and time-based full-
value awards are not qualifi ed as “performance-based” compensation
under Section 162(m). We may from time to time pay compensation
to our executive offi cers (including under our VCP) that may not be
deductible when, for example, we believe that such compensation is
appropriate and in the best interests of the stockholders after taking
various factors into consideration, including business conditions and
the performance of such executive offi cer.
• Section 409A of the Internal Revenue Code—Section 409A imposes
additional signifi cant taxes in the event that an executive offi cer,
director or service provider received “deferred compensation” that
does not satisfy the requirements of Section 409A. We consider
Section 409A in the design and operation of any plans.
Other Compensation Policies
To further align our executive compensation program with the interests
of our stockholders, at the end of fi scal 2009, a committee of the Board
approved a recoupment policy. Th e recoupment policy provides that, in
the event that there is an accounting restatement and there is a fi nding
by the Board that such restatement was due to the gross recklessness or
intentional misconduct of the chief executive offi cer or chief fi nancial
offi cer and it caused material noncompliance with any fi nancial reporting
requirement, then Coherent shall seek disgorgement of any portion of
the bonus or other incentive or equity based compensation related to
such accounting restatement received by such individual during the
12-month period following the originally fi led fi nancial document.
Compensation Committee Interlocks and Insider Participation
During fi scal 2012, the Compensation and H.R. Committee of the Board
consisted of Messrs. Vij (Chair), Krause, Rogerson and Tomlinson. In
December 2011, Mr. Flatley replaced Mr. Rogerson on the committee.
None of the members of the committee has been or is an offi cer or
employee of Coherent. None of our executive offi cers serves on the
board of directors or compensation committee of a company that has
an executive offi cer that serves on our Board or Compensation and
H.R. Committee. No member of our Board is an executive offi cer of
a company in which one of our executive offi cers serves as a member
of the board of directors or compensation committee of that company.
Committee Independence
Each of the members of the committee qualifi es as (i) an “independent director” under the requirements of Th e NASDAQ Stock Market,
(ii) a “non-employee director” under Rule 16b-3 of the Securities Exchange Act of 1934 (the “1934 Act”), (iii) an “outside director” under
Section 162(m) of the Code and (iv) an “independent outside director” as that term is defi ned by ISS.
Compensation and H.R. Committee Report
Th e Compensation and H.R. Committee of the Board has reviewed
and discussed the Compensation Discussion and Analysis required
by Item 402(b) of Regulation S-K with management and, based on
such review and discussions, the Compensation and H.R. Committee
recommended to the Board that the Compensation Discussion and
Analysis be included in this Proxy Statement .
Respectfully submitted by the Compensation and H.R. Committee
Sandeep Vij, Chair
Jay Flatley
L. William Krause
Larry Tomlinson
24
COHERENT, INC. - 2012 Proxy Statement
RECONCILIATION TABLENONGAAP EARNINGS PER SHARE
GAAP NET INCOME PER DILUTED SHARE
Stock based compensation
One-time tax expense (benefi t)
Write-off of intangibles and inventory
Gain on Finland dissolution
Restructuring costs
Stock option investigation and litigation expense (benefi t)
NONGAAP NET INCOME PER DILUTED SHARE
RECONCILIATION TABLEPRO FORMA EBIT DA%
NET INCOME % OF REVENUE
Income tax expense (benefi t)
Interest and other income (expense), net
Depreciation and amortization
Restructuring and one time benefi ts/charges
Stock based compensation
PRO FORMA EBITDA % OF REVENUE
COMPENSATION DISCUSSION AND ANALYSIS
Year Ended
September 29, 2012 October 1, 2011 October 2, 2010
$1. 47
0. 27
—
—
—
0. 24
(0. 06
$1. 92
$3. 66
0. 36
(0. 32 )
—
(0. 24 )
—
—
$3. 46
$2. 62
0. 48
(0. 19 )
0. 18
—
—
—
$3. 09
2012
8.2%
3.6%
0.1%
3.9%
0.6%
2.1%
18.4%
Fiscal Year
2011
11.6%
3.8%
1.2%
(
)
3.6%
0.1%
1.6%
19.5%
2010
6.1%
3.5%
0.1%
4.9%
1.1%
1.4%
17.0%
COHERENT, INC. - 2012 Proxy Statement
25
SUMMARY COMPENSATION AND EQUITY TABLE S
Fiscal 2012 Summary Compensation Table
Th e table below presents information concerning the total compensation of our Named Executive Offi cers for the fi scal years ended September 29, 2012,
October 1, 2011, and October 2, 2010.
Name and Principal Position
John Ambroseo,
Chief Executive Offi cer
and President
Helene Simonet,
Executive Vice President
and Chief Financial Offi cer
Mark Sobey,
Executive Vice President
General Manager, SLS
Paul Sechrist,(10)
Executive Vice President
Worldwide Sales, Service and Marketing
Bret DiMarco,
Executive Vice President
and General Counsel
Fiscal
Year
2012(1)
2011
2010
2012(1)
2011
2010
2012(1)
2011
2010
2012(1)
2011
2012(1)
2011
2010
Stock Awards
($)(2)
3,860,280
2,452,700
981,000
891,644
660,675
366,240
832,201
616,630
313,920
713,314
570,055
Option Awards
($)(3)
N/A
N/A
600,390
N/A
N/A
224,146
N/A
N/A
192,125
N/A
N/A
Non-Equity
Incentive Plan
Compensation
($)(4)
124,629
1,628,675
870,012
56,532
738,776
388,490
43,071
562,863
255,017
32,403
423,443
All Other
Compensation
($)(5)
34 ,591 (7)
46,841(7)
277,527(6)(7)
33,532(8)
41,183(8)
46,664(6)(8)
11,852(9)
27,277(9)
22,378(9)
12,233(11)
16,357(11)
594,429
440,450
274,680
N/A
N/A
168,109
33,400
436,478
225,000
27,543(12)
33,405(12)
36,527(12)
Salary ($)
625,019
612,901
580,008
405,018
395,587
369,990
360,006
343,856
293,673
325,000
306,573
333,985
325,580
297,309
Total ($)
4,644 ,519
4,741,117
3,308,937
1,386,725
1,836,221
1,395,530
1,247,130
1,550,626
1,077,113
1,082,950
1,316,428
989,357
1,235,913
1,001,625
(1) Reflects the dollar amount of salary earned in fiscal year 2012.
(2) Amounts shown reflect the grant date fair value of awards granted in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic
718. Reflects unvested time-based and performance-based RSUs; there is no guaranty that the recipients will ultimately receive this amount, or any amount.
(3) The amounts shown reflect the grant date fair value of stock options determined pursuant to FASB ASC Topic 718. These options vest annually over a three year period. Pursuant to
FASB ASC Topic 718, the amounts shown here exclude the effect of estimated forfeitures related to service-based vesting conditions. The assumptions used in the valuation of these
awards are set forth in Note 14, “Employee Stock Option and Benefit Plans” of the Financial Statements in our annual report on Form 10-K. These amounts do not correspond to
the actual value, if any, that may ultimately be recognized by the Named Executive Officers. As seen in the table, no stock options were granted to the named executive officers in
fiscal 2011 and 2012.
(4) Reflects the dollar amounts earned under the Variable Compensation Plan (VCP) during fiscal 2011, fiscal 2010 and fiscal 2009.
(5) As previously noted, effective January 1, 2011, the Compensation and H.R. Committee announced the elimination and phasing out of executive perquisites. Fiscal 2011, therefore,
included an executive medical benefit (which was on a calendar year calculation and is no longer in effect), the calendar 2010 contribution to the Company’s non-qualified deferred
compensation plan (which will not be made for calendar 2011), and automobile benefits. Fiscal 2012 includes an automobile benefit for Messrs. Ambroseo and DiMarco and
Ms. Simonet, which was phased out for Ms. Simonet and Mr. DiMarco in October, 2011 and April, 2012 for Mr. Ambroseo. The Company, however, administered its automobile
benefits on a December-November calendar basis and, therefore, imputed almost a full year of income for Mr. Ambroseo, Ms. Simonet and Mr. DiMarco even though in fiscal 2012
the benefit phased out after one month (Simonet and DiMarco) and seven months (Ambroseo) of the fiscal year. Executives will continue to receive the regular Company-provided
401(k) employee contribution match (subject to applicable IRS rule limitations).
(6) For fiscal year 2010, Mr. Ambroseo and Ms. Simonet “All Other Compensation” includes a payment for expired stock option grants that we previously disclosed on Form 8-K filing
dated December 9, 2009. As noted in the Form 8-K, from November 1, 2006 to December 31, 2007 we imposed a company-wide blackout on the exercise of stock options because
we were not current in our financial reporting obligations due to an internal historical stock option grant practices investigation. The Compensation and H.R. Committee approved
payments to these individuals, which amounts were determined pursuant to the same formula used for non-executive officers.
(7) For fiscal 2012, includes (a) amounts contributed by us under the Company’s 401(k) plan ($9,862 ), and (b) the use of a Company-leased and maintained automobile (“Car
Allowance”) ($21,414) which as previously noted, was phased out. For fiscal 2011, includes (a) amounts contributed by us under the Company’s 401(k) plan ($9,656) and deferred
compensation plan ($10,920), (b) Car Allowance ($20,630), (c) amounts reimbursed pursuant to executive medical reimbursement ($2,634). For fiscal 2010, includes (a) amounts
contributed by us under the Company’s 401(k) plan ($8,902) and deferred compensation plan ($10,177), (b) Car Allowance ($12,436), (c) the payment described in footnote
(7) above ($237,000), (d) payment for buy-out of earned vacation ($1,785) and (e) amounts reimbursed pursuant to executive medical reimbursement ($5,228).
(8) For fiscal 2012, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,477), and (b) Car Allowance ($17,513) which as previously noted, was phased out. For
fiscal 2011, includes (a) amounts contributed by us under the Company’s 401(k) plan ($7,446) and deferred compensation plan ($4,927), (b) Car Allowance ($17,513), (c) amounts
reimbursed pursuant to executive medical reimbursement ($7,468). For fiscal 2010, includes (a) amounts contributed by us under the Company’s 401(k) plan ($8,662) and deferred
compensation plan ($4,184), (b) a Car Allowance ($17,513), (d) the payment described in footnote (7) above ($8,550), and (e) amounts reimbursed pursuant to executive medical
reimbursement ($4,195).
(9) For fiscal 2012, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,000). For fiscal 2011, includes (a) amounts contributed by us under the Company’s
401(k) plan ($10,622) and deferred compensation plan ($1,919), (b) Car Allowance ($4,500), (c) amounts reimbursed pursuant to executive medical reimbursement ($8,473).
For fiscal 2010, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,358) and deferred compensation plan ($953), (b) a Car Allowance ($9,000) and
(c) amounts reimbursed pursuant to executive medical reimbursement ($668).
(10) Mr. Sechrist was promoted to Executive Vice President Worldwide Sales, Service and Marketing and became an executive officer on March 31, 2011. Accordingly, information for
2010 for Mr. Sechrist has been omitted.
(11) For fiscal 2012, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,577). For fiscal 2011, includes (a) amounts contributed by us under the Company’s
401(k) plan ($11,023) and deferred compensation plan ($792) and (b) amounts reimbursed pursuant to executive medical reimbursement ($2,987).
(12) For fiscal 2012, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,008), (b) Car Allowance ($16,790) which as previously noted, was phased out. For
fiscal 2011, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,469) and deferred compensation plan ($2,062), (b) Car Allowance ($16,790), (c) amounts
reimbursed pursuant to executive medical reimbursement ($3,362). For fiscal 2010, includes (a) amounts contributed by us under the Company’s 401(k) plan ($10,154) and deferred
compensation plan ($1,425), (b) Car Allowance ($16,296), and (d) amounts reimbursed pursuant to executive medical reimbursement ($7,992).
26
COHERENT, INC. - 2012 Proxy Statement
SUMMARY COMPENSATION AND EQUITY TABLE S
Grants of Plan-Based Awards in Fiscal 2012
Except as set forth in the footnotes, the following table shows all plan-based equity and non-equity incentive awards granted to our Named
Executive Offi cers during fi scal 2012.
GRANTS OF PLANBASED AWARDS
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
Th res-
hold
($)
Target
($)
Maxi-
mum
($)
Actual
Payouts
Under
Non-Equity
Incentive
Plan Awards
($)
Estimated Future Payouts
Under Equity Incentive
Plan Awards
Th res-
hold
(#)
Target
(#)
0 36,000
Maxi-
mum
(#)
72,000
All Other
Stock
Awards:
# of
Securities
Underlying
Options
(#)
All Other
Option
Awards:
# of
Securities
Underlying
Options
(#)
24,000
Exercise
or Base
Price of
Option
Awards
($)
Grant
Date Fair
Value
($)(1)
$ 2,577,240
$ 1,283,040
0 (2) 312,500
625,000
124,629
0 (2) 312,500
625,000
0 (2) 625,000 1,250,000
0
124,629(3)
0 (2) 141,750
283,500
56,532
0 (2) 141,750
0 (2) 283,500
283,500
567,000
0
56,532(3)
0 (2) 108,000
216,000
43,071
0 (2) 108,000
0 (2) 216,000
216,000
432,000
0
43,071(3)
0 (2)
81,250
162,500
32,403
0 (2)
81,250
0 (2) 162,500
162,500
325,000
0
32,403(3)
0 (2)
83,750
167,500
33,400
0
4,950
9,900
10,050
$
$
354,370
537,273
0
4,620
9,240
0
3,960
7,920
0
3,300
6,600
9,380
8,040
6,700
$
$
330,746
501,455
$
$
283,496
429,818
$
$
236,247
358,182
Name
John
Ambroseo
Type
PRSU
RSU
1st semi-annual
bonus
Grant
Date
11/8/2011
11/8/2011
Helene
Simonet
Mark
Sobey
Paul
Sechrist
Bret
DiMarco
11/8/2011
11/8/2011
11/8/2011
11/8/2011
11/8/2011
11/8/2011
11/8/2011
11/8/2011
2nd semi-annual
bonus
Total
PRSU
RSU
1st semi-annual
bonus
2nd semi-annual
bonus
Total
PRSU
RSU
1st semi-annual
bonus
2nd semi-annual
bonus
Total
PRSU
RSU
1st semi-annual
bonus
2nd semi-annual
bonus
Total
PRSU
RSU
1st semi-annual
bonus
2nd semi-annual
bonus
Total
0 (2)
83,750
0 (2) 167,500
167,500
335,000
0
33,400(3)
(1) Reflects the dollar amount recognized for financial statement reporting purposes (disregarding an estimate of forfeitures related to service-based vesting conditions) for fiscal
2012 in accordance with ASC 718, and includes grants made in fiscal 2012. The assumptions used in the valuation of these awards are set forth in Note 14 “Employee Stock
Option and Benefits Plans” of the Financial Statements in the Annual Report on Form 10-K. These amounts do not correspond to the actual value that will be recognized
by the Named Executive Officers.
(2) Failure to meet a minimum level of performance would have resulted in no bonus paid out under the 2012 Variable Compensation Plan.
(3) Reflects the amount earned under the 2012 Variable Compensation Plan during the 2012 fiscal year.
COHERENT, INC. - 2012 Proxy Statement
27
SUMMARY COMPENSATION AND EQUITY TABLE S
Option Exercises and Stock Vested at 2012 Fiscal Year-End
Th e table below sets forth certain information for each Named Executive Offi cer regarding the exercise of options and the vesting of stock awards
during the year ended September 29, 2012, including the aggregate value realized upon such exercise or vesting.
Option Awards
Stock Awards
Name
John Ambroseo
Helene Simonet
Mark Sobey
Paul Sechrist
Bret DiMarco
(1) Reflects the difference between the exercise price of the option and market price of our Common Stock on the exercise date.
(2) Reflects the market price of our Common Stock on the vesting date.
Value Realized
on Exercise ($)(1)
—
—
469,520
—
394,612
Number
of Shares
Acquired on
Exercise (#)
—
—
15,500
—
14,084
Number
of Shares
Acquired on
Vesting (#)
44,083
13,867
11,915
9,515
10,050
Value Realized
on Vesting ($)(2)
2,201,062
685,569
589,379
484,280
496,419
28
COHERENT, INC. - 2012 Proxy Statement
SUMMARY COMPENSATION AND EQUITY TABLE S
Outstanding Equity Awards at Fiscal 2012 Year-End
Th e following table presents information concerning unexercised options and stock that has not yet vested for each Named Executive Offi cer
outstanding as of September 29, 2012.
—
—
—
—
—
Helene
Simonet
Name
John
Ambroseo
Option Awards(1)
Stock Awards
Option
Exercise
Price
—
—
—
—
—
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
Number of
Securities
Underlying
Options (#)
Exercisable
—
—
—
—
—
50,000
25,200
121,853
—
—
—
—
—
9,333
8,984
—
—
—
—
—
—
—
—
—
—
—
—
—
12,000
16,500
10,000
—
—
—
—
—
—
Grant Date
11/08/2011
11/08/2011
11/29/2010
11/29/2010
11/20/2009
11/20/2009
11/17/2008
10/03/2007
11/08/2011
11/08/2011
11/29/2010
11/29/2010
11/20/2009
11/20/2009
11/17/2008
11/08/2011
11/08/2011
11/29/2010
11/29/2010
11/20/2009
11/20/2009
11/08/2011
11/08/2011
3/30/2011
3/30/2011
11/3/2010
11/3/2010
11/20/2009
11/20/2009
11/17/2008
10/03/2007
Bret DiMarco 11/08/2011
11/08/2011
11/29/2010
11/29/2010
11/20/2009
11/20/2009
—
—
—
—
—
25,000 $
— $
— $
—
—
—
—
—
9,334 $
— $
—
—
—
—
—
8,000 $
—
—
—
—
—
—
—
6,000 $
— $
— $
—
—
—
—
—
7,000 $
(1) Each of the unvested option grants set forth above vest in three equal installments on the anniversary of the date of grant.
(2) Market value is determined by multiplying the number of shares by $45.86, the closing price of the Company’s common stock on September 28, 2012, the last trading
Option
Expiration
Date
—
—
—
—
—
26.16 11/20/2016
23.16 11/17/2014
32.95 10/03/2013
—
—
—
—
—
26.16 11/20/2016
23.16 11/17/2014
—
—
—
—
—
26.16 11/20/2016
—
—
—
—
—
—
—
26.16 11/20/2016
23.16 11/17/2014
32.95 10/03/2013
—
—
—
—
—
26.16 11/20/2016
Market Value
of Shares
or Units of
Stock Th at
Have Not
Vested ($)(2)
1,100,640
3,301,920
611,451
2,140,103
573,250
—
—
—
460,893
454,014
229,300
458,600
213,983
—
—
430,167
423,746
213,983
427,966
183,440
—
368,714
363,211
30,543
61,086
137,580
275,160
137,580
—
—
—
307,262
302,676
152,851
305,703
160,510
—
Number
of Shares
or Units of
Stock Th at
Have Not
Vested (#)
24,000
72,000(5)
13,333
46,666(3)
12,500
—
—
—
10,050
9,900(5)
5,000
10,000(3)
4,666
—
—
9,380
9,240(5)
4,666
9,332(3)
4,000
—
8,040
7,920(5)
666
1,332(4)
3,000
6,000(4)
3,000
—
—
—
6,700
6,600(5)
3,333
6,666(3)
3,500
—
Equity
incentive
plan awards:
Number
of unearned
shares, units
or other rights
that have
not vested (#)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Equity
incentive
plan awards:
Market or
payout value
of unearned
shares, units
or other rights
that have
not vested ($)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Paul Sechrist
Mark Sobey
date of the fiscal year.
(3) The performance-based RSU vesting determination dates are November 29, 2011, November 29, 2012 and November 29, 2013. The performance based RSUs will vest
in an amount which is 0-200% subject to the achievement of certain performance metrics. The amount reflected in the table is the maximum amount or 200%.
(4) The performance-based RSU vesting determination dates are November 3, 2011, November 2, 2012 and November 1, 2013. The performance based RSUs will vest in
an amount which is 0-200% subject to the achievement of certain performance metrics. The amount reflected in the table is the maximum amount or 200%.
(5) The performance-based RSU vesting determination date is November 7, 2014. The performance based RSUs will vest in an amount which is 0-200% subject to the
achievement of certain performance metrics. The amount reflected in the table is the maximum amount or 200%.
COHERENT, INC. - 2012 Proxy Statement
29
SUMMARY COMPENSATION AND EQUITY TABLE S
Fiscal 2012 Non-Qualifi ed Deferred Compensation
For a description of our Deferred Compensation Plan, see “Compensation Discussion and Analysis—Retirement Plans.” Th e following table
presents information regarding the non-qualifi ed deferred compensation activity for each Named Executive Offi cer during fi scal 2012:
Name
John Ambroseo
SRP(3)
Helene Simonet
SRP(3)
Paul Sechrist
SRP(3)
Mark Sobey
Bret DiMarco
(1) Amounts in this column consist of salary and/or bonus earned by the individual during fiscal year 2012, which is also reported in the Summary Compensation Table.
(2) The deferred compensation in a participant’s account is fully vested and is credited with positive or negative investment results based upon plan investment options selected
—
—
—
Executive
Contributions
in Last FY ($)(1)
289,632
—
101,937
—
116,854
—
11,077
24,090
Executive Deferrals
including Company
Contribution in
Last FY ($)
—
—
—
—
—
—
—
—
Aggregate
Balance at Last
FYE ($)(2)
6,090,306
1,223,679
885,153
127,089
540,938
147,053
30,341
57,828
Registrant
Contributions
in Last FY ($)
—
—
—
—
—
—
—
—
Aggregate
Earnings in
Last FY ($)
941,415
194,958
37,750
9,764
79,776
30,695
3,888
7,900
Aggregate
Withdrawals/
Distributions ($)
—
—
—
—
by the participant.
(3) Amounts represent account balances and earnings from the Supplementary Retirement Plan (SRP) which was suspended on December 31, 2004. Deferrals (both executive
and company) into this plan have been suspended. The Deferred Compensation Plan is the only non-qualified deferred compensation plan available for executive
management.
Potential Payments upon Termination or Change of Control
Our Change of Control Plan provides for the payment of specifi ed
compensation and benefi ts upon certain terminations of the employment
of the participants following a change of control of the Company. Th e
Board has evaluated the economic and social impact of an acquisition
or other change of control on its key employees. Th e Board recognizes
that the potential of such an acquisition or change of control can be
a distraction to its key employees and can cause them to consider
alternative employment opportunities. Th e Board has determined that
it is in the best interests of Coherent and its stockholders to assure
that Coherent will have the continued dedication and objectivity of
its key employees. Th e Board believes that the change of control plan
will enhance the ability of our key employees to assist the Board in
objectively evaluating potential acquisitions or other changes of control.
Th e Change of Control Plan provides that if within 24 months after (or
two months prior to) a change of control the executive’s employment
is terminated other than by reason of his or her death, disability,
retirement or for cause, or the executive offi cer terminates his or her
employment for “good reason,” the executive will receive a lump sum
severance payment equal to 2.99 (in the case of Mr. Ambroseo) or 2.0
(in the case of Ms. Simonet and Messrs. DiMarco, Sechrist and Sobey)
times the executive’s annual base salary and annual bonus (assuming
achievement of all performance requirements thereof). “Good reason” is
defi ned under the Change of Control Plan as any of the following that
occurs after a change of control of the Company: a material reduction
in cash and equity incentive opportunities, taken as a whole; a change
in the site of employment by more than 25 miles; material reduction
in the executive’s duties and responsibilities; the Company’s failure to
obtain the written assumption by its successor of the obligations set forth
in the Agreement; attempted termination of employment on grounds
insuffi cient to constitute a basis of termination for cause under the
terms of the change of control plan; or the Company’s breach of any of
the provisions of the Change of Control Plan. Under the terms of the
plan, the executives will also have acceleration of all vesting conditions
for equity grants and a payment in lieu of health care for the executive
(and his or her covered family members) will be provided on the same
terms for two years and, in the case of Mr. Ambroseo, three years.
Th e following table shows the potential payments and benefi ts that
we (or our successor) would be obligated to make or provide upon
termination of employment of each our Named Executive Offi cers
pursuant to the terms of the Change of Control Plan. Other than this
plan, there are no other employment agreements or other contractual
obligations triggered upon a change of control. For purposes of this
table, it is assumed that each Named Executive Offi cer’s employment
terminated at the close of business on September 28, 2012 (the last
business day before the end of our fi scal year end on September 29,
2012). Th ese payments are conditioned upon the execution of a form
release of claims by the Named Executive Offi cer in favor of us. Th e
amounts reported below do not include the nonqualifi ed deferred
compensation distributions that would be made to the Named Executive
Offi cers following a termination of employment (for those amounts
and descriptions, see the prior table). Th ere can be no assurance that
a triggering event would produce the same or similar results as those
estimated below if such event occurs on any other date or at any other
price, of if any other assumption used to estimate potential payments
and benefi ts is not correct. Due to the number of factors that aff ect
the nature and amount of any potential payments or benefi ts, any
actual payments and benefi ts may be diff erent. Th e total benefi t per
individual in the table below does not add to the total of the individual
components due to rounding within each component.
30
COHERENT, INC. - 2012 Proxy Statement
SUMMARY COMPENSATION AND EQUITY TABLE S
2X
2X
Mark Sobey
Helene Simonet
Termination
for Cause
Named Executive Offi cer
John Ambroseo
Multiplier for Base
Salary and Bonus
2.99X
Any Other
Termination
1,868,750
1,868,750
8,219,864
99,000
12,056,364
810,000
567,000
2,000,670
66,000
3,443,670
720,000
432,000
1,836,901
66,000
3,054,901
650,000
325,000
1,492,074
66,000
2,533,074
670,000
335,000
1,366,902
66,000
2,437,902
(1) Equity Compensation Acceleration is the in-the-money value of unvested stock options, time-based RSUs and performance-based RSUs, in each case as of September 28,
2012 at the closing stock price on that date ($45.86). The value of accelerated stock options are thus calculated by multiplying the number of unvested shares subject to
acceleration by the difference between the exercise price and the closing stock price on September 28, 2012; the value of accelerated RSUs is calculated by multiplying the
number of unvested shares subject to acceleration by the closing stock price on September 28, 2012. For purposes of the table we have assumed the immediate release and
vesting of the performance-based RSUs at the maximum, or 200% of target, achievement. In the event of a change of control, however, the performance-based RSUs would
be measured for achievement prior to the effective date of the change of control and converted to time-based awards subject to the terms of the plan. The amounts reflected
for Equity Compensation Acceleration do not reflect any applicable taxes, just gross proceeds. Since the table assumes a triggering event on September 28, 2012, only those
stock options and RSU grants outstanding as of that date are included in the table.
Nature of Benefi t
Salary Severance
Bonus Severance
Equity Compensation Acceleration(1)
Aggregate Healthcare Related Monthly Payment(2)
TOTAL BENEFIT
Salary Severance
Bonus Severance
Equity Compensation Acceleration(1)
Aggregate Healthcare Related Monthly Payment(2)
TOTAL BENEFIT
Salary Severance
Bonus Severance
Equity Compensation Acceleration(1)
Aggregate Healthcare Related Monthly Payment(2)
TOTAL BENEFIT
Salary Severance
Bonus Severance
Equity Compensation Acceleration(1)
Aggregate Healthcare Related Monthly Payment(2)
TOTAL BENEFIT
Salary Severance
Bonus Severance
Equity Compensation Acceleration(1)
Aggregate Healthcare Related Monthly Payment(2)
TOTAL BENEFIT
— $
— $
— $
— $
$
— $
— $
— $
— $
$
— $
— $
— $
— $
$
— $
— $
— $
— $
$
— $
— $
— $
— $
$
Bret DiMarco
Paul Sechrist
2X
2X
(2) Aggregate Monthly Payment is a monthly payment of $2,750 in lieu of receiving company subsidized COBRA benefits, life insurance premiums and/or other welfare
benefits, 36 months for the Chief Executive Officer and 24 months for the other named executive officers.
COHERENT, INC. - 2012 Proxy Statement
31
EQUITY COMPENSATION PLAN INFORMATION
Th e following table provides information as of September 29, 2012 about the Company’s equity compensation plans under which shares of our
common stock may be issued to employees, consultants or members of our Board:
(a) Number of
securities to be issued
upon exercise of
outstanding options,
warrants and rights
(c) Number of securities
remaining available for
future issuance under equity
compensation plans (excluding
securities refl ected in column (a))
(b) Weighted-average
exercise price of
outstanding options,
warrants and rights(1)
27.86
—
27.86
Plan category
Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders
TOTAL
(1) These weighted average exercise prices do not reflect the shares that will be issued upon the payment of outstanding awards of RSUs.
(2) This number does not include any options which may be assumed by us through mergers or acquisitions, however, we do have the authority, if necessary, to reserve additional
7,384,974(3)
—
7,384,974
—
1,233,304
1,233,304(2) $
$
shares of common stock under these plans to the extent necessary for assuming such options.
(3) This number of shares includes 1,013,543 shares of common stock reserved for future issuance under the Employee Stock Purchase Plan and 6,371,431 shares reserved for
future issuance under the 2011 Plan.
CERTAIN RELATIONSHIPS AND RELATED
PERSON TRANSACTIONS
Review, Approval or Ratifi cation of Related Person Transactions
In accordance with the charter for the Audit Committee of the Board,
the members of the Audit Committee, all of whom are independent
directors, review and approve in advance any proposed related person
transactions. Additionally, from time to time the Board may directly
consider these transactions. For purposes of these procedures, the
individuals and entities that are considered “related persons” include:
• Any of our directors, nominees for director and executive offi cers;
• Any person known to be the benefi cial owner of fi ve percent or more
of our common stock (a “5% Stockholder”); and
• Any immediate family member, as defined in Item 404(a) of
Regulation S-K, of a director, nominee for director, executive offi cer
and 5% Stockholder. We will report all such material related person
transactions under applicable accounting rules, federal securities laws
and SEC rules and regulations.
Related Person Transactions
We have entered into indemnifi cation agreements with each of our executive offi cers and directors. Such indemnifi cation agreements require us to
indemnify these individuals to the fullest extent permitted by law. We also intend to execute these agreements with our future directors and offi cers.
32
COHERENT, INC. - 2012 Proxy Statement
REPORT OF THE AUDIT COMMITTEE
OF THE BOARD OF DIRECTORS
Th e Audit Committee is responsible for overseeing our accounting and
fi nancial reporting processes and audits of our fi nancial statements. As
set forth in its charter, the Audit Committee acts only in an oversight
capacity and relies on the work and assurances of both management,
which has primary responsibilities for our fi nancial statements and
reports, as well as the independent registered public accounting fi rm
that is responsible for expressing an opinion on the conformity of our
audited fi nancial statements to generally accepted accounting principles.
Th e Audit Committee met eleven (11) times either in person or by
telephone during fi scal 2012. In the course of these meetings, the
Audit Committee met with management, the internal auditors and
our independent registered public accounting fi rm and reviewed the
results of the internal and external audit examinations, evaluations of
our internal controls and the overall quality of our fi nancial reporting.
Th e Audit Committee believes that a candid, substantive and focused
dialogue with the internal auditors and the independent registered public
accounting fi rm is fundamental to the Audit Committee’s oversight
responsibilities. To support this belief, the Audit Committee periodically
meets separately with the internal auditors and the independent auditors,
without management present. In the course of its discussions in these
meetings, the Audit Committee asked a number of questions intended
to bring to light any areas of potential concern related to our fi nancial
reporting and internal controls. Th ese questions include:
• Are there any signifi cant accounting judgments, estimates or adjustments
made by management in preparing the fi nancial statements that would
have been made diff erently had the auditors themselves prepared and
been responsible for the fi nancial statements;
• Based on the auditors’ experience, and their knowledge of our business,
do our fi nancial statements fairly present to investors, with clarity
and completeness, our fi nancial position and performance for the
reporting period in accordance with generally accepted accounting
principles and SEC disclosure requirements;
• Based on the auditors’ experience, and their knowledge of our business,
have we implemented internal controls and internal audit procedures
that are appropriate for our business.
Th e Audit Committee approved the engagement of Deloitte & Touche
LLP as our independent registered public accounting fi rm for fi scal 2012
and reviewed with the internal auditors and independent registered
public accounting fi rm their respective overall audit scope and plans.
In approving Deloitte & Touche LLP, the Audit Committee considered
the qualifi cations of Deloitte & Touche LLP and discussed with
Deloitte & Touche LLP their independence, including a review of
the audit and non-audit services provided by them to us. Th e Audit
Committee also discussed with Deloitte & Touche LLP the matters
required to be discussed by Statement on Auditing Standards No. 61,
as amended, (AICPA, Professional Standards, Vol. 1 AU section 380),
as adopted by the Public Company Accounting Oversight Board in
Rule 3200T, and it received the written disclosures and the letter from
Deloitte & Touche LLP required by the applicable requirements of the
Public Company Accounting Oversight Board regarding Deloitte &
Touche LLP’s communications with Audit Committee concerning
independence and has discussed Deloitte & Touche LLP’s independence
with Deloitte & Touche LLP.
Management has reviewed and discussed the audited fi nancial statements
for fi scal 2012 with the Audit Committee, including a discussion of the
quality and acceptability of the fi nancial reporting, the reasonableness
of signifi cant accounting judgments and estimates and the clarity
of disclosures in the fi nancial statements. In connection with this
review and discussion, the Audit Committee asked a number of
follow-up questions of management and the independent registered
public accounting fi rm to help give the Audit Committee comfort in
connection with its review.
In reliance on the reviews and discussions referred to above, the Audit
Committee recommended to the Board that the audited fi nancial
statements be included in the annual report on Form 10-K for the
fi scal year ended September 29, 2012, for fi ling with the SEC.
Respectively submitted by
Th e Audit Committee
Susan James, Chair
Garry Rogerson
Lawrence Tomlinson
COHERENT, INC. - 2012 Proxy Statement
33
OTHER MATTERS
We know of no other matters to be submitted to the meeting. If any other matters properly come before the meeting, it is the intention of the
persons named in the enclosed form Proxy to vote the shares they represent as the Board may recommend.
Dated: January 25, 2013
By Order of the Board of Directors
/s/ John R. Ambroseo
John R. Ambroseo
President and Chief Executive Offi cer
34
COHERENT, INC. - 2012 Proxy Statement
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________________________
FORM 10-K
(Mark One)
⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended September 29, 2012
or
(cid:134) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-33962
___________________________________________________
COHERENT, INC.
Delaware
(State or other jurisdiction of
incorporation or organization)
5100 Patrick Henry Drive, Santa Clara, California
(Address of principal executive offices)
94-1622541
(I.R.S. Employer
Identification No.)
95054
(Zip Code)
Registrant's telephone number, including area code: (408) 764-4000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, $0.01 par value
Name of each exchange on which
registered
The NASDAQ Stock Market LLC
Nasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ⌧ No (cid:134)
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
1934 (the "Exchange Act"). Yes (cid:134) No ⌧
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days. Yes ⌧ No (cid:134)
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files. Yes ⌧ No (cid:134)
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. (cid:134)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See definitions of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ⌧
Accelerated filer (cid:133)
Non-accelerated filer (cid:134)
(Do not check if a smaller reporting company)
Smaller reporting company (cid:134)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes (cid:134) No ⌧
As of November 23, 2012, 23,956,302 shares of common stock were outstanding. The aggregate market value of the voting shares (based on the
closing price reported on the NASDAQ Global Select Market on March 30, 2012, of Coherent, Inc., held by nonaffiliates was approximately
$875,486,753. For purposes of this disclosure, shares of common stock held by persons who own 5% or more of the outstanding common stock and shares
of common stock held by each officer and director have been excluded in that such persons may be deemed to be "affiliates" as that term is defined under
the Rules and Regulations of the Exchange Act. This determination of affiliate status is not necessarily conclusive.
DOCUMENT INCORPORATED BY REFERENCE
Portions of the registrant's Proxy Statement for the registrant's fiscal 2013 Annual Meeting of Stockholders are incorporated by reference into
Part III of the Form 10-K to the extent stated herein. The Proxy Statement or an amended report on Form 10-K will be filed within 120 days of the
registrant's fiscal year ended September 29, 2012.
This page intentionally left blank.
TABLE OF CONTENTS
PART I
ITEM 1.
ITEM 1A.
ITEM 1B.
ITEM 2.
ITEM 3.
ITEM 4.
BUSINESS .....................................................................................................................................
RISK FACTORS .............................................................................................................................
UNRESOLVED STAFF COMMENTS ..........................................................................................
PROPERTIES..................................................................................................................................
LEGAL PROCEEDINGS................................................................................................................
MINE SAFETY DISCLOSURES ...................................................................................................
PART II
ITEM 5.
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
ITEM 6.
ITEM 7.
SELECTED FINANCIAL DATA...................................................................................................
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
ITEM 7A.
ITEM 8.
ITEM 9.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK ................
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA ................................................
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
ITEM 9A.
ITEM 9B.
CONTROLS AND PROCEDURES................................................................................................
OTHER INFORMATION ...............................................................................................................
PART III
ITEM 10.
ITEM 11.
ITEM 12.
ITEM 13.
DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE ................
EXECUTIVE COMPENSATION...................................................................................................
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE
ITEM 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES.................................................................
PART IV
ITEM 15.
SIGNATURES
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES ......................................................
4
16
29
30
30
31
32
34
35
49
50
50
51
52
53
54
54
54
54
55
58
1
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS
This annual report contains forward-looking statements. These forward-looking statements include, without limitation,
statements relating to:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
expansion into, and financial returns from, new markets;
optimization of financial returns;
maintenance and development of current and new customer relationships;
enhancement of market position through existing or new technologies;
optimization of product mix;
future trends in microelectronics, scientific research and government programs, OEM components and instrumentation
and materials processing;
utilization of vertical integration;
adoption of our products or lasers generally;
applications and processes that will use lasers, including the suitability of our products;
capitalization on market trends;
alignment with current and new customer demands;
positioning in the marketplace and gains of market share;
design and development of products, services and solutions;
control of supply chain and partners;
realization of restructuring benefits;
protection of intellectual property rights;
compliance with environmental and safety regulations;
net sales and operating results;
variations in stock price;
market acceptance of products;
flat panel displays orders and related service orders for fiscal 2013;
trends in the instrumentation market;
sufficiency and management of cash, cash equivalents and investments;
acquisition efforts and utilization of technology from our acquisitions;
accounting for goodwill and intangible assets, inventory valuation, warranty reserves and taxes; and
future net revenue.
In addition, we include forward-looking statements under the "Our Strategy" and "Future Trends" headings set forth
below in "Business" and under the "Bookings and Book-to-Bill Ratio" heading set forth below in "Management's Discussion
and Analysis of Financial Condition and Results of Operations."
2
You can identify these and other forward-looking statements by the use of the words such as "may," "will," "could,"
"would," "should," "expects," "plans," "anticipates," "estimates," "intends," "potential," "projected," "continue," "our
observation," or the negative of such terms, or other comparable terminology. Forward-looking statements also include the
assumptions underlying or relating to any of the foregoing statements.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various
factors, including those set forth below in "Business," "Management's Discussion and Analysis of Financial Condition and
Results of Operations" and under the heading "Risk Factors." All forward-looking statements included in this document are
based on information available to us on the date hereof. We undertake no obligation to update these forward-looking statements
as a result of events or circumstances or to reflect the occurrence of unanticipated events or non-occurrence of anticipated
events.
3
PART I
ITEM 1. BUSINESS
GENERAL
Business Overview
Our fiscal year ends on the Saturday closest to September 30. Fiscal years 2012, 2011 and 2010 ended on September 29,
October 1, and October 2, respectively, and are referred to in this annual report as fiscal 2012, fiscal 2011 and fiscal 2010 for
convenience. Fiscal years 2012, 2011 and 2010 included 52 weeks.
We are one of the world's leading suppliers of photonics-based solutions in a broad range of commercial and scientific
research applications. We design, manufacture, service and market lasers and related accessories for a diverse group of
customers. Since inception in 1966, we have grown through internal expansion and through strategic acquisitions of
complementary businesses, technologies, intellectual property, manufacturing processes and product offerings.
We are organized into two operating segments: Commercial Lasers and Components ("CLC") and Specialty Lasers and
Systems ("SLS"). This segmentation reflects the go-to-market strategies for various products and markets. While both segments
deliver cost-effective photonics solutions, CLC focuses on higher volume products that are offered in set configurations. The
product architectures are designed for easy exchange at the point of use such that substantially all product service and repairs
are based upon advanced replacement and depot (i.e., factory) repair. CLC's primary markets include materials processing,
original equipment manufacturer ("OEM") components and instrumentation and microelectronics. SLS develops and
manufactures configurable, advanced performance products largely serving the microelectronics, scientific research and
government programs and OEM components and instrumentation markets. The size and complexity of many of the SLS
products require service to be performed at the customer site by factory-trained field service engineers.
Income (loss) from operations is the measure of profit and loss that our chief operating decision maker ("CODM") uses to
assess performance and make decisions. Income (loss) from operations represents the sales less the cost of sales and direct
operating expenses incurred within the operating segments as well as allocated expenses such as shared sales and
manufacturing costs. We do not allocate to our operating segments certain operating expenses, which we manage separately at
the corporate level. These unallocated costs include stock-based compensation and corporate functions (certain advanced
research and development, management, finance, legal and human resources) and are included in Corporate and other.
Management does not consider unallocated Corporate and other costs in its measurement of segment performance.
We were originally incorporated in California on May 26, 1966 and reincorporated in Delaware on October 1, 1990. Our
common stock is listed on the NASDAQ Global Select Market and we are a member of the Standard & Poor's SmallCap 600
Index and the Russell 2000 Index.
Additional information about Coherent, Inc. (referred to herein as the Company, we, our, or Coherent) is available on our
web site at www.coherent.com. We make available, free of charge on our web site, access to our annual report on Form 10-K,
our quarterly reports on Form 10-Q, our current reports on Form 8-K and amendments to those reports filed or furnished
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as soon as
reasonably practicable after we file or furnish them electronically with the Securities and Exchange Commission ("SEC").
Information contained on our web site is not part of this annual report or our other filings with the SEC. Any product, product
name, process, or technology described in these materials is the property of Coherent, Inc.
INDUSTRY BACKGROUND
The word "laser" is an acronym for "light amplification by stimulated emission of radiation." A laser emits an intense
coherent beam of light with some unique and highly useful properties. Most importantly, a laser is orders of magnitude brighter
than any lamp. As a result of its coherence, the beam can be focused to a very small and intense spot, useful for applications
requiring very high power densities including cutting and other materials processing procedures. The laser's high spatial
resolution is also useful for microscopic imaging and inspection applications. Laser light can be monochromatic—all the beam
energy is confined to a narrow wavelength band. Some lasers can be used to create ultrafast output—a series of pulses with
pulse durations as short as attoseconds (i.e., 10-18 seconds).
There are many types of lasers and one way of classifying them is by the material or medium used to create the lasing
action. This can be in the form of a gas, liquid, semiconductor, solid state crystal or fiber. Lasers can also be classified by their
output wavelength: ultraviolet, visible, infrared or wavelength tunable. We manufacture all of these laser types. There are also
many options in terms of pulsed output versus continuous wave, pulse duration, output power, beam dimensions, etc. In fact,
each application has its specific requirements in terms of laser performance. The broad technical depth at Coherent enables us
to offer a diverse set of product lines characterized by lasers targeted at growth opportunities and key applications. In all cases,
we aim to be the supplier of choice by offering a high-value combination of superior technical performance and high reliability.
4
Photonics has taken its place alongside electronics as a critical enabling technology for the twenty-first century.
Photonics based solutions are entrenched in a broad array of industries that include industrial automation, textile processing,
microelectronics, flat panel displays and medical diagnostics, with adoption continuing in ever more diverse applications.
Growth in these applications stems from two sources. First, there are many applications where the laser is displacing
conventional technology because it can do the job faster, better or more economically. Second, there are new applications
where the laser is the enabling tool that makes the work possible (e.g., the production of sub 50 micron microvias); these lasers
are used in the manufacturing of high density printed circuit boards ("PCBs") found in the latest smart phones and tablet
computers.
Key laser applications include: semiconductor inspection; manufacturing of advanced PCBs; flat panel display
manufacturing; solar cell production; medical and bio-instrumentation; materials processing; industrial process and quality
control; marking; imaging and printing; graphic arts and display; and, research and development. For example, ultraviolet
(“UV”) lasers are enabling the move towards miniaturization, which drives innovation and growth in many markets. In
addition, the advent of industrial grade ultrafast lasers continues to open up new applications for laser processing.
OUR STRATEGY
We strive to develop innovative and proprietary products and solutions that meet the needs of our customers and that are
based on our core expertise in lasers and optical technologies. In pursuit of our strategy, we intend to:
• Leverage our technology portfolio and application engineering to lead the proliferation of photonics into
broader markets—We will continue to identify opportunities in which our technology portfolio and application
engineering can be used to offer innovative solutions and gain access to new markets. We plan to utilize our expertise
to increase our market share in the mid to high power material processing applications.
• Optimize our leadership position in existing markets—There are a number of markets where we have historically
been at the forefront of technological development and product deployment and from which we have derived a
substantial portion of our revenues. We plan to optimize our financial returns from these markets.
• Maintain and develop additional strong collaborative customer and industry relationships—We believe that the
Coherent brand name and reputation for product quality, technical performance and customer satisfaction will help us
to further develop our loyal customer base. We plan to maintain our current customer relationships and develop new
ones with customers who are industry leaders and work together with these customers to design and develop
innovative product systems and solutions as they develop new technologies.
• Develop and acquire new technologies and market share—We will continue to enhance our market position
through our existing technologies and develop new technologies through our internal research and development
efforts, as well as through the acquisition of additional complementary technologies, intellectual property,
manufacturing processes and product offerings.
• Streamline our manufacturing structure and improve our cost structure—We will focus on optimizing the mix of
products that we manufacture internally and externally. We will utilize vertical integration where our internal
manufacturing process is considered proprietary and seek to leverage external sources when the capabilities and cost
structure are well developed and on a path towards commoditization.
• Focus on long-term improvement of adjusted EBITDA, in dollars and as a percentage of net sales—We define
adjusted EBITDA as operating income adjusted for depreciation, amortization, stock compensation expenses, major
restructuring costs and certain other non-operating income and expense items. Key initiatives to reach our goals for
EBITDA improvements include utilization of our Asian manufacturing locations, rationalizing our supply chain and
continued leveraging of our infrastructure.
5 APPLICATIONS
Our products address a broad range of applications that we group into the following markets: Microelectronics, Materials
Processing, OEM Components and Instrumentation and Scientific Research and Government Programs.
Microelectronics
Nowhere is the trend towards miniaturization more prevalent than in the Microelectronics market where smart phones,
tablets, ultrabooks, personal computers ("PC's") and televisions ("TV's") are driving advances in displays, integrated circuits
and PCBs. In response to market demands and expectations, semiconductor and device manufacturers are continually seeking
to improve their process and design technologies in order to manufacture smaller, more powerful and more reliable devices at
lower cost. New laser applications and new laser technologies are a key element in delivering higher resolution and higher
precision at lower manufacturing cost.
We support three major markets in the microelectronics industry: (1) flat panel display ("FPDs") manufacturing,
(2) advanced packaging and interconnects and (3) semiconductor front-end.
Microelectronics—flat panel display manufacturing
The high-volume consumer market is driving the production of FPDs in applications such as mobile phones, tablets,
ultrabooks, laptop computers, and TVs. There are several types of established and emerging displays based on quite different
technologies, including liquid crystal ("LCD") and organic polymers ("OLED"). Lasers have found applications in each of
these technologies given that lasers provide higher process speed, better yield, improved battery life, lower cost and/or superior
display brightness and resolution.
Several display types require a high-density pattern of silicon thin film transistors ("TFTs"). If this silicon is
polycrystalline, the performance is greatly enhanced. In the past, these polysilicon layers could only be produced on expensive
special glass at high temperatures. However, excimer-based processes, such as excimer laser annealing ("ELA") have allowed
high-volume production of low-temperature polysilicon ("LTPS") on conventional glass substrates. Our excimer lasers provide
an invaluable solution for LTPS because they are the only industrial-grade excimer lasers with the high pulse energy optimized
for this application. The current state-of-the-art product for this application is our excimer VYPER laser, which delivers over
1000W of power, enabling customers to scale to current Generation 5 & 5.5 substrates all the way up to Generation 8 sizes.
These systems are integral to the manufacturing process on all leading LTPS-based smart phone displays, with the highest
commercially available pixel densities of greater than 300 pixels per inch (ppi) and hold the potential for deployment in tablet
display and OLED TV manufacturing.
Our AVIA and DIAMOND lasers are also used in other production processes for FPDs. These processes include drilling,
cutting, patterning, marking and yield improvement.
Lasers have also become a valuable tool in high-brightness ("HB") LED manufacturing, improving LED performance
and yield. LED has seen rapid growth in the last year due to widespread adoption as the light source in all categories of LCD
displays, from phones all the way to full size TVs. Our lasers are used in the back-end processing of HB-LEDs.
Microelectronics—advanced packaging and interconnects
After a wafer is patterned, there are then a host of other processes, referred to as back-end processing, which finally result
in a packaged encapsulated silicon chip. Ultimately, these chips are then assembled into finished products. The advent of high-
speed logic and high-memory content devices has caused chip manufacturers to look for alternative technologies to improve
performance and lower process costs. In terms of materials, this search includes new types of materials, such as low-k and
thinner silicon. Our AVIA, Talisker and Matrix lasers are providing economical methods of cutting and scribing these wafers
while delivering higher yields than traditional mechanical methods.
There are similar trends in chip packaging and PCB manufacturing requiring more compact packaging and denser
interconnects. In many cases, lasers present enabling technologies. For instance, lasers are now the only economically practical
method for drilling microvias in chip assemblies and in both rigid and flexible PCBs. These microvias are tiny interconnects
that are essential for enabling high-density circuitry commonly used in smart phones, tablets and advanced computing systems.
Our DIAMOND carbon dioxide ("CO2") and AVIA DPSS lasers are the lasers of choice in this application. The ability of these
lasers to operate at very high repetition rates translates into faster drilling speeds and increased throughput in microvia
processing applications. In addition, multi-layer circuit boards require more flexible production methods than conventional
printing technologies can offer, which has led to widespread adoption of Laser Direct Imaging. Our Paladin laser is used for
this application.
6
Microelectronics—semiconductor front-end
The term "front-end" refers to the production of semiconductor devices which occurs prior to packaging.
As semiconductor device geometries decrease in size, devices become increasingly susceptible to smaller defects during
each phase of the manufacturing process and these defects can negatively impact yield. One of the semiconductor industry's
responses to the increasing vulnerability of semiconductor devices to smaller defects has been to use defect detection and
inspection techniques that are closely linked to the manufacturing process. For example, automated laser-based inspection
systems are now used to detect and locate defects as small as 0.01 micron, which may not be observable by conventional
optical microscopes.
Detecting the presence of defects is only the first step in preventing their recurrence. After detection, defects must be
examined in order to identify their size, shape and the process step in which the defect occurred. This examination is called
defect classification. Identification of the sources of defects in the lengthy and complex semiconductor manufacturing process
has become essential for maintaining high yield production. Semiconductor manufacturing has become an around-the-clock
operation and it is important for products used for inspection, measurement and testing to be reliable and to have long lifetimes.
Our Azure, Paladin and Excimer lasers are used to detect and characterize defects in semiconductor chips.
Materials Processing
Lasers are widely accepted today in many important industrial manufacturing applications including cutting, welding,
joining, drilling, perforating, and marking of metals and nonmetals. We supply high-power lasers for metal processing and low-
to-medium power lasers for laser marking, nonmetals processing and precision micromachining.
Our high power industrial laser systems are used for cutting, cladding and hardening of metals, joining materials, and
other materials processing applications. Other applications include welding of plastics and direct metal welding.
Our Semiconductor business provides higher power arrays with powers in excess of 50 kilowatts through its proprietary
cooling and stacking technology. This unique technology provides the engine for both our Highlight direct diode systems as
well as our kW class fiber laser. Complementing our high power solid state lasers is our industry leading DIAMOND E1000
CO2 laser. Introduced in 2009, this laser remains in high demand due to its high power, small size and completely sealed
design - all ideal for material processing.
Combining the high power Direct Diode, Fiber and CO2 offerings with our MetaBeam 1000 flatbed cutting tool provides
a strong, compelling four-pronged approach to meeting the needs of our diverse materials processing customers. The new
METABEAM 1000 offers the industry's most compact 1kW tool, with tool footprints at least 50% smaller than competitive
designs. Operating costs, due to a combination of input power efficiencies and the sealed nature of the DIAMOND series of
CO2 lasers, are 50% less than similar, but larger tools.
We also participate in the low to medium power area, including such applications as the cutting, drilling and joining of a
host of materials using our DIAMOND CO2 lasers; Highlight FAP semiconductor lasers in OEM opportunities and direct end
user applications with the lower power OMNIBEAM and METABEAM cutting tools; applications including cutting,
perforating and scoring of paper, thin metals and packaging materials; and various cutting and patterning applications in the
textile, wood and sign industries. In the specific area of textiles and clothing, our DIAMOND lasers service older applications,
such as cutting complex shapes in leather for footwear, as well as newer applications such as creating detailed fade patterns on
designer denims.
Laser marking and coding are generally considered part of the precision materials processing applications market for
which we remain a leading supplier. One such area where applications are growing rapidly is the displacement of ink-jet coding
due to both aesthetic and environmental pressures. The optimum choice of laser depends on the material being marked, whether
it is a surface mark (engraved) or a sub-surface mark, and the specific economics of the application. Our DIAMOND C and
GEM Series of CO2 lasers provide many systems manufacturers with a reliable cost effective source for marking and engraving
on non-metals. In addition, our Matrix product line of reliable, compact and low-cost diode pumped solid state lasers provides
an ideal solution for marking of other materials in high volume manufacturing.
OEM components and instrumentation
Instrumentation is one of our more mature commercial applications. Representative applications within this market
include bio-instrumentation, medical OEMs, graphic arts and display and machine vision. We also support the laser-based
instrumentation market with a range of laser-related components, including diode lasers for optical pumping. Some of our
OEM component business includes sales to other, less integrated laser manufacturers participating in OEM markets such as
materials processing, scientific, and medical.
Bio-instrumentation
7
Bio-instrumentation applications for lasers include bio-agent detection for point source and standoff detection of
pathogens or other bio-toxins; confocal microscopy for biological imaging that allows researchers and clinicians to visualize
cellular and subcellular structures and processes with an incredible amount of detail; DNA sequencing that provides automation
and data acquisition rates that would be impossible by any other method; drug discovery—genomic and proteomic analyses
that enable drug discovery to proceed at very high throughput rates; and flow cytometry for analyzing single cells or
populations of cells in a heterogeneous mixture, including blood samples. Specifically, our OBIS, Sapphire, Compass and
Coherent CUBE lasers are used in several bio-instrumentation applications.
Medical Therapy
We sell a variety of components and lasers to medical laser companies in end-user applications such as ophthalmology,
aesthetic, surgical, therapeutic and dentistry. Our DIAMOND series CO2 lasers are widely used in ophthalmic, aesthetic and
surgical markets. In addition, we have a leading position in Lasik and photorefractive keratectomy ("PRK") surgery methods
with our ExciStar XS excimer laser platform.
The unique ability of our optically pumped semiconductor lasers ("OPSL") technology to match a wavelength to an
application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as
Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to
match the peak in absorption of oxygenated hemoglobin thereby allowing treatment to occur at a lower power level, and thus
reducing stress and heat-load placed on the eye with traditional green-based (530nm) solid state lasers. Other applications
where our OBIS, Genesis and Sapphire series of lasers are used include the retinal scanning market in diagnostic imaging
systems as well as new ground breaking in-vivo imaging.
Scientific research and government programs
We are widely recognized as a technology innovator and the scientific market has historically provided an ideal "test
market" for our leading-edge innovations. These have included ultrafast lasers, DPSS lasers, continuous-wave ("CW") systems,
excimer gas lasers and water-cooled ion gas lasers. Our portfolio of lasers that address the scientific research market is broad
and includes our Chameleon, COMPexPro, Evolution, Legend, Libra, MBD, MBR, Vitara, Mira and Verdi lasers. Many of the
innovations and products pioneered in the scientific marketplace have become commercial successes for both our OEM
customers and us.
We have a large installed base of scientific lasers which are used in a wide range of applications spanning virtually every
branch of science and engineering. These applications include biology and life science, engineering, physical chemistry and
physics. Most of these applications require the use of ultrafast lasers that enable the generation of pulses short enough to be
measured in femto- or attoseconds (10-15 to 10-18 seconds). Because of these very short pulse durations, ultrafast lasers enable
the study of fundamental physical and chemical processes with temporal resolution unachievable with any other tool. These
lasers also deliver very high peak power and large bandwidths, which can be used to generate many exotic effects. Some of
these are now finding their way into mainstream applications, such as microscopy or materials processing. In fact, the use of
ultrafast lasers such as the Chameleon in microscopy is now a common occurrence in bio-imaging labs.
FUTURE TRENDS
Microelectronics
Lasers are widely used in mass production microelectronics applications largely because they enable entirely new
application capabilities that cannot be realized by any other known means. These laser-based fabrication and testing methods
provide a level of precision, typically on a micrometer and nanometer level, that are unique, faster, are touch free, deliver
superior end products, increase yields, and/or cut production costs. We anticipate this trend to continue, driven primarily by the
increasing sophistication of consumer electronic goods and their convergence via the internet, resulting in increasing demand
for better displays, more bandwidth and memory, and all packaged into devices which are lighter, thinner and consume less
power. Although this market follows the macro-economic trends and carries inherent risks, we believe that we are well
positioned to continue to capitalize on the current market trends and that we will see continued increased adoption of our solid-
state, CO2, pulsed fiber, direct diode and excimer lasers, as all these lasers enable entirely new applications, performance
improvements and reduced process costs.
LTPS-based high resolution mobile displays (greater than 300ppi), and especially the emergence of OLED technology, is
evolving as the prevalent FPD technology. We believe we are well positioned, especially with our Vyper Excimer lasers and
LB optical systems, to take advantage of this trend, including the possibility of LTPS-based OLED TVs. CO2, Avia, Talisker
and direct diode lasers all seem aligned with the need for related FPD touch panel, film cutting, light guide technology, repair,
frit welding and glass cutting applications.
Semiconductor devices look set to continue Moore's Law, shrinking device geometries for at least another decade, as well
as expanding vertically into new 3D structures. As a result we believe our many UV laser sources (such as Paladin, Avia,
8
Talisker, ExiStar and Matrix) will continue to find increasing adoption, since their unique optical properties align well with the
process demands of a nanometer scale world.
The same lasers plus CO2 are also widely adopted for back end Advanced Packaging and Interconnect (API) applications.
With dimension roadmaps showing a decade of dimension shrink on PCBs, interconnects, Silicon & LED scribe widths and
glass thickness, we believe that our portfolio of lasers aligns well with these demands as well as new processes that seem likely
to be enabled by our lasers, to meet the increasing demands and decreasing tolerances of these markets.
Materials processing
The market for low to medium power CO2, solid state and semiconductor lasers used in industrial materials processing
has experienced a nice rebound and is expected to see continued growth driven by wider adoption of lasers in new processes
especially in emerging markets. Key design wins as well as more favorable markets continue to support our growth in this area.
These lasers represent a cost-effective manufacturing solution for cutting, joining, marking and engraving of non-metal
materials including marking/coding, flat bed cutting, engraving, as well as the production of capital equipment for apparel and
leather goods manufacturing. Our four-pronged approach to the higher power industrial laser market provides us with a unique
combination of high power, precision and compact size, which we believe will be highly desirable in existing manufacturing
environments as well as those of the future. We offer kilowatt Diamond CO2 lasers, Highlight direct diode lasers and
MetaBEAM family of turnkey laser machine tools. We recently introduced a 1kW fiber to round-out our four-pronged strategy.
Several factors are enabling us to gain market share in the materials processing market. First, we have developed an expanded
portfolio of lasers with a broad spectrum of wavelengths, enabling optimum solutions for virtually every metal and non-metal
material type. At the same time, the reliability of these products has been achieved at even higher levels, lowering the cost of
ownership.
OEM components and instrumentation
The instrumentation market is seeing a gradual migration from the use of mature laser technologies, such as water-cooled
ion gas lasers, to new technologies, primarily based on solid state and semiconductor lasers. Using our unique portfolio of such
lasers, as well as our patented OPSL technology, we are able to both assist and stimulate this transition as well as to be the
technology of choice for developing applications such as security and clinical diagnostics. Our OPSL technology resulted in the
first truly continuous wave solid-state UV laser which enables the use of UV in a clinical as well as a research environment.
Furthermore we anticipate greater future opportunities in bio-instrumentation, including DNA sequencing, drug discovery, flow
cytometry, and microscopy, based on our product enhancements and evolving market developments, particularly in increased
migration from clinical to point-of-care diagnostics. Our newer laser technologies are the basis of a number of clinical
procedures. In the area of photocoagulation, the Genesis OPSL yellow lasers are being used as the wavelength is particularly
suitable for the treatment of blood vessels. In aesthetic laser procedures, we are an OEM supplier of CO2 and semiconductor
lasers to the major manufacturers of equipment used in the latest procedures in dermatology and hair removal. We supply
excimer lasers used in refractive eye surgery and are actively involved in further developments in laser vision correction.
Scientific research and government programs
The scientific market benefited from stimulus funding during fiscal 2011, with applications in ultrashort pulses and in
bio-research being the drivers of this anticipated expansion. We have recently seen the total amount of government-related
funding for scientific research decline to pre-stimulus levels and are uncertain as to impact of the fiscal cliff on future
government funding. However, we believe that as we push the boundaries of performance and ease of use in our ultrafast
lasers, we have the potential to capture a large share of the available market by enabling our customers to win funding for new
research fields that drive discovery. While these markets remain highly competitive, we believe our leadership position and
new product pipeline will drive attosecond science boundaries and Biological Imaging ease of use, enabling new research
frontiers to be forged and we would expect a gain in market share as a result.
9
MARKET APPLICATIONS
We design, manufacture and market lasers, laser tools, precision optics and related accessories for a diverse group of
customers. The following table lists our major markets and the Coherent technologies serving these markets.*
Market
Microelectronics
Application
Technology
Flat panel display
Advanced packaging and
interconnects
Semiconductor front-end
Materials processing
Metal cutting, joining, surface
treatment
Laser marking and coding
Non-metal cutting, drilling
OEM components and
instrumentation
Bio-Instrumentation
Graphic arts and display
Medical therapy (OEM)
Scientific research and government
programs
All scientific applications
CO2
DPSS
Excimer
Ultrafast
Semiconductor
CO2
DPSS
Excimer
Ultrafast
CO2
DPSS
OPSL
Excimer
Ion
CO2
Fiber
Semiconductor
Laser Machine Tools
CO2
DPSS
CO2
DPSS
Excimer
Semiconductor
Laser Machine Tools
DPSS
OPSL
Semiconductor
Ultrafast
OPSL
CO2
CO2
DPSS
Excimer
OPSL
Semiconductor
DPSS
Excimer
OPSL
Ultrafast
*Coherent sells its laser measurement and control products into a number of these applications.
In addition to products we provide, we invest routinely in the core technologies needed to create substantial
differentiation for our products in the marketplace. Our semiconductor, crystal and fiber facilities all maintain an external
customer base providing value-added solutions. We direct significant engineering efforts to produce unique solutions targeted
for internal consumption. These investments, once integrated into our broader product portfolio, provide our customers with
uniquely differentiated solutions and the opportunity to substantially enhance the performance, reliability and capability of the
products we offer.
10
TECHNOLOGIES
Diode-pumped solid-state ("DPSS") lasers
DPSS lasers use semiconductor lasers to pump a crystal to produce a laser beam. By changing the energy, optical
components and the types of crystals used in the laser, different wavelengths and types of laser light can be produced.
The efficiency, reliability, longevity and relatively low cost of DPSS lasers make them ideally suited for a wide range of
OEM and end-user applications, particularly those requiring 24-hour operations. Our DPSS systems are compact and self-
contained sealed units. Unlike conventional tools and other lasers, our DPSS lasers require minimal maintenance since they do
not have internal controls or components that require adjusting and cleaning to maintain consistency. They are also less
affected by environmental changes in temperature and humidity, which can alter alignment and inhibit performance in many
systems.
We manufacture a variety of types of DPSS lasers for different applications including semiconductor inspection;
advanced packaging and interconnects; laser pumping; spectroscopy; bio-agent detection; DNA sequencing; drug discovery;
flow cytometry; forensics; computer-to-plate printing; entertainment lighting (display); medical; rapid prototyping and
marking, welding, engraving, cutting and drilling.
Fiber lasers
Fiber lasers use semiconductor lasers to pump a doped optical fiber to produce a laser beam. The unique features of a
fiber laser make them suitable for producing high power, continuous wave laser beams. We have introduced a 1 kilowatt fiber
laser. Our fiber laser design has several unique features including a modular design for improved serviceability and diode bar
based pumping. Due to packaging efficiency, diode bars reduce the overall cost of a fiber laser. Some of the most critical
components inside a fiber laser include the gain fiber itself and the diodes providing the pump power. We are well positioned
as a fiber laser supplier since we are vertically integrated with respect to these key technologies; we use diode bars and fiber
manufactured in-house. We plan to continue to drive cost reduction in our diode laser pumps and demonstrate the scalability of
the platform by moving up the power scale into the multi kilowatt regime. This platform will address the growing high power
metal cutting and joining market.
Gas lasers (CO2, Excimer, Ion)
The breadth of our gas laser portfolio is industry leading, encompassing CO2, excimer and ion laser technologies. Gas
lasers derive their name from the use of one or more gases as a lasing medium. They collectively span an extremely diverse and
useful emission range, from the very deep ultraviolet to the far infrared. This diverse range of available wavelengths, coupled
with high optical output power, and an abundance of other attractive characteristics, makes gas lasers extremely useful and
popular for a variety of microelectronics, scientific, medical therapeutic and materials processing applications.
Optically Pumped Semiconductor Lasers ("OPSL")
Our OPSL platform is a surface emitting semiconductor laser that is energized or pumped by a semiconductor laser. The
use of optical pumping circumvents inherent power scaling limitations of electrically pumped lasers, enabling very high
powered devices. A wide range of wavelengths can be achieved by varying the semiconductor materials used in the device and
changing the frequency of the laser beam using techniques common in solid state lasers. The platform leverages high reliability
technologies developed for telecommunications and produces a compact, rugged, high power, single-mode laser.
Our OPSL products are well suited to a wide range of applications, including the bio-instrumentation, medical
therapeutics and graphic arts and display markets. In fiscal 2009, our Genesis yellow laser continued to make progress in
ophthalmology and we have expanded our offerings in the area of entertainment lighting using a variety of products across the
visible spectrum. We also continue to expand our ultraviolet version of the OPSL platform called the Genesis, which was
developed for the bio-instrumentation market.
Semiconductor lasers
High power edge emitting semiconductor diode lasers use the same principles as widely-used CD and DVD lasers, but
produce significantly higher power levels. The advantages of this type of laser include smaller size, longer life, enhanced
reliability and greater efficiency. We manufacture a wide range of discrete semiconductor laser products with wavelengths
ranging from 650nm to over 1000nm and output powers ranging from 1W to over 100W, with highly integrated products in the
kW range. These products are available in a variety of industry standard form factors including the following: bare die,
packaged and fiber coupled single emitters and bars, monolithic stacks, and fully integrated modules with microprocessor
controlled units that contain power supplies and active coolers.
Our semiconductor lasers are used internally as the pump lasers in DPSS, fiber and OPSL products that are manufactured
by us, as well as a wide variety of external medical, OEM, military and industrial applications, including aesthetic (hair
11
removal, cosmetic dentistry), graphic arts, counter measures, rangefinders, target designators, and plastic welding.
Ultrafast ("UF") Lasers
Ultrafast lasers are lasers generating light pulses with durations of a few femtoseconds (10-15 seconds) to a few tens of
picoseconds (10-11 seconds). These types of lasers are primarily used for scientific research and also are finding use in
sophisticated materials processing applications. Ultrafast lasers are usually pumped by a green DPSS laser. UF laser oscillators
generate a train of pulses at 50-100 MHz, with peak powers of tens of kilowatts, and UF laser amplifiers generate pulses at 1-
10 kHz, with peak powers up to several Terawatts.
The extremely short duration of UF laser pulses enables temporally resolving fast events like the dynamics of atoms or
electrons. In addition, the high peak power enables so-called non-linear effects where several photons can be absorbed by a
molecule at the same time. This type of process enables applications like multi-photon excitation microscopy or UF ablation of
materials with minimal thermal damage.
SALES AND MARKETING
We market our products domestically through a direct sales force. Our foreign sales are made principally to customers in
Japan, South Korea, Germany and other European and Asia-Pacific countries. We sell internationally through direct sales
personnel located in Canada, France, Germany, Italy, Japan, the Netherlands, China, South Korea, Taiwan and the United
Kingdom, as well as through independent representatives in certain jurisdictions around the world. Foreign sales accounted for
76% of our total net sales in fiscal 2012, 74% of our total net sales in fiscal 2011 and 67% of our total net sales in fiscal 2010.
In fiscal 2012, sales to Asian markets continued to grow at a faster rate than sales to other geographic regions. Sales made to
independent representatives and distributors are generally priced in U.S. dollars. A large portion of foreign sales that we make
directly to customers are priced in local currencies and are therefore subject to currency exchange fluctuations. Foreign sales
are also subject to other normal risks of foreign operations such as protective tariffs, export and import controls and political
instability.
We had two customers during fiscal 2012 who contributed more than 10% of revenue, Japan Steel Works, Ltd. and
Advanced Process Systems Corporation. There were no major customers over 10% of revenues for fiscal 2011 or 2010.
To support our sales efforts we maintain and continue to invest in a number of applications centers around the world,
where our applications experts work closely with customers on developing laser processes to meet their manufacturing needs.
The applications span a wide range, but are mostly centered around the materials processing and microelectronics markets.
Locations include several facilities in the US, Europe and Asia.
We maintain customer support and field service staff in major markets within the United States, Europe, Japan, China,
South Korea, Taiwan and other Asia-Pacific countries. This organization works closely with customers, customer groups and
independent representatives in servicing equipment, training customers to use our products and exploring additional
applications of our technologies.
We typically provide parts and service warranties on our lasers, laser-based systems, optical and laser components and
related accessories and services. Warranties on some of our products and services may be shorter or longer than one year.
Warranty reserves, as reflected on our consolidated balance sheets, have generally been sufficient to cover product warranty
repair and replacement costs. The weighted average warranty period covered is approximately 15 months.
RESEARCH AND DEVELOPMENT
We are committed to the development of new products, as well as the improvement and refinement of existing products,
including better cost-of-ownership. Our development efforts are focused on designing and developing products, services and
solutions that anticipate customers' changing needs and emerging technological trends. Our efforts are also focused on
identifying the areas where we believe we can make valuable contributions. Research and development expenditures for fiscal
2012 were $78.3 million, or 10.2% of net sales compared to $81.2 million, or 10.1% of net sales for fiscal 2011 and $72.4
million, or 12.0% of net sales for fiscal 2010. We work closely with customers, both individually and through our sponsored
seminars, to develop products to meet customer application and performance needs. In addition, we are working with leading
research and educational institutions to develop new photonics based solutions.
MANUFACTURING
Strategies
One of our core manufacturing strategies is to tightly control our supply of key parts, components, sub-assemblies and
outsourcing partners. We primarily utilize vertical integration when we have proprietary internal capabilities that are not
available from external sources cost-effectively. We believe this is essential to maintain high quality products and enable rapid
development and deployment of new products and technologies. We provide customers with 24-hour technical expertise and
12
quality that is International Organization for Standardization ("ISO") certified at our principal manufacturing sites.
Committed to quality and customer satisfaction, we design and produce many of our own components and sub-
assemblies in order to retain quality control. We have also outsourced certain components, sub-assemblies and finished goods
where we can maintain our high quality standards while improving our cost structure. In 2007, we embarked on a plan to
consolidate and close certain of our manufacturing facilities in order to reduce our footprint, realize synergies, and improve our
cost structure and operating leverage. We have successfully executed this plan and closed six of our manufacturing facilities
including Auburn and Lundy, California; St. Louis, Missouri; Montreal, Canada; Munich, Germany; and Tampere, Finland.
The manufacturing of products from these six facilities were transferred to our other facilities or outsourced to our contract
manufacturing partners.
As part of our strategy to increase our market share and customer support in Asia as well as our continuing efforts to
manage costs, we acquired the business assets of privately-held Hypertronics in the second quarter of fiscal 2011. Hypertronics'
assets included an engineering and integration center in Singapore and a low cost manufacturing facility in Penang, Malaysia.
We have increased the footprint of both the Singapore and Malaysia factories and plan to use these operations to serve as a
nucleus for laser manufacturing and repair in Asia. This will allow us to reduce service response time and inventories,
providing benefits to us and to our customers. We have also established an International Procurement Office in Singapore and
plan to increase our sourcing of materials from Asia. As this function is developed, we will be able to reduce material costs on
a global basis. In fiscal 2012, we opened a tube refurbishment manufacturing site in South Korea to better service our
customers in that region.
We have designed and implemented proprietary manufacturing tools, equipment and techniques in an effort to provide
products that differentiate us from our competitors. These proprietary manufacturing techniques are utilized in a number of our
product lines including our gas laser production, crystal growth, beam alignment as well as the wafer growth for our
semiconductor and optically pumped semiconductor laser product family.
Raw materials or sub-components required in the manufacturing process are generally available from several sources.
However, we currently purchase several key components and materials, including exotic materials, crystals and optics, used in
the manufacture of our products from sole source or limited source suppliers. We also purchase assemblies and turnkey
solutions from contract manufacturers based on our proprietary designs. We rely on our own production and design capability
to manufacture and specify certain strategic components, crystals, fibers, semiconductor lasers, lasers and laser based systems.
For a discussion of the importance to our business of, and the risks attendant to sourcing, see "Risk Factors—We depend
on sole source or limited source suppliers, both internal and external, for some of our key components and materials, including
exotic materials, certain cutting-edge optics and crystals, in our products, which make us susceptible to supply shortages or
price fluctuations that could adversely affect our business" in Item 1A.
Operations
Our products are manufactured at our sites in Santa Clara and Sunnyvale, California; Wilsonville, Oregon; East Hanover,
New Jersey; Bloomfield, Connecticut; Lübeck, Germany; Göttingen, Germany; Glasgow, Scotland; Salem, New Hampshire;
Kallang Sector, Singapore; and Penang, Malaysia. In addition, we also use contract manufacturers for the production of certain
assemblies and turnkey solutions. Our ion gas lasers, a portion of our DPSS lasers that are used in microelectronics, scientific
research and materials processing applications, semiconductor lasers, fiber lasers and ultrafast scientific lasers are
manufactured at our Santa Clara, California site. Our laser diode module products, laser instrumentation products, test and
measurement equipment products are manufactured in Wilsonville, Oregon. We manufacture exotic crystals in East Hanover,
New Jersey and both active and passive fibers are manufactured in our Salem, New Hampshire facility. Our CO2 gas lasers are
manufactured in Bloomfield, Connecticut. We manufacture a portion of our DPSS lasers used in microelectronics and OEM
components and instrumentation applications in Lübeck, Germany. Our excimer gas laser products are manufactured in
Göttingen, Germany. We manufacture the fiber-based lasers and a portion of our DPSS lasers used in microelectronics and
scientific research applications in Glasgow, Scotland. Our facility in Sunnyvale, California grows the aluminum-free materials
that are incorporated into our semiconductor lasers. We have transferred several products and subassemblies for manufacture at
our Singapore and Malaysia facilities and we are in the process of transferring additional product manufacturing to Singapore
and Malaysia as part of our Asia strategy. We refurbish excimer tubes at our manufacturing site in South Korea.
INTELLECTUAL PROPERTY
We rely on a combination of patent, copyright, trademark and trade secret laws and restrictions on disclosure to protect
our intellectual property rights. As of September 29, 2012, we held approximately 403 U.S. and foreign patents, which expire
from 2013 through 2029 (depending on the payment of maintenance fees) and we have approximately 136 additional pending
patent applications that have been filed. The issued patents cover various products in all of the major markets that we serve.
For a discussion of the importance to our business of, and the risks attendant to intellectual property rights, see "Risk
Factors—Risks Associated with Our Industry, Our Business and Market Conditions" 'We may not be able to protect our
13
proprietary technology which could adversely affect our competitive advantage' and 'We may, in the future, be subject to
claims or litigation from third parties, for claims of infringement of their proprietary rights or to determine the scope and
validity of our proprietary rights or the proprietary rights of competitors or other rights holders. These claims could result in
costly litigation and the diversion of our technical and management personnel. Adverse resolution of litigation may harm our
operating results or financial condition' in Item 1A.
COMPETITION
Competition in the various photonics markets in which we provide products is very intense. We compete against a
number of companies including CVI Melles Griot, Cymer, Inc., GSI Group, Inc., IPG Photonics Corporation, JDS Uniphase
Corporation, Newport Corporation, Rofin-Sinar Technologies, Inc., and Trumpf GmbH, as well as other smaller companies.
We compete globally based on our broad product offering, reliability, cost, and performance advantages for the widest range of
commercial and scientific research applications. Other considerations by our customers include warranty, global service and
support and distribution.
BACKLOG
At fiscal 2012 year-end, our backlog of orders scheduled for shipment (generally within one year) was $352.8 million
compared to $356.5 million at fiscal 2011 and $262.0 million at fiscal 2010 year-end. Orders used to compute backlog are
generally cancelable without substantial penalties. Historically, the rate of cancellation experienced by us has not been
significant though we cannot guarantee that cancellations will not increase in the future.
SEASONALITY
We have historically experienced decreased bookings and revenue in the first fiscal quarter compared to other quarters in
our fiscal year due to the impact of time off and business closures at many of our customers due to year-end holidays. This
historical pattern should not be considered a reliable indicator of the Company's future net sales or financial performance.
EMPLOYEES
As of fiscal 2012 year-end, we had 2,328 employees. Approximately 371 of our employees are involved in research and
development; 1,384 of our employees are involved in operations, manufacturing, service and quality assurance; and 573 of our
employees are involved in sales, order administration, marketing, finance, information technology and other administrative
functions. Our success will depend in large part upon our ability to attract and retain employees. We face competition in this
regard from other companies, research and academic institutions, government entities and other organizations. We consider our
relations with our employees to be good.
ACQUISITIONS
In July 2012, we acquired all of the outstanding shares of MiDAZ Lasers Ltd for approximately $3.8 million in cash.
MiDAZ was a technology-based acquisition. We intend to utilize the acquired technology in low cost, compact pulsed solid
state lasers. MiDAZ has been included in our Specialty Lasers and Systems segment.
In January 2011, we acquired all of the assets and assumed certain liabilities of Hypertronics Pte Ltd for approximately
$14.5 million in cash. Hypertronics designs and manufactures laser-and vision-based tools for flat panel, storage,
semiconductor and solar applications at facilities in Singapore and Malaysia. Hypertronics has been included in our Specialty
Lasers and Systems segment.
In April 2010, we acquired Beam Dynamics, Inc. for $5.9 million in cash and $0.3 million in deferred compensation
related to an employment contract, which was recognized in expense as earned. Beam Dynamics manufactures flexible laser
cutting tools for the materials processing market. Beam Dynamics has been included in our Commercial Lasers and
Components segment.
In October 2009, we acquired all the assets and certain liabilities of StockerYale, Inc.'s ("StockerYale") laser module
product line in Montreal and its specialty fiber product line in Salem, New Hampshire for $15.0 million in cash. StockerYale
designs, develops and manufactures low power laser modules, light emitting diode (LED) systems and specialty optical fiber
products. These assets and liabilities have been included in our Commercial Lasers and Components segment.
Please refer to "Note 4. Business Combinations" of Notes to Consolidated Financial Statements under Item 15 of this
annual report for further discussion of the acquisition completed during fiscal 2012.
RESTRUCTURINGS AND CONSOLIDATION
There were no new restructuring activities undertaken during fiscal 2012. During the first quarter of fiscal 2010, we
acquired the assets and certain liabilities of StockerYale's laser module product line in Montreal, Canada and began to
transition those activities to contract manufacturers and other Coherent facilities in Salem, Massachusetts, Wilsonville, Oregon
14
and Sunnyvale, California. The transfer was completed in the second quarter of fiscal 2011. The fiscal 2010 severance related
costs were primarily comprised of severance pay, outplacement services, medical and other related benefits for employees
being terminated due to the transition of activities out of Montreal, Canada, and Tampere, Finland. The fiscal 2011 severance
related costs were primarily comprised of severance pay, outplacement services, medical and other related benefits for
employees being terminated due to the transition of activities out of Tampere, Finland.
During the second quarter of fiscal 2009, we announced our plans to close our facilities in Tampere, Finland and
St. Louis, Missouri. The closure of our St. Louis, Missouri and Yokohama, Japan sites were completed in the fourth quarter of
fiscal 2009. The closure of our Finland site was scheduled for completion by the end of fiscal 2010, but we decided to delay the
closure due to increased demand for products manufactured in Finland. In the second quarter of fiscal 2011, we ceased
manufacturing operations in our Finland facility and we exited the facility in the third quarter of fiscal 2011. These closure
plans resulted in charges primarily for employee termination and other exit related costs associated with a plan approved by
management. We completed the last restructuring activities under these plans during fiscal 2012.
GOVERNMENT REGULATION
Environmental regulation
Our operations are subject to various federal, state and local environmental protection regulations governing the use,
storage, handling and disposal of hazardous materials, chemicals, various radioactive materials and certain waste products. In
the United States, we are subject to the federal regulation and control of the Environmental Protection Agency. Comparable
authorities are involved in other countries. We believe that compliance with federal, state and local environmental protection
regulations will not have a material adverse effect on our capital expenditures, earnings and competitive and financial position.
Although we believe that our safety procedures for using, handling, storing and disposing of such materials comply with
the standards required by federal and state laws and regulations, we cannot completely eliminate the risk of accidental
contamination or injury from these materials. In the event of such an accident involving such materials, we could be liable for
damages and such liability could exceed the amount of our liability insurance coverage and the resources of our business.
We may face potentially increasing complexity in our product designs and procurement operations as we adjust to
requirements relating to the materials composition of products entering specific markets. Such regulations went into effect in
the European Union ("EU") in 2006, and China in 2007. We could face significant costs and liabilities in connection with
product take-back legislation. Beginning in 2006, the EU Waste Electrical and Electronic Equipment Directive made producers
of electrical goods financially responsible for specified collection, recycling, treatment and disposal of past and future covered
products. In addition, the EU has added the Registration, Evaluation and Authorization of Chemicals Regulation, otherwise
known as the REACH Regulation, which further regulates substances and products imported, manufactured or sold within the
EU. Similar laws are now pending in various jurisdictions around the world, including the United States.
We further discuss the impact of environmental regulation under "Risk Factors—Compliance or the failure to comply
with current and future environmental regulations could cause us significant expense" in Item 1A.
SEGMENT INFORMATION
We are organized into two operating segments: Commercial Lasers and Components ("CLC") and Specialty Lasers and
Systems ("SLS"). This segmentation reflects the go-to-market strategies for various products and markets. While both segments
work to deliver cost-effective photonics solutions, CLC focuses on higher volume products that are offered in set
configurations. The product architectures are designed for easy exchange at the point of use such that product service and
repairs are based upon advanced replacement and depot (i.e., factory) repair. CLC's primary markets include materials
processing, OEM components and instrumentation and microelectronics. SLS develops and manufacturers configurable,
advanced-performance products largely serving the microelectronics, scientific research and government programs and OEM
components and instrumentation markets. The size and complexity of many of the SLS products require service to be
performed at the customer site by factory-trained field service engineers.
We have identified CLC and SLS as operating segments for which discrete financial information was available. Both
units have dedicated engineering, manufacturing, product business management and product line management functions. A
small portion of our outside revenue is attributable to projects and recently developed products for which a segment has not yet
been determined. The associated direct and indirect costs are presented in the category of Corporate and other, along with other
corporate costs.
FINANCIAL INFORMATION ABOUT FOREIGN AND DOMESTIC OPERATIONS AND EXPORT SALES
Financial information relating to foreign and domestic operations for fiscal years 2012, 2011 and 2010, is set forth in
Note 18, "Segment and Geographic Information" of our Notes to Consolidated Financial Statements under Item 15 of this
annual report.
15
ITEM 1A. RISK FACTORS
You should carefully consider the followings risks when considering an investment in our Common Stock. These risks could
materially affect our business, results of operations or financial condition, cause the trading price of our Common Stock to
decline materially or cause our actual results to differ materially from those expected or those expressed in any forward-
looking statements made by us. These risks are not exclusive, and additional risks to which we are subject include, but are not
limited to, the factors mentioned under “Forward-Looking Statements” and the risk of our businesses described elsewhere in
this annual report. Additionally, these risks and uncertainties described herein are not the only ones facing us. Other events
that we do not currently anticipate or that we currently deem immaterial also may affect our business, results of operations or
financial conditions.
BUSINESS ENVIRONMENT AND INDUSTRY TRENDS
Risks Associated with Our Industry, Our Business and Market Conditions
Our operating results, including net sales, net income (loss) and adjusted EBITDA in dollars and as a percentage of net
sales, as well as our stock price have varied in the past, and our future operating results will continue to be subject to
quarterly and annual fluctuations based upon numerous factors, including those discussed in this Item 1A and
throughout this report. Our stock price will continue to be subject to daily variations as well. Our future operating
results and stock price may not follow any past trends or meet our guidance and expectations.
Our net sales and operating results, such as adjusted EBITDA percentage, net income (loss) and operating expenses, and
our stock price have varied in the past and may vary significantly from quarter to quarter and from year to year in the future.
We believe a number of factors, many of which are outside of our control, could cause these variations and make them difficult
to predict, including:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
general economic uncertainties in the macroeconomic and local economies facing us, our customers and the markets
we serve;
fluctuations in demand for our products or downturns in the industries that we serve;
the ability of our suppliers, both internal and external, to produce and deliver components and parts, including sole or
limited source components, in a timely manner, in the quantity, quality and prices desired;
the timing of conversion of bookings to revenue;
the concentration of a significant amount of our backlog with a few customers;
cancellation of customer orders and rescheduling of shipments;
fluctuations in our product mix;
the ability of our customers' other suppliers to provide sufficient material to support our customers' products;
currency fluctuations and stability, in particular the Euro and the US dollar as compared to other international
currencies;
commodity pricing;
introductions of new products and product enhancements by our competitors, entry of new competitors into our
markets, pricing pressures and other competitive factors;
our ability to develop, introduce, manufacture and ship new and enhanced products in a timely manner without
defects;
our ability to manage our capacity and that of our suppliers;
our increased reliance on contract manufacturing;
the rate of market acceptance of our new products;
16
•
•
•
•
•
•
•
•
•
•
•
•
•
the ability of our customers to pay for our products;
expenses associated with acquisition-related activities;
seasonal sales trends;
access to applicable credit markets by us, our customers and their end customers;
delays or reductions in customer purchases of our products in anticipation of the introduction of new and enhanced
products by us or our competitors;
our ability to control expenses;
the level of capital spending of our customers;
potential excess and/or obsolescence of our inventory;
costs and timing of adhering to current and developing governmental regulations and reviews relating to our products
and business;
costs related to acquisitions of technology or businesses;
impairment of goodwill, intangible assets and other long-lived assets;
our ability to meet our expectations and forecasts and those of public market analysts and investors;
the availability of research funding by governments with regard to our customers in the scientific business, such as
universities;
•
continued government spending on defense-related projects where we are a subcontractor;
• maintenance of supply relating to products sold to the government on terms which we would prefer not to accept;
•
changes in policy, interpretations, or challenges to the allowability of costs incurred under government cost accounting
standards;
•
damage to our reputation as a result of coverage in social media, Internet blogs or other media outlets;
• managing our and other parties' compliance with contracts in multiple languages and jurisdictions;
• managing our internal and third party sales representatives and distributors, including compliance with all applicable
laws;
•
•
•
•
•
impact of government economic policies on macroeconomic conditions;
costs and expenses from litigation;
costs associated with designing around or payment of licensing fees associated with issued patents in our fields of
business;
government support of the alternative energy industries, such as solar;
the future impact of legislation, rulemaking, and changes in accounting, tax, defense procurement, or export policies;
and
•
distraction of management related to acquisition or divestment activities.
In addition, we often recognize a substantial portion of our sales in the last month of our fiscal quarters. Our expenses for
any given quarter are typically based on expected sales and if sales are below expectations in any given quarter, the adverse
impact of the shortfall on our operating results may be magnified by our inability to adjust spending quickly enough to
compensate for the shortfall. We also base our manufacturing on our forecasted product mix for the quarter. If the actual
17
product mix varies significantly from our forecast, we may not be able to fill some orders during that quarter, which would
result in delays in the shipment of our products. Accordingly, variations in timing of sales, particularly for our higher priced,
higher margin products, can cause significant fluctuations in quarterly operating results.
Due to these and other factors, such as varying product mix, we believe that quarter-to-quarter and year-to-year
comparisons of our historical operating results may not be meaningful. You should not rely on our results for any quarter or
year as an indication of our future performance. Our operating results in future quarters and years may be below public market
analysts' or investors' expectations, which would likely cause the price of our stock to fall. In addition, over the past several
years, the stock market has experienced extreme price and volume fluctuations that have affected the stock prices of many
technology companies both in and outside our industry. There has not always been a direct correlation between this volatility
and the performance of particular companies subject to these stock price fluctuations. Further, over the last twelve months,
equity markets around the world have significantly fluctuated across most sectors. These factors, as well as general economic
and political conditions or investors' concerns regarding the credibility of corporate financial statements, may have a material
adverse effect on the market price of our stock in the future.
We are exposed to risks associated with worldwide economic conditions and related uncertainties which could negatively
impact demand for our products and results of operations.
Volatility and disruption in the capital and credit markets, depressed consumer confidence, government economic
policies, negative economic conditions, volatile corporate profits and reduced capital spending could negatively impact demand
for our products. In particular, it is difficult to develop and implement strategy, sustainable business models and efficient
operations, as well as effectively manage supply chain relationships in the face of such conditions including uncertainty
regarding the ability of some of our suppliers to continue operations and provide us with uninterrupted supply flow. Our ability
to maintain our research and development investments in our broad product offerings may be adversely impacted in the event
that our sales decline and do not increase in the future. Spending and the timing thereof by consumers and businesses has a
significant impact on our results and, where such spending is delayed or canceled, it could have a material negative impact on
our operating results. The current global economic conditions remain uncertain and challenging. Weakness in our end markets
could negatively impact our revenue, gross margin and operating expenses, and consequently have a material adverse effect on
our business, financial condition and results of operations.
In the United States, uncertainty over U.S. fiscal policy, including the potential for the so-called “fiscal cliff” has likely
had a recent adverse impact on U.S. financial markets and overall economic activity. The “fiscal cliff” refers to a series of tax
increases and government spending reductions that will automatically occur at the end of 2012 in the absence of Congressional
action to delay or offset these actions. If ultimately realized, the fiscal cliff would likely negatively impact global economic
activity, including possibly sending the U.S. into a new recession. It would also likely have negative repercussions on U.S. and
global credit and financial markets, and further exacerbate sovereign debt concerns in the European Union. All of these factors
would likely adversely impact the global demand for our products and the performance of our investments, and would likely
have a material adverse effect on our business, results of operations and financial condition.
The financial turmoil which recently affected the banking system and financial markets continues to negatively impact
financial institutions and has resulted in tighter credit markets, and lower levels of liquidity in some financial markets. There
could be a number of follow-on effects from the tightened credit environment on our business, including the insolvency of key
suppliers or their inability to obtain credit to finance development and/or manufacture products resulting in product delays;
inability of customers to obtain credit to finance purchases of our products and/or customer insolvencies; and failure of
financial institutions negatively impacting our treasury functions. In the event our customers are unable to obtain credit or
otherwise pay for our shipped products it could significantly impact our ability to collect on our outstanding accounts
receivable. Other income and expense also could vary materially from expectations depending on gains or losses realized on
the sale or exchange of financial instruments; impairment charges resulting from revaluations of debt and equity securities and
other investments; interest rates; cash balances; and changes in fair value of derivative instruments. Volatility in the financial
markets and any overall economic uncertainty increase the risk that the actual amounts realized in the future on our financial
instruments could differ significantly from the fair values currently assigned to them. Uncertainty about current global
economic conditions could also continue to increase the volatility of our stock price.
In addition, political and social turmoil related to international conflicts, terrorist acts and civil unrest may put further
pressure on economic conditions in the United States and abroad. Unstable economic, political and social conditions make it
difficult for our customers, our suppliers and us to accurately forecast and plan future business activities. If such conditions
persist, our business, financial condition and results of operations could suffer. Additionally, unstable economic conditions can
provide significant pressures and burdens on individuals, which could cause them to engage in inappropriate business conduct.
See “Part II, Item 4A. CONTROLS AND PROCEDURES-Inherent Limitations over Internal Control.”
18
We depend on sole source or limited source suppliers, both internal and external, for some of our key components and
materials, including exotic materials, certain cutting-edge optics and crystals, in our products, which make us susceptible to
supply shortages or price fluctuations that could adversely affect our business.
We currently purchase several key components and materials used in the manufacture of our products from sole source or
limited source suppliers, both internal and external. Our failure to timely receive these key components and materials, such as
the large optics used in our flat panel display manufacturing applications, could cause delays in the shipment of our products.
Some of these suppliers are relatively small private companies that may discontinue their operations at any time and which may
be particularly susceptible to prevailing economic conditions. Some of our suppliers are located in regions which may be
susceptible to natural disasters, such as last year's flooding in Thailand and the earthquake, tsunami and resulting nuclear
disaster in Japan and this year's severe flooding and power loss in the Eastern part of the United States. We typically purchase
our components and materials through purchase orders or agreed upon terms and conditions and we do not have guaranteed
supply arrangements with many of these suppliers. Some of our products, particularly in the flat panel display industry, require
designs and specifications which are at the cutting-edge of available technologies. Our and our customers' designs and
specifications frequently change to meet rapidly evolving market demands. Accordingly certain of our products require
components and supplies which may be technologically difficult and unpredictable to manufacture. These characteristics
further pressure the timely delivery of such components. We may fail to obtain these supplies in a timely manner in the future.
We may experience difficulty identifying alternative sources of supply for certain components used in our products and may
have to incur expenses and management distraction in assisting our current and future suppliers to meet our and our customers'
technical requirements. We would experience further delays while identifying, evaluating and testing the products of these
potential alternative suppliers. Furthermore, financial or other difficulties faced by these suppliers or significant changes in
demand for these components or materials could limit their availability. We continue to consolidate our supply base and move
supplier locations. When we transition locations we may increase our inventory of such products as a “safety stock” during the
transition, which may cause the amount of inventory reflected on our balance sheet to increase. Additionally, many of our
customers rely on sole source suppliers. In the event of a disruption of our customers' supply chain, orders from our customers
could decrease or be delayed.
Any interruption or delay in the supply of any of these components or materials, or the inability to obtain these
components and materials from alternate sources at acceptable prices and within a reasonable amount of time, or our failure to
properly manage these moves, would impair our ability to meet scheduled product deliveries to our customers and could cause
customers to cancel orders. We have historically relied exclusively on our own production capability to manufacture certain
strategic components, crystals, semiconductor lasers, lasers and laser-based systems. Because we manufacture, package and test
these components, products and systems at our own facilities, and such components, products and systems are not readily
available from other sources, any interruption in manufacturing would adversely affect our business. In addition, our failure to
achieve adequate manufacturing yields of these items at our manufacturing facilities may materially and adversely affect our
operating results and financial condition.
We participate in the microelectronics market, which requires significant research and development expenses to develop
and maintain products and a failure to achieve market acceptance for our products could have a significant negative impact
on our business and results of operations.
The microelectronics market is characterized by rapid technological change, frequent product introductions, the volatility
of product supply and demand, changing customer requirements and evolving industry standards. The nature of this market
requires significant research and development expenses to participate, with substantial resources invested in advance of
material sales of our products to our customers in this market. Additionally, our product offerings may become obsolete given
the frequent introduction of alternative technologies. In the event either our customers' or our products fail to gain market
acceptance, or the microelectronics market fails to grow, it would likely have a significant negative effect on our business and
results of operations.
We participate in the flat panel display market, which has a relatively limited number of end customer manufacturers. Our
backlog, timing of revenues and results of operations could be negatively impacted in the event our customers reschedule
orders.
In the flat panel display market, there are a relatively limited number of manufacturers who are the end customers for our
annealing products. Given macroeconomic conditions, varying consumer demand and technical process limitations at
manufacturers, our customers may seek to reschedule or cancel orders. Challenges in meeting evolving technological
requirements for these complex products by us and our suppliers could also result in delays in shipments, rescheduled or
canceled orders by our customers. This could negatively impact our backlog, timing of revenues and results of operations.
Some of our laser systems are complex in design and may contain defects that are not detected until deployed by our
customers, which could increase our costs and reduce our revenues.
19
Lasers and laser systems are inherently complex in design and require ongoing regular maintenance. The manufacture of
our lasers, laser products and systems involves a highly complex and precise process. As a result of the technological
complexity of our products, in particular the flat panel annealing systems, changes in our or our suppliers' manufacturing
processes or the inadvertent use of defective materials by us or our suppliers could result in a material adverse effect on our
ability to achieve acceptable manufacturing yields and product reliability. To the extent that we do not achieve and maintain
our projected yields or product reliability, our business, operating results, financial condition and customer relationships would
be adversely affected. We provide warranties on a majority of our product sales, and reserves for estimated warranty costs are
recorded during the period of sale. The determination of such reserves requires us to make estimates of failure rates and
expected costs to repair or replace the products under warranty. We typically establish warranty reserves based on historical
warranty costs for each product line. If actual return rates and/or repair and replacement costs differ significantly from our
estimates, adjustments to cost of sales may be required in future periods which could have an adverse effect on our results of
operations.
Our customers may discover defects in our products after the products have been fully deployed and operated under the
end user's peak stress conditions. In addition, some of our products are combined with products from other vendors, which may
contain defects. As a result, should problems occur, it may be difficult to identify the source of the problem. If we are unable to
identify and fix defects or other problems, we could experience, among other things:
•
•
•
•
•
•
loss of customers or orders;
increased costs of product returns and warranty expenses;
damage to our brand reputation;
failure to attract new customers or achieve market acceptance;
diversion of development and engineering resources; and
legal actions by our customers and/or their end users.
The occurrence of any one or more of the foregoing factors could seriously harm our business, financial condition and
results of operations.
Continued volatility in the semiconductor manufacturing industry could adversely affect our business, financial condition
and results of operations.
A portion of our net sales in the microelectronics market depend on the demand for our products by semiconductor
equipment companies. The semiconductor market has historically been characterized by sudden and severe cyclical variations
in product supply and demand, which have often severely affected the demand for semiconductor manufacturing equipment,
including laser-based tools and systems. The timing, severity and duration of these market cycles are difficult to predict, and
we may not be able to respond effectively to these cycles. The continuing uncertainty in this market severely limits our ability
to predict our business prospects or financial results in this market.
During industry downturns, our revenues from this market may decline suddenly and significantly. Our ability to rapidly
and effectively reduce our cost structure in response to such downturns is limited by the fixed nature of many of our expenses
in the near term and by our need to continue our investment in next-generation product technology and to support and service
our products. In addition, due to the relatively long manufacturing lead times for some of the systems and subsystems we sell to
this market, we may incur expenditures or purchase raw materials or components for products we cannot sell. Accordingly,
downturns in the semiconductor capital equipment market may materially harm our operating results. Conversely, when
upturns in this market occur, we must be able to rapidly and effectively increase our manufacturing capacity to meet increases
in customer demand that may be extremely rapid, and if we fail to do so we may lose business to our competitors and our
relationships with our customers may be harmed.
Our cash and cash equivalents and short-term investments are managed through various banks around the world and
volatility in the capital and credit market conditions could cause financial institutions to fail or materially harm service
levels provided by such banks, both of which could have an adverse affect on our ability to timely access funds.
World capital and credit markets have been and may continue to experience volatility and disruption. In some cases, the
markets have exerted downward pressure on stock prices and credit capacity for certain issuers, as well as pressured the
solvency of some financial institutions. These financial institutions, including banks, have had difficulty timely performing
20
regular services and in some cases have failed or otherwise been largely taken over by governments. We maintain our cash,
cash equivalents and short-term investments with a number of financial institutions around the world. Should some or all of
these financial institutions fail or otherwise be unable to timely perform requested services, we would likely have a limited
ability to timely access our cash deposited with such institutions, or, in extreme circumstances the failure of such institutions
could cause us to be unable to access cash for the foreseeable future. If we are unable to quickly access our funds when we
need them, we may need to increase the use of our existing credit lines or access more expensive credit, if available. If we are
unable to access our cash or if we access existing or additional credit or are unable to access additional credit, it could have a
negative impact on our operations, including our reported net income.
We are exposed to credit risk and fluctuations in the market values of our investment portfolio.
Although we have not recognized any material losses on our cash, cash equivalents and short-term investments, future
declines in their market values could have a material adverse effect on our financial condition and operating results. Given the
global nature of our business, we have investments both domestically and internationally. There has recently been growing
pressure on the creditworthiness of sovereign nations, particularly in Europe where a significant portion of our cash, cash
equivalents and short-term investments are invested, which results in corresponding pressure on the valuation of the securities
issued by such nations. Additionally, our overall investment portfolio is often concentrated in certificates of deposit and money
market funds. We maintain a mix of government-issued securities. Credit ratings and pricing of these investments can be
negatively impacted by liquidity, credit deterioration or losses, financial results, or other factors. Additionally, liquidity issues
or political actions by sovereign nations could result in decreased values for our investments in certain government securities.
As a result, the value or liquidity of our cash, cash equivalents and short-term investments could decline or become materially
impaired, which could have a material adverse effect on our financial condition and operating results. See “Item 7A.
Quantitative and Qualitative Disclosures about Market Risk.”
Our future success depends on our ability to increase our sales volumes and decrease our costs to offset potential declines in
the average selling prices (“ASPs”) of our products and, if we are unable to realize greater sales volumes and lower costs,
our operating results may suffer.
Our ability to increase our sales volume and our future success depends on the continued growth of the markets for lasers,
laser systems and related accessories, as well as our ability to identify, in advance, emerging markets for laser-based systems.
We cannot assure you that we will be able to successfully identify, on a timely basis, new high-growth markets in the future.
Moreover, we cannot assure you that new markets will develop for our products or our customers' products, or that our
technology or pricing will enable such markets to develop. Future demand for our products is uncertain and will depend to a
great degree on continued technological development and the introduction of new or enhanced products. If this does not
continue, sales of our products may decline and our business will be harmed.
We have in the past experienced decreases in the ASPs of some of our products. As competing products become more
widely available, the ASPs of our products may decrease. If we are unable to offset any decrease in our ASPs by increasing our
sales volumes, our net sales will decline. In addition, to maintain our gross margins, we must continue to reduce the cost of
manufacturing our products while maintaining their high quality. From time to time, our products, like many complex
technological products, may fail in greater frequency than anticipated. This can lead to further charges, which can result in
higher costs, lower gross margins and lower operating results. Furthermore, as ASPs of our current products decline, we must
develop and introduce new products and product enhancements with higher margins. If we cannot maintain our gross margins,
our operating results could be seriously harmed, particularly if the ASPs of our products decrease significantly.
Our future success depends on our ability to develop and successfully introduce new and enhanced products that meet the
needs of our customers.
Our current products address a broad range of commercial and scientific research applications in the photonics markets.
We cannot assure you that the market for these applications will continue to generate significant or consistent demand for our
products. Demand for our products could be significantly diminished by disrupting technologies or products that replace them
or render them obsolete. Furthermore, the new and enhanced products in certain markets generally continue to be smaller in
size and have lower ASPs, and therefore, we have to sell more units to maintain revenue levels. Accordingly, we must continue
to invest in research and development in order to develop competitive products.
Our future success depends on our ability to anticipate our customers' needs and develop products that address those
needs. Introduction of new products and product enhancements will require that we effectively transfer production processes
from research and development to manufacturing and coordinate our efforts with those of our suppliers to achieve volume
production rapidly. If we fail to transfer production processes effectively, develop product enhancements or introduce new
products in sufficient quantities to meet the needs of our customers as scheduled, our net sales may be reduced and our business
may be harmed.
21
We face risks associated with our foreign operations and sales that could harm our financial condition and results of
operations.
For fiscal 2012, fiscal 2011 and fiscal 2010, 76%, 74% and 67%, respectively, of our net sales were derived from
customers outside of the United States. We anticipate that foreign sales, particularly in Asia, will continue to account for a
significant portion of our revenues in the foreseeable future.
A global economic slowdown or a natural disaster could have a negative effect on various foreign markets in which we
operate, such as the earthquake, tsunami and resulting nuclear disaster during fiscal 2011 in Japan and last year's flooding in
Thailand. Such a slowdown may cause us to reduce our presence in certain countries, which may negatively affect the overall
level of business in such countries. Our foreign sales are primarily through our direct sales force. Additionally, some foreign
sales are made through foreign distributors and resellers. Our foreign operations and sales are subject to a number of risks,
including:
•
•
•
•
•
•
•
•
•
•
•
•
•
longer accounts receivable collection periods;
the impact of recessions and other economic conditions in economies outside the United States;
unexpected changes in regulatory requirements;
certification requirements;
environmental regulations;
reduced protection for intellectual property rights in some countries;
potentially adverse tax consequences;
political and economic instability;
import/export regulations, tariffs and trade barriers;
compliance with applicable United States and foreign anti-corruption laws;
cultural and management differences;
preference for locally produced products; and
shipping and other logistics complications.
Our business could also be impacted by international conflicts, terrorist and military activity, civil unrest and pandemic
illness which could cause a slowdown in customer orders or cause customer order cancellations.
We are also subject to the risks of fluctuating foreign currency exchange rates, which could materially adversely affect
the sales price of our products in foreign markets, as well as the costs and expenses of our foreign subsidiaries. While we use
forward exchange contracts and other risk management techniques to hedge our foreign currency exposure, we remain exposed
to the economic risks of foreign currency fluctuations.
We may not be able to protect our proprietary technology which could adversely affect our competitive advantage.
Maintenance of intellectual property rights and the protection thereof is important to our business. We rely on a
combination of patent, copyright, trademark and trade secret laws and restrictions on disclosure to protect our intellectual
property rights. We cannot assure you that our patent applications will be approved, that any patents that may be issued will
protect our intellectual property or that any issued patents will not be challenged by third parties. Other parties may
independently develop similar or competing technology or design around any patents that may be issued to us. We cannot be
certain that the steps we have taken will prevent the misappropriation of our intellectual property, particularly in foreign
countries where the laws may not protect our proprietary rights as fully as in the United States. Further, we may be required to
enforce our intellectual property or other proprietary rights through litigation, which, regardless of success, could result in
substantial costs and diversion of management's attention. Additionally, there may be existing patents of which we are unaware
22
that could be pertinent to our business and it is not possible for us to know whether there are patent applications pending that
our products might infringe upon since these applications are often not publicly available until a patent is issued or published.
We may, in the future, be subject to claims or litigation from third parties, for claims of infringement of their proprietary
rights or to determine the scope and validity of our proprietary rights or the proprietary rights of competitors or other rights
holders. These claims could result in costly litigation and the diversion of our technical and management personnel.
Adverse resolution of litigation may harm our operating results or financial condition.
In recent years, there has been significant litigation in the United States involving patents and other intellectual property
rights. This has been seen in our industry, for example in the recently concluded patent-related litigation between IMRA
America, Inc. and IPG Photonics Corporation. From time to time, like many other technology companies, we have received
communications from other parties asserting the existence of patent rights, copyrights, trademark rights or other intellectual
property rights which such third parties believe may cover certain of our products, processes, technologies or information. In
the future, we may be a party to litigation to protect our intellectual property or as a result of an alleged infringement of others'
intellectual property whether through direct claims or by way of indemnification claims of our customers, as, in some cases, we
contractually agree to indemnify our customers against third-party infringement claims relating to our products. These claims
and any resulting lawsuit, if successful, could subject us to significant liability for damages or invalidation of our proprietary
rights. These lawsuits, regardless of their success, would likely be time-consuming and expensive to resolve and would divert
management time and attention. Any potential intellectual property litigation could also force us to do one or more of the
following:
•
•
stop manufacturing, selling or using our products that use the infringed intellectual property;
obtain from the owner of the infringed intellectual property right a license to sell or use the relevant technology,
although such license may not be available on reasonable terms, or at all; or
•
redesign the products that use the technology.
If we are forced to take any of these actions or are otherwise a party to lawsuits of this nature, we may incur significant
losses for which we do not have insurance and our business may be seriously harmed. We do not have insurance to cover
potential claims of this type.
If our goodwill or intangible assets become impaired, we may be required to record a significant charge to earnings.
Under accounting principles generally accepted in the United States, we review our intangible assets for impairment
when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill is required to be tested
for impairment at least annually. Factors that may be considered include a change in circumstances indicating that the carrying
value of our goodwill or other intangible assets may not be recoverable include declines in our stock price and market
capitalization or future cash flows projections. We recorded a charge during the fourth quarter of fiscal 2012 related to the
impairment of intangibles in our SLS operating segment relating to the decision to discontinue the legacy Hypertronics
products. A decline in our stock price, or any other adverse change in market conditions, particularly if such change has the
effect of changing one of the critical assumptions or estimates we used to calculate the estimated fair value of our reporting
units, could result in a change to the estimation of fair value that could result in an impairment charge. Any such material
charges, whether related to goodwill or purchased intangible assets, may have a material negative impact on our financial and
operating results.
We depend on skilled personnel to operate our business effectively in a rapidly changing market, and if we are unable to
retain existing or hire additional personnel when needed, our ability to develop and sell our products could be harmed.
Our ability to continue to attract and retain highly skilled personnel will be a critical factor in determining whether we
will be successful in the future. Recruiting and retaining highly skilled personnel in certain functions continues to be difficult.
At certain locations where we operate, the cost of living is extremely high and it may be difficult to retain key employees and
management at a reasonable cost. We may not be successful in attracting, assimilating or retaining qualified personnel to fulfill
our current or future needs. Our failure to attract additional employees and retain our existing employees could adversely affect
our growth and our business.
Our future success depends upon the continued services of our executive officers and other key engineering, sales,
marketing, manufacturing and support personnel, any of whom may leave, which could harm our business and our results of
operations.
The long sales cycles for our products may cause us to incur significant expenses without offsetting revenues.
23
Customers often view the purchase of our products as a significant and strategic decision. As a result, customers typically
expend significant effort in evaluating, testing and qualifying our products before making a decision to purchase them, resulting
in a lengthy initial sales cycle. While our customers are evaluating our products and before they place an order with us, we may
incur substantial sales and marketing and research and development expenses to customize our products to the customers'
needs. We may also expend significant management efforts, increase manufacturing capacity and order long lead-time
components or materials prior to receiving an order. Even after this evaluation process, a potential customer may not purchase
our products. As a result, these long sales cycles may cause us to incur significant expenses without ever receiving revenue to
offset such expenses.
The markets in which we sell our products are intensely competitive and increased competition could cause reduced sales
levels, reduced gross margins or the loss of market share.
Competition in the various photonics markets in which we provide products is very intense. We compete against a
number of large public and private companies, including CVI Melles Griot, Cymer, Inc., GSI Group, Inc., IPG Photonics
Corporation, JDS Uniphase Corporation, Newport Corporation, Rofin-Sinar Technologies, Inc., and Trumpf GmbH, as well as
other smaller companies. Some of our competitors are large companies that have significant financial, technical, marketing and
other resources. These competitors may be able to devote greater resources than we can to the development, promotion, sale
and support of their products. Some of our competitors are much better positioned than we are to acquire other companies in
order to gain new technologies or products that may displace our product lines. Any of these acquisitions could give our
competitors a strategic advantage. Any business combinations or mergers among our competitors, forming larger companies
with greater resources, could result in increased competition, price reductions, reduced margins or loss of market share, any of
which could materially and adversely affect our business, results of operations and financial condition.
Additional competitors may enter the markets in which we serve, both foreign and domestic, and we are likely to compete
with new companies in the future. We may encounter potential customers that, due to existing relationships with our
competitors, are committed to the products offered by these competitors. Further, our current or potential customers may
determine to develop and produce products for their own use which are competitive to our products. As a result of the
foregoing factors, we expect that competitive pressures may result in price reductions, reduced margins, loss of sales and loss
of market share. In addition, in markets where there are a limited number of customers, competition is particularly intense.
If we fail to accurately forecast component and material requirements for our products, we could incur additional costs and
incur significant delays in shipments, which could result in a loss of customers.
We use rolling forecasts based on anticipated product orders and material requirements planning systems to determine our
product requirements. It is very important that we accurately predict both the demand for our products and the lead times
required to obtain the necessary components and materials. We depend on our suppliers for most of our product components
and materials. Lead times for components and materials that we order vary significantly and depend on factors including the
specific supplier requirements, the size of the order, contract terms and current market demand for components. For substantial
increases in our sales levels of certain products, some of our suppliers may need at least nine months lead-time. If we
overestimate our component and material requirements, we may have excess inventory, which would increase our costs. If we
underestimate our component and material requirements, we may have inadequate inventory, which could interrupt and delay
delivery of our products to our customers. Any of these occurrences would negatively impact our net sales, business or
operating results.
Our increased reliance on contract manufacturing and other outsourcing may adversely impact our financial results and
operations due to our decreased control over the performance and timing of certain aspects of our manufacturing.
Our manufacturing strategy includes partnering with contract manufacturers to outsource non-core subassemblies and less
complex turnkey products, including some performed at international sites located in Asia and Eastern Europe. Additionally,
we have outsourced the manufacture of certain of our optics components to certain third parties. Our ability to resume internal
manufacturing operations for certain products and components in a timely manner may be eliminated. The cost, quality,
performance and availability of contract manufacturing operations are and will be essential to the successful production and
sale of many of our products. Our financial condition or results of operation could be adversely impacted if any contract
manufacturer or other supplier is unable for any reason, including as a result of the impact of worldwide economic conditions,
to meet our cost, quality, performance, and availability standards. We may not be able to provide contract manufacturers with
product volumes that are high enough to achieve sufficient cost savings. If shipments fall below forecasted levels, we may
incur increased costs or be required to take ownership of the inventory. Also, our ability to control the quality of products
produced by contract manufacturers may be limited and quality issues may not be resolved in a timely manner, which could
adversely impact our financial condition or results of operations.
24
If we fail to effectively manage our growth or, alternatively, our spending during downturns, our business could be
disrupted, which could harm our operating results.
Growth in sales, combined with the challenges of managing geographically dispersed operations, can place a significant
strain on our management systems and resources, and our anticipated growth in future operations could continue to place such
a strain. The failure to effectively manage our growth could disrupt our business and harm our operating results. Our ability to
successfully offer our products and implement our business plan in evolving markets requires an effective planning and
management process. In economic downturns, we must effectively manage our spending and operations to ensure our
competitive position during the downturn, as well as our future opportunities when the economy improves, remain intact. The
failure to effectively manage our spending and operations could disrupt our business and harm our operating results.
Historically, acquisitions have been an important element of our strategy. However, we may not find suitable acquisition
candidates in the future and we may not be able to successfully integrate and manage acquired businesses. Any acquisitions
we make could disrupt our business and harm our financial condition.
We have in the past made strategic acquisitions of other corporations and entities, as well as asset purchases, and we
continue to evaluate potential strategic acquisitions of complementary companies, products and technologies. In the event of
any future acquisitions, we could:
•
•
•
•
•
issue stock that would dilute our current stockholders' percentage ownership;
pay cash that would decrease our working capital;
incur debt;
assume liabilities; or
incur expenses related to impairment of goodwill and amortization.
Acquisitions also involve numerous risks, including:
•
•
•
•
•
•
•
•
•
•
problems combining the acquired operations, systems, technologies or products;
an inability to realize expected operating efficiencies or product integration benefits;
difficulties in coordinating and integrating geographically separated personnel, organizations, systems and facilities;
difficulties integrating business cultures;
unanticipated costs or liabilities, including the costs associated with improving the internal controls of the acquired
company;
diversion of management's attention from our core businesses;
adverse effects on existing business relationships with suppliers and customers;
potential loss of key employees, particularly those of the purchased organizations;
incurring unforeseen obligations or liabilities in connection with acquisitions; and
the failure to complete acquisitions even after signing definitive agreements which, among other things, would result
in the expensing of potentially significant professional fees and other charges in the period in which the acquisition or
negotiations are terminated.
We cannot assure you that we will be able to successfully identify appropriate acquisition candidates, to integrate any
businesses, products, technologies or personnel that we might acquire in the future or achieve the anticipated benefits of such
transactions, which may harm our business.
We are exposed to lawsuits in the normal course of business which could have a material adverse effect on our business,
operating results, or financial condition.
25
We are exposed to lawsuits in the normal course of our business, including product liability claims, if personal injury,
death or commercial losses occur from the use of our products. While we typically maintain business insurance, including
directors' and officers' policies, litigation can be expensive, lengthy, and disruptive to normal business operations, including the
potential impact of indemnification obligations for individuals named in any such lawsuits. We may not, however, be able to
secure insurance coverage on terms acceptable to us in the future. Moreover, the results of complex legal proceedings are
difficult to predict. An unfavorable resolution of a particular lawsuit, including a recall or redesign of products if ultimately
determined to be defective, could have a material adverse effect on our business, operating results, or financial condition.
We use standard laboratory and manufacturing materials that could be considered hazardous and we could be liable for any
damage or liability resulting from accidental environmental contamination or injury.
Although most of our products do not incorporate hazardous or toxic materials and chemicals, some of the gases used in
our excimer lasers and some of the liquid dyes used in some of our scientific laser products are highly toxic. In addition, our
operations involve the use of standard laboratory and manufacturing materials that could be considered hazardous. Also, if a
facility fire were to occur at our Sunnyvale, California site and were to spread to a reactor used to grow semiconductor wafers,
it could release highly toxic emissions. We believe that our safety procedures for handling and disposing of such materials
comply with all federal, state and offshore regulations and standards. However, the risk of accidental environmental
contamination or injury from such materials cannot be entirely eliminated. In the event of such an accident involving such
materials, we could be liable for damages and such liability could exceed the amount of our liability insurance coverage and the
resources of our business which could have an adverse effect on our financial results or our business as a whole.
Compliance or the failure to comply with current and future environmental regulations could cause us significant expense.
We are subject to a variety of federal, state, local and foreign environmental regulations relating to the use, storage,
discharge and disposal of hazardous chemicals used during our manufacturing process or requiring design changes or recycling
of products we manufacture. If we fail to comply with any present and future regulations, we could be subject to future
liabilities, the suspension of production or a prohibition on the sale of products we manufacture. In addition, such regulations
could restrict our ability to expand our facilities or could require us to acquire costly equipment, or to incur other significant
expenses to comply with environmental regulations, including expenses associated with the recall of any non-compliant
product and the management of historical waste.
From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented
and enforced. We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These
regulations include, for example, the Registration, Evaluation, Authorization and Restriction of Chemical substances
(“REACH”), the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive
(“RoHS”) and the Waste Electrical and Electronic Equipment Directive (“WEEE”) enacted in the European Union which
regulate the use of certain hazardous substances in, and require the collection, reuse and recycling of waste from, certain
products we manufacture. This and similar legislation that has been or is in the process of being enacted in Japan, China, Korea
and various states of the United States may require us to re-design our products to ensure compliance with the applicable
standards, for example by requiring the use of different types of materials. These redesigns or alternative materials may
detrimentally impact the performance of our products, add greater testing lead-times for product introductions or have other
similar effects. We believe we comply with all such legislation where our products are sold and we will continue to monitor
these laws and the regulations being adopted under them to determine our responsibilities. In addition, we are monitoring
legislation relating to the reduction of carbon emissions from industrial operations to determine whether we may be required to
incur any additional material costs or expenses associated with our operations. We are not currently aware of any such material
costs or expenses. The SEC has recently promulgated rules requiring disclosure regarding the use of certain “conflict minerals”
mined from the Democratic Republic of Congo and adjoining countries and procedures regarding a manufacturer's efforts to
prevent the sourcing of such minerals. The implementation of such rules may require significant additional expense,
particularly in the event that only a limited pool of suppliers are available to certify that products are free from “conflict
minerals.” Our failure to comply with any of the foregoing regulatory requirements or contractual obligations could result in
our being directly or indirectly liable for costs, fines or penalties and third-party claims, and could jeopardize our ability to
conduct business in the United States and foreign countries.
Our and our customers' operations would be seriously harmed if our logistics or facilities or those of our suppliers, our
customers' suppliers or our contract manufacturers were to experience catastrophic loss.
Our and our customers' operations, logistics and facilities and those of our suppliers and contract manufacturers could be
subject to a catastrophic loss from fire, flood, earthquake, volcanic eruption, work stoppages, power outages, acts of war,
pandemic illnesses, energy shortages, theft of assets, other natural disasters or terrorist activity. A substantial portion of our
research and development activities, manufacturing, our corporate headquarters and other critical business operations are
located near major earthquake faults in Santa Clara, California, an area with a history of seismic events. Any such loss or
26
detrimental impact to any of our operations, logistics or facilities could disrupt our operations, delay production, shipments and
revenue and result in large expenses to repair or replace the facility. While we have obtained insurance to cover most potential
losses, after reviewing the costs and limitations associated with earthquake insurance, we have decided not to procure such
insurance. We believe that this decision is consistent with decisions reached by numerous other companies located nearby. We
cannot assure you that our existing insurance coverage will be adequate against all other possible losses.
Difficulties with our enterprise resource planning (“ERP”) system and other parts of our global information technology
system could harm our business and results of operation. If our network security measures are breached and unauthorized
access is obtained to a customer's data or our data or our information technology systems, we may incur significant legal
and financial exposure and liabilities.
Like many modern multinational corporations, we maintain a global information technology system, including software
products licensed from third parties. Any system, network or Internet failures, misuse by system users, the hacking into or
disruption caused by the unauthorized access by third parties or loss of license rights could disrupt our ability to timely and
accurately manufacture and ship products or to report our financial information in compliance with the timelines mandated by
the SEC. Any such failure, misuse, hacking, disruptions or loss would likely cause a diversion of management's attention from
the underlying business and could harm our operations. In addition, a significant failure of our global information technology
system could adversely affect our ability to complete an evaluation of our internal controls and attestation activities pursuant to
Section 404 of the Sarbanes-Oxley Act of 2002.
As part of our day-to-day business, we store our data and certain data about our customers in our global information
technology system. While our system is designed with access security, if a third party gains unauthorized access to our data,
including any regarding our customers, such security breach could expose us to a risk of loss of this information, loss of
business, litigation and possible liability. These security measures may be breached as a result of third-party action, including
intentional misconduct by computer hackers, employee error, malfeasance or otherwise. Additionally, third parties may attempt
to fraudulently induce employees or customers into disclosing sensitive information such as user names, passwords or other
information in order to gain access to our customers' data or our data, including our intellectual property and other confidential
business information, or our information technology systems. Because the techniques used to obtain unauthorized access, or to
sabotage systems, change frequently and generally are not recognized until launched against a target, we may be unable to
anticipate these techniques or to implement adequate preventative measures. Any security breach could result in a loss of
confidence by our customers, damage our reputation, disrupt our business, lead to legal liability and negatively impact our
future sales.
Changes in tax rates, tax liabilities or tax accounting rules could affect future results.
As a global company, we are subject to taxation in the United States and various other countries and jurisdictions.
Significant judgment is required to determine worldwide tax liabilities. Our future tax rates could be affected by changes in the
composition of earnings in countries or states with differing tax rates, changes in the valuation of our deferred tax assets and
liabilities, or changes in the tax laws. In addition, we are subject to regular examination of our income tax returns by the
Internal Revenue Service (“IRS”) and other tax authorities. From time to time the United States, foreign and state governments
make substantive changes to tax rules and the application of rules to companies, including various announcements from the
United States government potentially impacting our ability to defer taxes on international earnings. We regularly assess the
likelihood of favorable or unfavorable outcomes resulting from these examinations to determine the adequacy of our provision
for income taxes. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination
will not be materially different than the treatment reflected in our historical income tax provisions and accruals, which could
materially and adversely affect our operating results and financial condition.
Changing laws, regulations and standards relating to corporate governance and public disclosure may create uncertainty
regarding compliance matters.
Federal securities laws, rules and regulations, as well as the rules and regulations of self-regulatory organizations such as
NASDAQ and the NYSE, require companies to maintain extensive corporate governance measures, impose comprehensive
reporting and disclosure requirements, set strict independence and financial expertise standards for audit and other committee
members and impose civil and criminal penalties for companies and their chief executive officers, chief financial officers and
directors for securities law violations. These laws, rules and regulations have increased and will continue to increase the scope,
complexity and cost of our corporate governance, reporting and disclosure practices, which could harm our results of
operations and divert management's attention from business operations. Changing laws, regulations and standards relating to
corporate governance and public disclosure may create uncertainty regarding compliance matters. New or changed laws,
regulations and standards are subject to varying interpretations in many cases. As a result, their application in practice may
evolve over time. We are committed to maintaining high standards of ethics, corporate governance and public disclosure.
Complying with evolving interpretations of new or changed legal requirements may cause us to incur higher costs as we revise
current practices, policies and procedures, and may divert management time and attention from revenue generating to
27
compliance activities. If our efforts to comply with new or changed laws, regulations and standards differ from the activities
intended by regulatory or governing bodies due to ambiguities related to practice, our reputation may also be harmed.
Governmental regulations, including duties, affecting the import or export of products could negatively affect our revenues.
The United States and many foreign governments impose tariffs and duties on the import and export of products,
including some of those which we sell. In particular, given our worldwide operations, we pay duties on certain products when
they are imported into the United States for repair work as well as on certain of our products which are manufactured by our
foreign subsidiaries. These products can be subject to a duty on the product value. Additionally, the United States and various
foreign governments have imposed tariffs, controls, export license requirements and restrictions on the import or export of
some technologies, especially encryption technology. From time to time, government agencies have proposed additional
regulation of encryption technology, such as requiring the escrow and governmental recovery of private encryption keys.
Governmental regulation of encryption technology and regulation of imports or exports, or our failure to obtain required import
or export approval for our products, could harm our international and domestic sales and adversely affect our revenues. From
time to time our duty calculations and payments are audited by government agencies.
In addition, compliance with the directives of the Directorate of Defense Trade Controls (“DDTC”) may result in
substantial expenses and diversion of management. Any failure to adequately address the directives of DDTC could result in
civil fines or suspension or loss of our export privileges, any of which could have a material adverse effect on our business or
financial position, results of operations, or cash flows.
Our market is unpredictable and characterized by rapid technological changes and evolving standards demanding a
significant investment in research and development, and, if we fail to address changing market conditions, our business and
operating results will be harmed.
The photonics industry is characterized by extensive research and development, rapid technological change, frequent new
product introductions, changes in customer requirements and evolving industry standards. Because this industry is subject to
rapid change, it is difficult to predict its potential size or future growth rate. Our success in generating revenues in this industry
will depend on, among other things:
• maintaining and enhancing our relationships with our customers;
•
•
the education of potential end-user customers about the benefits of lasers and laser systems; and
our ability to accurately predict and develop our products to meet industry standards.
For our fiscal years 2012, 2011 and 2010, our research and development costs were $78.3 million (10.2% of net sales),
$81.2 million (10.1% of net sales) and $72.4 million (12.0% of net sales), respectively. We cannot assure you that our
expenditures for research and development will result in the introduction of new products or, if such products are introduced,
that those products will achieve sufficient market acceptance or to generate sales to offset the costs of development. Our failure
to address rapid technological changes in our markets could adversely affect our business and results of operations.
Failure to maintain effective internal controls may cause a loss of investor confidence in the reliability of our financial
statements or to cause us to delay filing our periodic reports with the SEC and adversely affect our stock price.
The SEC, as directed by Section 404 of the Sarbanes-Oxley Act of 2002, adopted rules requiring public companies to
include a report of management on internal control over financial reporting in their annual reports on Form 10-K that contain
an assessment by management of the effectiveness of the Company's internal control over financial reporting. In addition, our
independent registered public accounting firm must attest to and report on the effectiveness of our internal control over
financial reporting. Although we test our internal control over financial reporting in order to ensure compliance with the
Section 404 requirements, our failure to maintain adequate internal controls over financial reporting could result in an adverse
reaction in the financial marketplace due to a loss of investor confidence in the reliability of our financial statements or a delay
in our ability to timely file our periodic reports with the SEC, which ultimately could negatively impact our stock price.
Provisions of our charter documents and Delaware law, and our Change-of-Control Severance Plan may have anti-takeover
effects that could prevent or delay a change in control.
Provisions of our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition or
make removal of incumbent directors or officers more difficult. These provisions may discourage takeover attempts and bids
for our common stock at a premium over the market price. These provisions include:
28
•
•
•
the ability of our Board of Directors to alter our bylaws without stockholder approval;
limiting the ability of stockholders to call special meetings; and
establishing advance notice requirements for nominations for election to our Board of Directors or for proposing
matters that can be acted on by stockholders at stockholder meetings.
We are subject to Section 203 of the Delaware General Corporation Law, which prohibits a publicly-held Delaware
corporation from engaging in a merger, asset or stock sale or other transaction with an interested stockholder for a period of
three years following the date such person became an interested stockholder, unless prior approval of our board of directors is
obtained or as otherwise provided. These provisions of Delaware law also may discourage, delay or prevent someone from
acquiring or merging with us without obtaining the prior approval of our board of directors, which may cause the market price
of our common stock to decline. In addition, we have adopted a change of control severance plan, which provides for the
payment of a cash severance benefit to each eligible employee based on the employee's position. If a change of control occurs,
our successor or acquirer will be required to assume and agree to perform all of our obligations under the change of control
severance plan which may discourage potential acquirors or result in a lower stock price.
ITEM 1B. UNRESOLVED STAFF COMMENTS
Not Applicable.
29
ITEM 2. PROPERTIES
Our corporate headquarters is located in Santa Clara, California. At fiscal 2012 year-end, our primary locations were as
follows (all square footage is approximate) (unless otherwise indicated, each property is utilized jointly by our two segments):
Description
Use
Term
Santa Clara, CA
Santa Clara, CA (3)
Sunnyvale, CA (1)(3)
Bloomfield, CT (1)
Bloomfield, CT (1)
East Hanover, NJ (2)
Wilsonville, OR (1)
Salem, NH(1)(3)
Dieburg, Germany
Göttingen, Germany(2)
Lübeck, Germany (2)
Lübeck, Germany (2)
Lübeck, Germany (2)
Lübeck, Germany (2)(3)
Tokyo, Japan
Glasgow, Scotland (2)
YongIn-Si, South Korea (2)
Kallang Sector, Singapore
(2)
Penang, Malaysia (2)
8.5 acres of land, 200,000 square
foot building
90,120 square foot building
24,000 square foot building
61,155 square foot building
4,500 square foot building
Corporate headquarters,
manufacturing, R&D
Office, manufacturing
Office, manufacturing, R&D
Office, manufacturing, R&D
Manufacturing, warehouse
Owned
Leased through July 2020
Leased through December 2018
2017
Leased
December
through
2014
through
October
Leased through December 2012,
12 month extension options
Leased
Leased through December 2018
Leased
Leased through December 2020
Owned
October
through
2019
Office, manufacturing, R&D
Office, manufacturing, R&D
Office, manufacturing, R&D
Office
Office, manufacturing, R&D
Leased through December 2014
Office, manufacturing, R&D
Office, manufacturing, R&D Leased through December 2014
with option to purchase building
Manufacturing
Manufacturing, warehouse
Office
Office, manufacturing, R&D Owned
Leased through December 2018
Leased through December 2013
Leased through June 2015
Office, manufacturing
Office, manufacturing
Leased through November 2017
Leased through March 2016
30,000 square foot building
41,250 square foot building
44,153 square foot building
31,306 square foot building
7.6 acres of land, several buildings
totaling 132,100 square feet
41,328 square foot building
22,583 square foot building
8,159 square foot building
7,578 square foot building
17,602 square foot building
2 acres of land, 30,000 square foot
building
33,659 square foot building
31,894 square foot building
13,455 square foot building
Office, manufacturing
Leased through August 2014
_________________________________________
(1)
This facility is utilized primarily by our CLC operating segment.
(2)
This facility is utilized primarily by our SLS operating segment.
(3)
Portions of this property are not fully utilized.
We maintain other sales and service offices under varying leases expiring from 2013 through 2019 in the United States,
Japan, South Korea, China, Taiwan, Germany, France, Italy, the United Kingdom and the Netherlands.
We consider our facilities to be both suitable and adequate to provide for current and near term requirements. We plan to
renew leases on buildings as they expire.
ITEM 3. LEGAL PROCEEDINGS
We are subject to legal claims and litigation arising in the ordinary course of business, such as product liability,
employment or intellectual property claims, including, but not limited to, the matters described below. The outcome of any
such matters is currently not determinable. Although we do not expect that such legal claims and litigation will ultimately have
a material adverse effect on our consolidated financial position or results of operations, an adverse result in one or more matters
could negatively affect our results in the period in which they occur.
Derivative Lawsuits
Between February 15, 2007 and March 2, 2007, three purported shareholder derivative lawsuits were filed in the United
30
States District Court for the Northern District of California against certain of the Company's current and former officers and
directors. The Company was named as a nominal defendant. The complaints generally allege that the defendants breached their
fiduciary duties and violated the securities laws in connection with the granting of stock options, the accounting treatment for
such grants, the issuance of allegedly misleading public statements and stock sales by certain of the individual defendants. On
November 24, 2009, the United States District Court of the Northern District of California entered an Order and Final
Judgment, which approved a negotiated settlement and dismissed the action with prejudice. Following receipt of insurance
proceeds (which included reimbursement for certain legal costs incurred in prior years) and the payment of the plaintiff
attorneys' fees and expenses, we received a net cash benefit of $2.2 million from the settlement on December 11, 2009, which
was recorded in selling general and administrative expenses in the Consolidated Statement of Operations for the first quarter of
fiscal 2010.
Income Tax Audits
We are subject to taxation and file income tax returns in the U.S. federal jurisdiction and in many state and foreign
jurisdictions. For U.S. federal income tax purposes, all years prior to 2009 are closed. In our major foreign jurisdictions and our
major state jurisdictions, the years prior to 2006 and 2008, respectively, are closed to examination. Earlier years in our various
jurisdictions may remain open for adjustment to the extent that we have tax attribute carryforwards from those years. In
December 2011 and January 2012, our three German subsidiaries received notices of tax audits for the fiscal years 2006
through 2010. These audits are currently in process.
Management believes that it has adequately provided for any adjustments that may result from tax examinations. The
Company regularly engages in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions.
It is reasonably possible that certain federal, foreign and state tax matters may be concluded in the next 12 months. Although
the timing of the resolution and/or closure of audits is highly uncertain, it is reasonably possible that the balance of net
unrecognized tax benefits including interest and penalties could be reduced by approximately $0.5 million to $3.0 million in the
next 12 months.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
31
PART II
ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is quoted on the NASDAQ Stock Market under the symbol "COHR." The following table sets forth
the high and low sales prices for each quarterly period during the past two fiscal years as reported on the Nasdaq Global Select
Market.
First quarter
Second quarter
Third quarter
Fourth quarter
2012
High
54.50 $
59.70 $
59.28 $
50.46 $
$
$
$
$
Fiscal
2011
Low
40.50
52.29
39.76
42.59
$
$
$
$
High
46.85 $
62.29 $
63.76 $
59.61 $
Low
39.27
46.01
49.54
38.92
The number of stockholders of record as of November 23, 2012 was 935. No cash dividends have been declared or paid
since Coherent was founded and we have no present intention to declare or pay cash dividends. Our line of credit agreement
requires bank pre-approval for the payment of cash dividends.
There were no sales of unregistered securities in fiscal 2012.
There were no stock repurchases during the three months ended September 29, 2012.
32
COMPANY STOCK PRICE PERFORMANCE
The following graph shows a five-year comparison of cumulative total stockholder return, calculated on a dividend
reinvestment basis and based on a $100 investment, from September 29, 2007 through September 29, 2012 comparing the
return on our common stock with the Russell 2000 Index, the Standard and Poors Technology Index and the Nasdaq Composite
Index. No dividends have been declared or paid on our common stock during such period. The stock price performance shown
on the following graph is not necessarily indicative of future price performance.
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN AMONG COHERENT, INC.,
THE RUSSELL 2000 INDEX, THE S&P TECHNOLOGY INDEX AND
THE NASDAQ COMPOSITE INDEX.
Company Name / Index
Coherent, Inc.
Russell 2000 Index
S&P Technology Index
NASDAQ Composite Index
INDEXED RETURNS
Base
Period
9/29/2007
100
100
100
100
9/27/2008
109.07
88.68
80.08
65.59
10/3/2009
71.60
74.27
80.47
74.90
Years Ending
10/2/2010
125.31
88.09
91.88
84.99
10/1/2011
133.92
84.58
95.52
86.87
9/29/2012
142.96
111.57
126.48
110.79
The information contained above under the caption "Company Stock Price Performance" shall not be deemed to be
"soliciting material" or to be "filed" with the SEC, nor will such information be incorporated by reference into any future SEC
filing except to the extent that we specifically incorporate it by reference into such filing.
33
ITEM 6. SELECTED FINANCIAL DATA
The information set forth below is not necessarily indicative of results of future operations and should be read in
conjunction with Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the
Consolidated Financial Statements and Notes to Consolidated Financial Statements.
We derived the selected consolidated financial data as of fiscal 2012 and 2011 year-end and for fiscal 2012, 2011 and
2010 from our audited consolidated financial statements, and accompanying notes, contained in this annual report. The
consolidated statements of operations data for fiscal 2009 and 2008 and the consolidated balance sheet data as of fiscal 2010,
2009 and 2008 year-end are derived from our consolidated financial statements which are not included in this report.
Consolidated financial data
Fiscal
2012(1)
Fiscal
2011(2)
Fiscal
2010(3)
Fiscal
2009(4)
Fiscal
2008(5)
(in thousands, except per share data)
$
$
$
769,088 $
315,985 $
62,962 $
802,834 $
350,822 $
93,238 $
Net sales
Gross profit
Net income(loss)
Net income (loss) per share(6):
Basic
Diluted
Shares used in computation(6):
24,924
Basic
25,464
Diluted
843,266 $
Total assets
19 $
Long-term obligations
62,841 $
Other long-term liabilities
618,001 $
Stockholders' equity
_______________________________________________________________________________
23,561
24,026
880,772 $
2 $
55,326 $
671,656 $
3.74 $
3.66 $
2.67 $
2.62 $
$
$
$
$
$
$
605,067 $
260,811 $
36,916 $
$
435,882
$
161,110
(35,319 ) $
1.49 $
1.47 $
(1.45 ) $
(1.45 ) $
24,718
25,091
803,104 $
33 $
79,688 $
591,463 $
24,281
24,281
753,604
6
91,685
575,571
$
$
$
$
599,262
251,906
23,403
0.85
0.83
27,505
28,054
806,383
15
94,606
598,435
(1)
(2)
(3)
(4)
(5)
(6)
Includes a charge of $4.3 million after tax related to the write-off of previously acquired intangible assets and
inventories, a $2.8 million tax benefit due to decreases in valuation allowances against deferred tax assets and a $1.6
million tax benefit related to the release of tax reserves and related interest as a result of the closure of open tax years.
Includes a gain of $6.1 million after tax related to the dissolution of our Finland operations, a $9.7 million tax benefit
from the release of tax reserves and related interest as a result of an IRS settlement and the closure of open tax years and
a $1.5 million tax charge due to an increase in valuation allowances against deferred tax assets.
Includes restructuring expenses of $5.8 million after tax primarily related to the closure of our Finland site and the
consolidation of our Montreal, Canada site under the management of our Wilsonville, Oregon site and a net benefit after
tax of $1.4 million related to a receipt from the settlement of litigation resulting from our internal stock option
investigation.
Includes $19.3 million in after-tax expense related to the impairment of goodwill, restructuring expenses of
$11.5 million after tax primarily related to the consolidation of our Munich site into our Gottingen and Lubeck, Germany
sites and our Finland site, the exit of our Auburn, California facility, the exit of our St. Louis, Missouri facility and
headcount reductions due to the evolving global economic conditions, $0.8 million in after-tax costs related to our stock
option investigation and litigation and a tax charge of $3.8 million composed of the impact of a recently enacted change
in state tax law and a valuation allowance in one of our European subsidiaries.
Includes $5.5 million in after-tax costs related to our stock option investigation and litigation, restructuring expenses of
$3.9 million after-tax related to the exit of our Auburn, California facility, the consolidation of our German DPSS
manufacturing into one location in Germany and headcount reductions due to the evolving global economic situation,
and a tax charge of $1.4 million in connection with a dividend from one of our European subsidiaries.
See Note 2, "Significant Accounting Policies" in our Notes to Consolidated Financial Statements under Item 15 of this
annual report for an explanation of the determination of the number of shares used in computing net income (loss) per
share.
34
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction
with our Consolidated Financial Statements and related notes included in Item 8, "Financial Statements and Supplementary
Data" in this annual report. This discussion contains forward-looking statements, which involve risks and uncertainties. Our
actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors,
including but not limited to those discussed in Item 1A,"Risk Factors" and elsewhere in this annual report. Please see the
discussion of forward-looking statements at the beginning of this annual report under "Special Note Regarding Forward-
Looking Statements."
KEY PERFORMANCE INDICATORS
Below is a summary of some of the quantitative performance indicators (as defined below) that are evaluated by
management to assess our financial performance. Some of the indicators are non-GAAP measures and should not be considered
as an alternative to any other measure for determining operating performance or liquidity that is calculated in accordance with
generally accepted accounting principles.
Bookings
Book-to-bill ratio
Net Sales—Commercial Lasers and Components
Net Sales—Specialty Lasers and Systems
Gross Profit as a Percentage of Net Sales—Commercial Lasers and
Components
Gross Profit as a Percentage of Net Sales—Specialty Lasers and Systems
Research and Development Expenses as a Percentage of Net Sales
Income Before Income Taxes
Net Cash Provided by Operating Activities
Days Sales Outstanding in Receivables
Fourth Quarter Inventory Turns
Capital Spending as a Percentage of Net Sales
Adjusted EBITDA as a Percentage of Net Sales
Definitions and analysis of these performance indicators are as follows:
2012
Fiscal
2011
$ 773,199
1.01
$ 220,240
$ 548,848
(Dollars in thousands)
$ 895,017
$
1.11
$ 283,098
$ 519,736
$
$
2010
695,954
1.15
208,691
396,276
$
$
36.7 %
43.2 %
10.2 %
41.1 %
45.4 %
10.1 %
$
$
90,622
64,771
67.6
2.8
4.7 %
18.4 %
$ 123,829
86,676
$
63.2
3.1
4.6 %
19.5 %
36.2%
47.0%
12.0%
57,979
78,813
65.6
3.4
2.5%
17.0%
Bookings and Book-to-Bill Ratio
Bookings represent orders expected to be shipped within 12 months and services to be provided pursuant to service
contracts. While we generally have not experienced a significant rate of cancellation, bookings are generally cancelable by our
customers without substantial penalty and, therefore, we cannot assure all bookings will be converted to net sales.
The book-to-bill ratio is calculated as annual bookings divided by annual net sales. This is an indication of the strength of
our business but can sometimes be impacted by a single large order. A ratio greater than 1.0 indicates that demand for our
products is greater than what we supply in the year.
Fiscal 2012 bookings decreased from record bookings in fiscal 2011. Although we maintained a positive book-to-bill of
1.01, the book-to-bill ratio declined to 0.90 in the fourth quarter of fiscal 2012. Bookings decreased 13.6% from fiscal 2011,
with decreases in all markets. Bookings decreases by market compared to fiscal 2011 were microelectronics (16%), OEM
components and instrumentation (14%), scientific (13%) and materials processing (2%). Although fiscal 2012 bookings
decreased in all markets, decreases in bookings in the fourth quarter of fiscal 2012 in the microelectronics market due to timing
of large orders were partially offset by increases in the OEM components and instrumentation, scientific and materials
processing markets.
Fiscal 2011 bookings reached a new record for us. Bookings increased 28.6% from fiscal 2010, with a significant
increase in the microelectronics market. Bookings increases by market compared to fiscal 2010 were microelectronics (62%),
35
materials processing (22%) and scientific (3%), partially offset by a decrease in the OEM components and instrumentation
market (3%). Although fiscal 2011 bookings were a record, bookings in the fourth quarter of fiscal 2011 decreased from the
third quarter of fiscal 2011, with a fourth quarter book-to-bill of 0.94, primarily due to timing of large orders in the
microelectronics market.
Microelectronics
Fiscal 2012 bookings decreased 16% from record-setting bookings in fiscal 2011 and the book-to-bill ratio for the year
was 1.05.
Flat panel display orders for fiscal 2012 decreased 10% from record orders in fiscal 2011, but orders continued to be
strong. In response to the increased demand, we invested in manufacturing capacity in Göttingen and South Korea during fiscal
2012. In the third quarter of fiscal 2012, we received record laser annealing system orders to be used for liquid crystal display
("LCD") and active-matrix organic light emitting diode ("AMOLED") production from integrators for flat panel display
manufacturers in Japan, Korea and China as well as strong service orders. We expect follow-on system orders as well as
increasing service orders in fiscal 2013 and continued fluctuations in order volumes on a quarterly basis as evidenced by lower
orders in the fourth quarter of fiscal 2012. During the third quarter of fiscal 2012, we shipped our first Gen 8 system, a device
that sets a new throughput standard for laser annealing tools.
Advanced packaging ("API") orders decreased significantly for the full fiscal year as the overall market was very soft. In
addition, the market was impacted by tight credit in China where it has been difficult for customers to establish letters of credit
for new equipment purchases. Although the API market remains slow, we are seeing increasing signals for a recovery later in
calendar 2013. Part of the market growth in mobile packaging has been satisfied by utilizing the capacity freed up by slow
orders in personal computer applications, but we believe integrators will need to place replenishment orders later in calendar
2013.
Orders from semiconductor capital equipment OEMs increased 11% in fiscal 2012 reflecting increased orders for
inspection applications and strong service orders. Orders for sales and service of semiconductor lasers trended down towards
the end of fiscal 2012, which is consistent with indications that the semiconductor business is slowing down. Data from
industry reports suggests that calendar 2013 semiconductor business will decrease from calendar 2012 and will increase in
calendar 2014, which should favorably impact orders later in calendar 2013. On the product development front, we continue to
advance the state of the art in support of 450mm and EUV inspection and metrology applications.
OEM Components and Instrumentation
Bookings in fiscal 2012 decreased 14% from fiscal 2011 and the book-to-bill ratio for the year was 0.96. Although
bookings declined for the full fiscal year primarily due to decreased government spending on life sciences and closer inventory
management by customers resulting in smaller batch orders rather than semi-annual or annual orders in the first three quarters
of fiscal 2012, orders in the fourth quarter of fiscal 2012 were strong due to the timing of certain large orders and strength in
the instrumentation market.
Instrumentation orders in the fourth quarter of fiscal 2012 increased significantly from the third quarter of fiscal 2012 due
to the timing of large orders from key accounts in the flow cytometry market, including higher bookings for our OBIS™
portfolio. We expect OBIS adoption to further strengthen throughout fiscal 2013 and will also expand our offering of OBIS-
based subsystems that will provide customers with a broad range of customizable solutions.
Orders from the medical OEM market benefitted during fiscal 2012 from strong consumer demand for vision and
aesthetic procedures in emerging markets. Customers in the refractive markets are projecting good growth rates for calendar
2013, which led to semiannual or annual orders for low-power excimer lasers during the fourth quarter of fiscal 2012. The
home-based aesthetic market continues to expand as more individuals are turning towards laser-based hair reduction and skin
treatment, resulting in solid bookings for our semiconductor lasers in fiscal 2012.
Materials Processing
Although annual bookings decreased 2% from fiscal 2011 and fiscal 2012's book-to-bill ratio was 1.00, bookings in the
fourth quarter of fiscal 2012 increased slightly from the previous quarter. Although materials processing orders in the first
quarter of fiscal 2012 were negatively impacted by the tight credit policies in China and sovereign debt issues in Europe, they
were strong in the remainder of fiscal 2012 in spite of the difficult macroeconomic conditions.
Our materials processing business is comprised of multiple applications whose results often offset each other. In the
fourth quarter of fiscal 2012, we had record bookings for our Meta™ laser workstations following the release of a new model
utilizing a Diamond™ E-1000 CO2 laser. Meta orders were strongest in North America and we plan to augment the platform
by introducing a fiber laser equipped version later in fiscal 2013.
36
During fiscal 2012, marking and engraving application orders were strong and in the second half of fiscal 2012, led all
applications with continued demand for ultraviolet lasers used in consumer electronics manufacturing. In the second half of
fiscal 2012, traditional low power CO2 marking exhibited seasonal softness.
We formally released our first kilowatt class fiber laser, the Highlight™ 1000FL and received our first order from a
commercial customer in the fourth quarter of fiscal 2012. Our goals for fiscal 2013 are three-fold: capture additional seed
orders for the 1000FL, drive cost reduction in our semiconductor pumps and demonstrate the scalability of the architecture by
moving up the power scale into the multi-kilowatt regime.
Scientific and Government Programs
Fiscal 2012 orders decreased 13% from record-setting bookings in fiscal 2011 primarily due to the completion of
stimulus programs and the book-to-bill ratio for the year was 0.93. Although orders in the first quarter of fiscal 2012 carried
over from the fiscal 2011 strength particularly due to investment in biological research in China, orders softened in the middle
of fiscal 2012 before increasing in the typically stronger fourth quarter.
Multiphoton imaging was the leading application within the scientific market for the fourth quarter and the full fiscal
2012 and has proven to be very resilient to funding changes. Part of the strength comes from continued adoption of imaging
techniques worldwide. The market has also benefitted from the emergence of specialty microscope suppliers that focus on
niche and leading-edge applications, thereby complementing the larger established scope manufacturers.
Funding for physical sciences research has experienced a larger decline from the stimulus levels of fiscal 2011, especially
for high-end systems priced over $500,000. We have now reverted to normalized funding where researchers have to draw upon
multiple sources to make the same purchases. The strength of our portfolio and customer support network allowed us to
maintain market share.
Net Sales
Net sales include sales of lasers, laser tools, related accessories and service contracts. Net sales for fiscal 2012 decreased
4.2% from fiscal 2011. Net sales for fiscal 2011 increased 32.7% from fiscal 2010. For a description of the reasons for changes
in net sales refer to the "Results of Operations" section below.
Gross Profit as a Percentage of Net Sales
Gross profit as a percentage of net sales ("gross profit percentage") is calculated as gross profit for the period divided by
net sales for the period. Gross profit percentage for CLC decreased to 36.7% in fiscal 2012 from 41.1% in fiscal 2011 and
increased from 36.2% in fiscal 2010. Gross profit percentage for SLS decreased to 43.2% in fiscal 2012 from 45.4% in fiscal
2011 and from 47.0% in fiscal 2010. For a description of the reasons for changes in gross profit refer to the "Results of
Operations" section below.
Research and Development as a Percentage of Net Sales
Research and development as a percentage of net sales ("R&D percentage") is calculated as research and development
expense for the period divided by net sales for the period. Management considers R&D percentage to be an important indicator
in managing our business as investing in new technologies is a key to future growth. R&D percentage increased to 10.2% from
10.1% in fiscal 2011 and decreased from 12.0% in fiscal 2010. For a description of the reasons for changes in R&D spending
refer to the "Results of Operations" section below.
Net Cash Provided by Operating Activities
Net cash provided by operating activities shown on our Consolidated Statements of Cash Flows primarily represents the
excess of cash collected from billings to our customers and other receipts over cash paid to our vendors for expenses and
inventory purchases to run our business. We believe that cash flows from operations are an important performance indicator
because cash generation over the long term is essential to maintaining a healthy business and providing funds to help fuel
growth. For a description of the reasons for changes in Net Cash Provided by Operating Activities refer to the "Liquidity and
Capital Resources" section below.
Days Sales Outstanding in Receivables
We calculate days sales outstanding ("DSO") in receivables as net receivables at the end of the period divided by net
sales during the period and then multiplied by the number of days in the period, using 360 days for years. DSO in receivables
indicates how well we are managing our collection of receivables, with lower DSO in receivables resulting in higher working
capital availability. The more money we have tied up in receivables, the less money we have available for research and
development, acquisitions, expansion, marketing and other activities to grow our business. Our DSO in receivables for fiscal
2012 increased 4.4 days from fiscal 2011 to 67.6 days. The increase in DSO in receivables is primarily due to the higher mix of
37
revenue and related receivables in Asia where customary payment terms result in higher DSOs than the average DSO for the
Company taken as a whole as well as a higher concentration of sales in the last month of the fiscal year.
Annualized Fourth Quarter Inventory Turns
We calculate annualized fourth quarter inventory turns as cost of sales during the fourth quarter annualized and divided
by net inventories at the end of the fourth quarter. This indicates how well we are managing our inventory levels, with higher
inventory turns resulting in more working capital availability and a higher return on our investments in inventory. The more
money we have tied up in inventory, the less money we have available for research and development, acquisitions, expansion,
marketing and other activities to grow our business. Our annualized inventory turns for fiscal 2012 decreased 0.3 turns from
fiscal 2011 to 2.8 turns. The deterioration in inventory turns is primarily due to the impact of decreased sales volumes in
relation to inventory levels in certain businesses as well as increased inventory to support a sizable backlog of flat panel laser
annealing systems.
Capital Spending as a Percentage of Net Sales
Capital spending as a percentage of net sales ("capital spending percentage") is calculated as capital expenditures for the
period divided by net sales for the period. Capital spending percentage indicates the extent to which we are expanding or
improving our operations, including investments in technology and equipment. Management monitors capital spending levels
as this assists management in measuring our cash flows, net of capital expenditures. Our capital spending percentage increased
to 4.7% in fiscal 2012 from 4.6% in fiscal 2011 and 2.5% in fiscal 2010. The fiscal 2012 increase was primarily due to building
improvements and purchases of production-related assets to support our expansion in Asia (South Korea and Singapore) and
Germany. The fiscal 2011 increase was primarily due to purchases of production-related assets and building improvements to
support higher sales volumes. We expect capital spending for fiscal 2013 to be approximately 3.5% of net sales.
Adjusted EBITDA as a Percentage of Net Sales
We define adjusted EBITDA as operating income adjusted for depreciation, amortization, stock compensation expenses,
major restructuring costs and certain other non-operating income and expense items. Key initiatives to reach our goals for
EBITDA improvements include utilization of our Asian manufacturing locations, rationalizing our supply chain and continued
leveraging of our infrastructure.
SIGNIFICANT EVENTS
Restructuring Activities
During fiscal 2008, we initiated restructuring plans to decrease costs by consolidating facilities and reducing our
workforce. As of September 29, 2012, we had made payments in connection with the restructuring plans in the amount of $27.7
million. We completed payments for substantially all anticipated costs related to the restructuring plans in the third quarter of
fiscal 2011. In the second quarter of fiscal 2011, we ceased manufacturing operations in our Finland facility and recognized a
$6.1 million gain, primarily in other income (expense), due to a non-recurring translation adjustment related to the dissolution
of our Finland operations.
Acquisitions
On October 13, 2009, we acquired all the assets and certain liabilities of StockerYale's laser module product line in
Montreal and its specialty fiber product line in Salem, New Hampshire for $15.0 million in cash. StockerYale designs,
develops and manufactures low power laser modules, light emitting diode (LED) systems and specialty optical fiber products.
These assets and liabilities have been included in our Commercial Lasers and Components segment.
On April 29, 2010, we acquired Beam Dynamics for $6.25 million, excluding transaction fees. Beam Dynamics
manufactures flexible laser cutting tools for the materials processing market. These assets and liabilities have been included in
our Commercial Lasers and Components segment.
On January 5, 2011, we acquired all the assets and assumed certain liabilities of Hypertronics Pte Ltd for $14.5 million,
excluding transaction fees. Hypertronics designs and manufactures laser- and vision-based tools for flat panel display, storage,
semiconductor and solar applications at facilities in Singapore and Malaysia. These assets and liabilities have been included in
our Specialty Lasers and Systems segment. During the fourth quarter of fiscal 2012, we decided to no longer pursue orders of
Hypertronics legacy products and we performed an impairment analysis of Hypertronics' intangible assets and determined that
such assets were impaired. As a result, we recorded a $4.0 million non-cash intangibles amortization charge and a $0.3 million
inventory write-off in the fourth quarter of fiscal 2012.
On July 23, 2012, we acquired all of the outstanding shares of MiDaZ Lasers Limited "Midaz" for $3.8 million in cash,
excluding transaction fees. Midaz was a technology based-acquisition and we intend to utilize the acquired technology in low
cost, compact pulsed solid state lasers. These assets and liabilities have been included in our Specialty Lasers and Systems
38
segment.
On October 30, 2012, we acquired all of the outstanding shares of Innolight Innovative Laser and Systemtechnik GmbH
for approximately $18.4 million, excluding transaction costs. See Note 19 "Subsequent Events" in the notes to the Consolidated
Financial Statements under Item 15 of this annual report for further information.
Stock Repurchases
In the second half of fiscal 2010, we repurchased and retired 1,195,829 shares of outstanding common stock for a total of
$43.3 million, excluding expenses.
In March 2011, we repurchased and retired 454,682 shares of outstanding common stock at an average price of $59.00
per share for a total of $26.8 million, excluding expenses. During the third and fourth quarters of fiscal 2011, we repurchased
and retired 1,024,409 shares of outstanding common stock at an average price of $47.03 per share for a total of $48.2 million,
excluding expenses.
On August 25, 2011, we announced that the Board of Directors had authorized the repurchase of up to $50.0 million of
our common stock. During fiscal 2011, we repurchased and retired 586,200 shares of outstanding common stock at an average
price of $42.67 per share for a total of $25.0 million excluding expenses. During fiscal 2012, we repurchased and retired
543,200 shares of outstanding common stock at an average price of $45.99 per share for a total of $25.0 million, excluding
expenses. There were no funds remaining authorized for repurchase at September 29, 2012 under that repurchase program.
On October 4, 2012, the Board of Directors authorized a buyback program whereby we are authorized to repurchase up to
$25 million of our common stock. This buyback program is discussed in Note 19 "Subsequent Events" in the notes to the
Consolidated Financial Statements under Item 15 of this annual report.
RESULTS OF OPERATIONS—FISCAL 2012, 2011 AND 2010
Fiscal 2012, 2011 and 2010 consist of 52 weeks.
Consolidated Summary
The following table sets forth, for the years indicated, the percentage of total net sales represented by the line items
reflected in our consolidated statement of operations:
Net sales
Cost of sales
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Amortization of intangible assets
Total operating expenses
Income from operations
Other income (net)
Income before income taxes
Provision for income taxes
Net income
2012
Fiscal
2011
2010
(As a percentage of net sales)
100.0 %
58.9 %
41.1 %
10.2 %
18.0 %
1.3 %
29.5 %
11.6 %
0.2 %
11.8 %
3.6 %
8.2 %
100.0 %
56.3 %
43.7 %
10.1 %
18.6 %
1.0 %
29.7 %
14.0 %
1.4 %
15.4 %
3.8 %
11.6 %
100.0 %
56.9 %
43.1 %
12.0 %
20.4 %
1.3 %
33.7 %
9.4 %
0.2 %
9.6 %
3.5 %
6.1 %
Refer to Item 6 "Selected Financial Data" for a description of significant events that impacted the results of operations for
fiscal years 2012, 2011 and 2010.
Net Sales
Market Application
39
The following table sets forth, for the periods indicated, the amount of net sales and their relative percentages of total net
sales by market application (dollars in thousands):
Fiscal 2012
Fiscal 2011
Fiscal 2010
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
Consolidated:
Microelectronics
OEM components and
instrumentation
$
373,696
48.6 % $
377,331
47.0 % $
230,763
143,729
18.7 %
164,508
20.5 %
151,243
Materials processing
108,666
14.1 %
104,497
13.0 %
82,181
Scientific and government
programs
Total
142,997
769,088
$
18.6 %
100.0 % $
156,498
802,834
19.5 %
100.0 % $
140,880
605,067
38.1%
25.0%
13.6%
23.3%
100.0%
During fiscal 2012, net sales decreased by $33.7 million, or 4%, compared to fiscal 2011, including a decrease of
$2.4 million due to the impact of foreign currency exchange rates, with sales decreases in the OEM components and
instrumentation, scientific and government program and microelectronics markets partially offset by increases in the materials
processing market. Microelectronics sales decreased $3.6 million, or 1%, primarily due to lower shipments for advanced
packaging and solar applications partially offset by higher sales in flat panel display applications. The decrease in the OEM
components and instrumentation market of $20.8 million, or 13%, during fiscal 2012 was primarily due to lower shipments for
bio-instrumentation, military and machine vision applications partially offset by higher shipments for medical applications.
Materials processing sales increased $4.2 million, or 4%, during fiscal 2012 primarily due to higher shipments for marking and
heat treating applications as well as higher shipments of laser system tools. The decrease in scientific and government program
market sales of $13.5 million, or 9%, during fiscal 2012 was due to lower demand for advanced research applications used by
university and government research groups partly due to lower U.S. stimulus funding.
During fiscal 2011, net sales increased by $197.8 million, or 33%, compared to fiscal 2010, including an increase of
$14.9 million due to the impact of foreign currency exchange rates, with sales increasing in all four markets. Microelectronics
sales increased $146.6 million, or 64%, primarily due to higher sales in flat panel display, advanced packaging, semiconductor
and solar applications. The increase in the OEM components and instrumentation market of $13.3 million, or 9%, during fiscal
2011 was primarily due to higher shipments for bio-instrumentation, medical and machine vision applications. Materials
processing sales increased $22.3 million, or 27%, during fiscal 2011 primarily due to higher shipments for marking, cutting and
drilling applications. The increase in scientific and government program market sales of $15.6 million, or 11%, during fiscal
2011 was due to higher demand for advanced research applications used by university and government research groups in part
due to Federal stimulus money.
In fiscal 2012, two customers accounted for 11% each of net sales; in 2011 and 2010, no customers accounted for greater
than 10% of net sales.
Segments
We are organized into two reportable operating segments: Commercial Lasers and Components ("CLC") and Specialty
Lasers and Systems ("SLS"). CLC focuses on higher volume products that are offered in set configurations. CLC's primary
markets include materials processing, OEM components and instrumentation and microelectronics. SLS develops and
manufactures configurable, advanced-performance products largely serving the microelectronics, scientific research and
government programs and OEM components and instrumentation markets.
The following table sets forth, for the periods indicated, the amount of net sales and their relative percentages of total net
sales by segment (dollars in thousands):
40
Consolidated:
Commercial Lasers and
Components (CLC)
Specialty Lasers and Systems
(SLS)
Corporate and other
Total
$
Fiscal 2012
Fiscal 2011
Fiscal 2010
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
$
220,240
28.6% $
283,098
35.3 % $
208,691
34.5 %
548,848
—
769,088
71.4%
—
100.0% $
519,736
—
802,834
64.7 %
—
100.0 % $
396,276
100
605,067
65.5 %
—
100.0 %
Net sales for fiscal 2012 decreased $33.7 million, or 4%, compared to fiscal 2011, with decreases of $62.9 million, or
22%, in our CLC segment and increases of $29.1 million, or 6%, in our SLS segment. Net sales for fiscal 2011 increased
$197.8 million, or 33%, compared to fiscal 2010, with increases of $123.5 million, or 31%, in our SLS segment and increases
of $74.4 million, or 36%, in our CLC segment.
The decrease in our CLC segment sales from fiscal 2011 to fiscal 2012 was primarily due to lower advanced packaging,
and certain flat panel display application sales as well as lower instrumentation application sales. The increase in our CLC
segment sales from fiscal 2010 to fiscal 2011 was primarily due to higher advanced packaging, materials processing and certain
flat panel display application sales.
The increase in our SLS segment sales from fiscal 2011 to fiscal 2012 was primarily due to higher revenue for flat panel
display annealing applications partially offset by lower shipments for scientific and government programs, instrumentation and
solar applications. The increase in our SLS segment sales from fiscal 2010 to fiscal 2011 was primarily due to higher sales for
flat panel display annealing, semiconductor, scientific and advanced packaging applications.
Gross Profit
Consolidated
Our gross profit rate decreased by 2.6% to 41.1% in fiscal 2012 from 43.7% in fiscal 2011 primarily due to unfavorable
product margins (1.6%) due to lower volumes in several business units serving particularly the advanced packaging and
components markets, and higher manufacturing expense and start-up costs to expand manufacturing capacity in Germany and
Excimer tube production in Korea. These decreases were net of the favorable impact of foreign exchange rates and favorable
product mix in the microelectronics market as well as higher installation and warranty costs (0.9%) including installations and
higher service events in flat panel display markets.
Our gross profit rate increased by 0.6% to 43.7% in fiscal 2011 from 43.1% in fiscal 2010 primarily due to a lower
manufacturing cost structure and higher sales volumes as well as a favorable product mix due to higher margins within the
microelectronics market.
Our gross profit rate has been and will continue to be affected by a variety of factors including market mix, pricing on
volume orders, our ability to manufacture advanced and more complex products, manufacturing efficiencies, excess and
obsolete inventory write-downs, warranty costs, pricing by competitors or suppliers, new product introductions, production
volume, customization and reconfiguration of systems, commodity prices and foreign currency fluctuations.
Commercial Lasers and Components
Our CLC gross profit rate decreased by 4.4% to 36.7% in fiscal 2012 from 41.1% in fiscal 2011 primarily due to
unfavorable product costs (2.9%) resulting from the impact of lower volumes in a few business units serving primarily the
advanced packaging and components markets and unfavorable product mix within the instrumentation and semiconductor
markets, higher other costs (1.0%) due to higher inventory provisions and the impact of lower sales volumes and higher
warranty and installation costs (0.5%) due to a higher installed base and the impact of lower sales volumes.
Our CLC gross profit rate increased by 4.9% to 41.1% in fiscal 2011 from 36.2% in fiscal 2010 primarily due to
favorable product costs (2.4%) due to the impact of increased volumes and favorable product mix within the microelectronics
market, lower restructuring costs (2.2%) and lower other costs (0.6%) due to lower inventory provisions partially offset by
higher warranty costs (0.3%).
Specialty Lasers and Systems
Our SLS gross profit rate decreased by 2.2% to 43.2% in fiscal 2012 from 45.4% in fiscal 2011 primarily due to
41
unfavorable product costs (1.4%) due to increased investments in Excimer manufacturing capabilities to support the growing
flat panel display revenue net of the favorable impact of exchange rates and favorable product mix within the microelectronics
market and higher installation and warranty costs (1.0%) due to higher service events and costs to support installations of a
growing number of laser annealing systems in the flat panel display market partially offset by lower other costs (0.3%).
Our SLS gross profit rate decreased by 1.6% to 45.4% in fiscal 2011 from 47.0% in fiscal 2010 primarily due to
unfavorable product costs (0.8%) resulting from unfavorable mix within the microelectronics market and the acquisition of
Hypertronics net of the impact of increased volumes and cost reduction efforts as well as higher other costs (1.0%) due to
higher inventory provisions and higher freight costs partially offset by lower warranty costs (0.2%).
Operating Expenses
The following table sets forth, for the periods indicated, the amount of operating expenses and their relative percentages
of total net sales by the line items reflected in our consolidated statement of operations (dollars in thousands):
2012
Fiscal
2011
2010
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
Amount
Percentage
of total
net sales
(Dollars in thousands)
Research and development
Selling, general and administrative
Amortization of intangible assets
Total operating expenses
$
78,260
138,519
10,376
$ 227,155
10.2 % $
18.0 %
1.3 %
29.5 % $
81,232
149,499
8,082
238,813
72,354
10.1 % $
123,575
18.6 %
8,002
1.0 %
29.7 % $ 203,931
12.0 %
20.4 %
1.3 %
33.7 %
Research and development
Fiscal 2012 research and development ("R&D") expenses decreased $3.0 million, or 4%, from fiscal 2011. The decrease
was due primarily to lower payroll spending ($4.9 million) due to lower performance-related compensation net of increased
headcount partially offset by higher project and other spending ($1.9 million). As a percentage of sales, the slight increase was
primarily due to decreased sales volumes. On a segment basis, CLC spending decreased $2.2 million primarily due to lower
payroll spending partially offset by higher project spending. SLS spending increased $0.1 million primarily due to higher
project and other spending partially offset by lower payroll spending and the impact of foreign exchange rates. Corporate and
other spending decreased $0.8 million.
Fiscal 2011 R&D expenses increased $8.9 million, or 12%, from fiscal 2010. The increase was due primarily to higher
payroll spending ($7.0 million) due to increased headcount and higher performance-related compensation and the acquisitions
of Hypertronics in the second quarter of fiscal 2011 and Beam Dynamics in the middle of the third quarter of fiscal 2010 ($2.3
million). As a percentage of sales, the decrease was primarily due to increased sales volumes. On a segment basis, CLC
spending increased $1.9 million primarily due to higher payroll spending and the acquisition of Beam Dynamics in the middle
of the third quarter of fiscal 2010 partially offset by lower project spending and lower restructuring costs. SLS spending
increased $5.9 million primarily due to higher payroll spending, the acquisition of Hypertronics in the second quarter of fiscal
2011, higher project spending and the impact of foreign exchange rates. Corporate and other spending increased $1.1 million.
Selling, general and administrative
Fiscal 2012 selling, general and administrative ("SG&A") expenses decreased $11.0 million, or 7%, from fiscal 2011.
The decrease was primarily due to $12.1 million lower payroll spending due to lower performance-related compensation
spending net of higher headcount and increased salaries and $1.8 million lower other variable spending partially offset by $2.9
million higher stock-related compensation expense. On a segment basis, CLC spending decreased $4.2 million primarily due to
lower payroll spending and lower other variable spending. SLS segment expenses decreased $4.4 million primarily due to
lower payroll spending and lower other variable spending. Spending for Corporate and other decreased $2.4 million primarily
due to lower payroll spending and lower other variable spending partially offset by higher stock-related compensation expense.
Fiscal 2011 SG&A expenses increased $25.9 million, or 21%, from fiscal 2010. The increase was primarily due to
$12.3 million higher payroll spending due to higher performance-related compensation spending, higher headcount and
increased salaries, $7.6 million higher other variable spending, $3.8 million higher stock-related compensation expense and the
acquisitions of Hypertronics in the second quarter of fiscal 2011 and Beam Dynamics in the middle of the third quarter of fiscal
2010 ($2.2 million), partially offset by lower restructuring costs ($2.2 million). In addition, fiscal 2010 SG&A expenses were
reduced by a $2.2 million net receipt from the settlement of litigation resulting from our stock option investigation. On a
42
segment basis, CLC spending increased $3.5 million primarily due to higher payroll spending and higher other variable
spending partially offset by lower restructuring costs. SLS segment expenses increased $12.6 million primarily due to higher
payroll spending, the acquisition of Hypertronics and higher other variable spending. Spending for Corporate and other
increased $9.8 million primarily due to higher stock-related compensation expense, the net receipt from the settlement of
litigation resulting from our stock option investigation in the first quarter of fiscal 2010, higher payroll spending, higher
charges for increases in deferred compensation plan liabilities and higher other variable spending.
Amortization of intangible assets
Amortization of intangible assets increased $2.3 million, or 28%, from fiscal 2011 to fiscal 2012 primarily due to the
fourth quarter fiscal 2012 impairment of $4.0 million of Hypertronics intangibles partially offset by completion of amortization
of certain intangibles related to prior acquisitions.
Amortization of intangible assets increased $0.1 million, or 1%, from fiscal 2010 to fiscal 2011 primarily due to the
amortization of intangibles from the acquisition of Hypertronics in the second quarter of fiscal 2011 and Beam Dynamics in the
third quarter of fiscal 2010, partially offset by completion of amortization of certain intangibles related to prior acquisitions.
Other income (expense), net
Other income (expense), net, decreased $10.0 million from fiscal 2011 to fiscal 2012. The decrease was primarily due to
the $6.5 million non-recurring translation adjustment related to the dissolution of our Finland operations in the second quarter
of fiscal 2011, lower net foreign currency exchange gains ($1.9 million) and lower gains on our deferred compensation plan
assets net of expenses ($1.5 million) including death benefits of $0.2 million in fiscal 2012 and $1.5 million in fiscal 2011.
Other income (expense), net, increased $10.7 million from fiscal 2010 to fiscal 2011. The increase was primarily due to
the $6.5 million non-recurring translation adjustment related to the dissolution of our Finland operations, higher net foreign
currency exchange gains ($2.9 million) and higher gains on our deferred compensation plan assets net of expenses ($2.4
million) including a $1.5 million death benefit, partially offset by lower interest income ($1.0 million) primarily due to interest
on a tax refund in fiscal 2010.
Income taxes
The effective tax rate on income before income taxes for fiscal 2012 of 30.5% was lower than the statutory rate of 35.0%.
This was primarily due to the benefit of income subject to foreign tax rates that are lower than U.S. tax rates and the benefit of
releasing state tax reserves accrued under ASC 740-10 Income Taxes (formerly FASB Financial Interpretation No. 48,
“Accounting for Uncertainty in Income Taxes”) and related interest.
During fiscal 2012, we increased our valuation allowance on deferred tax assets by $0.3 million to $9.1 million primarily
due to the reduced ability to utilize California research and development tax credits and offset by the net increased ability to
utilize foreign tax attributes and net operating losses of our subsidiaries in the fourth quarter. During fiscal 2011, we increased
our valuation allowance on deferred tax assets by $1.5 million to $8.8 million, primarily due to the reduced ability to utilize
foreign tax attributes and net operating losses and the reduced ability to utilize California research and development tax credits
as a result of releasing net unrecognized tax benefits under ASC 740-10 that supported the credits. During fiscal 2010, we
increased our valuation allowance on deferred tax assets to $7.4 million, primarily due to a capital loss limitation true-up, the
reduced ability to utilize California research and development tax credits as a result of the current apportionment factor and the
reduced ability to utilize foreign net operating losses.
In making the determination to record the valuation allowance, management considered the likelihood of future taxable
income and feasible and prudent tax planning strategies to realize deferred tax assets. In the future, if we determine that we
expect to realize deferred tax assets, an adjustment to the valuation allowance will affect income in the period such
determination is made.
The effective tax rate on income before income taxes for fiscal 2011 of 24.7% was lower than the statutory rate of 35.0%.
This was primarily due to the benefit of releasing unrecognized tax benefits under ASC 740-10 and related interest, the benefit
of federal research and development credits, including additional credits reinstated from fiscal 2010 resulting from the
enactment of the “Tax Relief, Unemployment Insurance Reauthorization and Jobs Creation Acts of 2010,” the benefit of
foreign tax credits, the benefit of currency translation adjustments related to closure of Coherent Finland's operations, the
benefit from income subject to foreign tax rates that are lower than U.S. tax rates and the benefit from the unrealized gain on
life insurance policy investments related to our deferred compensation plans. These amounts are partially offset by state income
tax, limitations on the utilization of certain foreign tax attributes and net operating losses, limitations on the deductibility of
compensation under IRC Section 162(m), deemed dividend inclusions under the Subpart F tax rules and a currency translation
adjustment related to a dividend from a foreign subsidiary.
The effective tax rate on income before income taxes for fiscal 2010 of 36.3% was higher than the statutory rate of
35.0%. This was primarily due to stock compensation not deductible for tax purposes and an increase in valuation allowance
43
against capital loss carryforwards, California research and development tax credits as a result of California legislation enacted
in February 2009 and certain foreign net operating loss carryforwards. These increases are partially offset by the benefit of
income subject to foreign tax rates that are lower than U.S. tax rates and research and development credits.
We operate under tax holiday in Singapore which is effective from fiscal year 2012 through fiscal year 2017 and may be
extended if certain additional requirements are satisfied. The tax holiday is conditional upon our meeting certain revenue,
business spending and employment thresholds. As a result of a current loss, we did not realize a benefit for the Singapore tax
holiday in fiscal year 2012.
FINANCIAL CONDITION
Liquidity and capital resources
At September 29, 2012, we had assets classified as cash and cash equivalents, as well as time deposits and fixed income
securities classified as short-term investments, in an aggregate amount of $224.9 million, compared to $220.2 million at
October 1, 2011. At September 29, 2012, approximately $139.4 million of the cash and securities was held in certain of our
foreign operations, $46.1 million of which was denominated in currencies other than the U.S. dollar. In January 2012, we
converted $89.8 million of assets formerly denominated in Euro to U.S. dollars and invested those funds in U.S. Treasury
securities within a European subsidiary whose functional currency is the U.S. dollar. Accordingly, there is no translation
adjustment arising from these U.S. dollar denominated investments. The converted funds were not repatriated to the U.S. and
no U.S. tax was triggered on the transfer of these funds to the European subsidiary. We incurred additional foreign income
taxes of approximately $0.8 million related to this distribution. We currently have approximately $131 million of cash,
including the investment in U.S. Treasury securities, held by foreign subsidiaries. We intend to permanently reinvest our
accumulated earnings in these entities and our current plans do not demonstrate a need for these funds to support our domestic
operations. If, however, a portion of these funds were needed for and distributed to our operations in the United States, we
would be subject to additional U.S. income taxes and foreign withholding taxes. The amount of the taxes due would depend on
the amount and manner of repatriation, as well as the location from where the funds are repatriated. We actively monitor the
third-party depository institutions that hold these assets, primarily focusing on the safety of principal and secondarily
maximizing yield on these assets. We diversify our cash and cash equivalents and investments among various financial
institutions, money market funds and sovereign debt in order to reduce our exposure should any one of these financial
institutions or financial instruments fail or encounter difficulties. To date, we have not experienced any material loss or lack of
access to our invested cash, cash equivalents or short-term investments. However, we can provide no assurances that access to
our invested cash, cash equivalents or short-term investments will not be impacted by adverse conditions in the financial
markets.
Sources and Uses of Cash
Historically, our primary source of cash has been provided by operations. Other sources of cash in the past three fiscal
years include proceeds received from the sale of our stock through our employee stock option and purchase plans. Our
historical uses of cash have primarily been for the repurchase of our common stock, capital expenditures and acquisitions of
businesses and technologies. Supplemental information pertaining to our historical sources and uses of cash is presented as
follows and should be read in conjunction with our Consolidated Statements of Cash Flows and notes thereto (in thousands):
Net cash provided by operating activities
Sales of shares under employee stock plans
Repurchase of common stock
Capital expenditures
Acquisition of businesses, net of cash acquired
$
$
2012
64,771
13,288
(24,999 )
(36,051 )
(3,687 )
Fiscal
2011
86,676 $
34,720
(100,637 )
(37,117 )
(14,108 )
2010
78,813
33,438
(43,335 )
(15,139 )
(20,745 )
Net cash provided by operating activities decreased by $21.9 million in fiscal 2012 compared to fiscal 2011 and increased
by $7.9 million in fiscal 2011 compared to fiscal 2010. The decrease in cash provided by operating activities in fiscal 2012 was
primarily due to lower net income, higher tax payments and lower cash flows from other current liabilities including variable
compensation and accounts payable partially offset by higher cash flows from inventories and accounts receivable. The
increase in cash provided by operating activities in fiscal 2011 was primarily due to higher net income partially offset by lower
cash flows from inventories, accounts payable and other current liabilities. We believe that our existing cash, cash equivalents
and short term investments combined with cash to be provided by operating activities will be adequate to cover our working
capital needs and planned capital expenditures for at least the next 12 months to the extent such items are known or are
reasonably determinable based on current business and market conditions. However, we may elect to finance certain of our
44
capital expenditure requirements through borrowings under our bank credit facilities or other sources of capital. We continue to
follow our strategy to further strengthen our financial position by using available cash flow to fund operations.
We intend to continue pursuing acquisition opportunities at valuations we believe are reasonable based upon market
conditions. However, we cannot accurately predict the timing, size and success of our acquisition efforts or our associated
potential capital commitments. Furthermore, we cannot assure you that we will be able to acquire businesses on terms
acceptable to us. We expect to fund future acquisitions primarily through existing cash balances and cash flows from
operations. If required, we will look for additional borrowings or consider the issuance of securities. The extent to which we
will be willing or able to use our common stock to make acquisitions will depend on its market value at the time and the
willingness of potential sellers to accept it as full or partial payment.
On April 29, 2010, we announced that the Board of Directors had authorized the repurchase of up to $50.0 million of our
common stock. During fiscal 2010, we repurchased and retired 1,195,829 shares of outstanding common stock at an average
price of $36.21 per share for a total of $43.3 million, excluding expenses.
On January 26, 2011, the Board canceled this program and authorized the repurchase of up to $75.0 million of our
common stock. The program was authorized for 12 months from the date of authorization. In March 2011, we repurchased and
retired 454,682 shares of outstanding common stock under a modified "Dutch Auction" tender offer at an average price of
$59.00 per share for a total of $26.8 million, excluding expenses. During the third and fourth quarters of fiscal 2011, we
repurchased and retired an additional 1,024,409 shares of outstanding common stock at an average price of $47.03 per share for
a total of $48.2 million, excluding expenses.
On August 25, 2011, we announced that the Board of Directors had authorized the repurchase of up to $50.0 million of
our common stock. The program was authorized for 12 months from the date of authorization. During fiscal 2011, we
repurchased and retired 586,200 shares of outstanding common stock at an average price of $42.67 per share for a total of
$25.0 million, excluding expenses. During fiscal 2012, we repurchased and retired 543,200 shares of outstanding common
stock at an average price of $45.99 per share for a total of $25.0 million, excluding expenses, completing the repurchase.
On October 4, 2012, the Board of Directors authorized a buyback program whereby we are authorized to repurchase up to
$25 million of our common stock. This buyback program is discussed in Note 19 "Subsequent Events" in the notes to the
Consolidated Financial Statements under Item 15 of this annual report.
During fiscal year 2008, we initiated restructuring plans to decrease costs by consolidating facilities and reducing our
workforce. As of September 29, 2012, we had made payments in connection with the restructuring plans in the amount of $27.7
million. We completed payments for substantially all anticipated costs related to the restructuring plans in the third quarter of
fiscal 2011.
Additional sources of cash available to us were domestic and international currency lines of credit and bank credit
facilities totaling $70.2 million as of September 29, 2012, of which $68.2 million was unused and available. These unsecured
credit facilities were used in Europe and Japan during fiscal 2012. Our domestic line of credit consists of a $50.0 million
unsecured revolving credit account with Union Bank of California, which expires on May 31, 2014 and is subject to covenants
related to financial ratios and tangible net worth. No amounts have been drawn upon our domestic line of credit and $1.9
million of the international currency lines has been used as guarantees as of September 29, 2012.
Our ratio of current assets to current liabilities was 4.0:1 at September 29, 2012, compared to 3.6:1 at October 1, 2011.
The increase in our ratio is primarily due increases in cash and short-term investments and inventories as well as decreases in
accounts payable and other current liabilities. Our cash and cash equivalents, short-term investments, working capital and debt
obligations are as follows (in thousands):
Cash and cash equivalents
Short-term investments
Working capital
Total debt obligations
$
Fiscal
2012
67,761 $
157,168
460,697
19
2011
167,061
53,142
418,241
34
Contractual Obligations and Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements as defined by Regulation S-K of the Securities Act of 1933. The following
summarizes our contractual obligations at September 29, 2012 and the effect such obligations are expected to have on our
liquidity and cash flow in future periods (in thousands):
45
Long-term debt payments
Operating lease payments
Asset retirement obligations
Purchase commitments with suppliers
Purchase obligations
Total
Total
$
19 $
42,053
2,299
65,543
6,763
$ 116,677 $
Less than
1 year
17 $
8,721
—
65,543
6,565
80,846 $
1 to 3 years
3 to 5 years
2 $
13,297
1,077
—
198
14,574 $
$
—
10,308
38
—
—
10,346
$
More than
5 years
—
9,727
1,184
—
—
10,911
Because of the uncertainty as to the timing of such payments, we have excluded cash payments related to our contractual
obligations for our deferred compensation plans aggregating $25.7 million at September 29, 2012.
As of September 29, 2012, we recorded gross unrecognized tax benefits of $27.6 million including gross interest and
penalties of $1.6 million. As of October 1, 2011, we recorded gross unrecognized tax benefits of $33.7 million including gross
interest and penalties of $3.4 million. Both gross unrecognized tax benefits and gross interest and penalties are classified as
non-current liabilities in the consolidated balance sheet. At this time, we are unable to make a reasonably reliable estimate of
the timing of payments in individual years due to uncertainties in the timing of tax audit outcomes. As a result, these amounts
are not included in the table above.
Changes in financial condition
Cash provided by operating activities in fiscal 2012 was $64.8 million, which included net income of $63.0 million,
depreciation and amortization of $29.6 million, stock-based compensation expense of $16.3 million and the $4.1 million write-
off of Hypertronics intangibles partially offset by cash used by operating assets and liabilities of $42.0 million, increases in net
deferred tax assets of $4.8 million and $1.4 million other.
Cash used in investing activities in fiscal 2012 of $142.9 million included $103.5 million net purchases of available-for-
sale securities, $35.7 million, net, used to acquire property and equipment and improve buildings and $3.7 million used to
acquire Midaz.
Cash used in financing activities in fiscal 2012 was $15.0 million, including $25.0 million used to repurchase our
common stock and $3.3 million other partially offset by $13.3 million generated from our employee stock purchase plans.
Changes in exchange rates in fiscal 2012 resulted in a decrease in cash balances of $6.1 million.
RECENT ACCOUNTING PRONOUNCEMENTS
See Note 2. "Significant Accounting Policies" in the Notes to Consolidated Financial Statements under Item 15 of this
annual report for a full description of recent accounting pronouncements, including the respective dates of adoption or expected
adoption and effects on our consolidated financial position, results of operations and cash flows.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial
statements, which have been prepared in accordance with accounting principles generally accepted in the United States of
America and pursuant to the rules and regulations of the SEC. The preparation of these financial statements requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses
during the reporting period. We have identified the following as the items that require the most significant judgment and often
involve complex estimation: revenue recognition, accounting for long-lived assets (including goodwill and intangible assets),
inventory valuation, warranty reserves, stock-based compensation and accounting for income taxes.
Revenue Recognition
We recognize revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement
exists, the product has been delivered or the service has been rendered, the price is fixed or determinable and collection is
probable. Revenue from product sales is recorded when all of the foregoing conditions are met and risk of loss and title passes
to the customer. Our products typically include a warranty and the estimated cost of product warranty claims (based on
historical experience) is recorded at the time the sale is recognized. Sales to customers are generally not subject to any price
protection or return rights.
The vast majority of our sales are made to original equipment manufacturers ("OEMs"), distributors, resellers and end-
users in the non-scientific market. Sales made to these customers do not require installation of the products by us and are not
46
subject to other post-delivery obligations, except in occasional instances where we have agreed to perform installation or
provide training. In those instances, we defer revenue related to installation services or training until these services have been
rendered. We allocate revenue from multiple element arrangements to the various elements based upon fair values or a selling
price hierarchy, for arrangements entered into subsequent to October 2, 2010, as more fully described in Note 2, "Significant
Accounting Policies - Revenue Recognition," in our consolidated financial statements.
Should changes in conditions cause management to determine these criteria are not met for certain future transactions,
revenue recognized for any reporting period could be adversely affected. Failure to obtain anticipated orders due to delays or
cancellations of orders could have a material adverse effect on our revenue. In addition, pressures from customers to reduce our
prices or to modify our existing sales terms may have a material adverse effect on our revenue in future periods.
Our sales to distributors, resellers and end-user customers typically do not have customer acceptance provisions and only
certain of our sales to OEM customers and integrators have customer acceptance provisions. Customer acceptance is generally
limited to performance under our published product specifications. For the few product sales that have customer acceptance
provisions because of higher than published specifications, (1) the products are tested and accepted by the customer at our site
or by the customer's acceptance of the results of our testing program prior to shipment to the customer, or (2) the revenue is
deferred until customer acceptance occurs.
Sales to end-users in the scientific market typically require installation and, thus, involve post-delivery obligations;
however our post-delivery installation obligations are not essential to the functionality of our products. We defer revenue
related to installation services until completion of these services.
For most products, training is not provided; therefore, no post-delivery training obligation exists. However, when training
is provided to our customers, it is typically priced separately and recognized as revenue as these services are provided.
For multiple element arrangements which include extended maintenance contracts, we allocate and defer the amount of
consideration equal to the separately stated price and recognize revenue on a straight-line basis over the contract period.
Long-Lived Assets and Goodwill
We evaluate long-lived assets and amortizable intangible assets whenever events or changes in business circumstances or
our planned use of assets indicate that their carrying amounts may not be fully recoverable or that their useful lives are no
longer appropriate. Reviews are performed to determine whether the carrying values of the assets are impaired based on
comparison to the undiscounted expected future cash flows identifiable to such long-lived and amortizable intangible assets. If
the comparison indicates that impairment exists, the impaired asset is written down to its fair value.
We have determined that our reporting units are the same as our operating segments as each constitutes a business for
which discrete financial information is available and for which segment management regularly reviews the operating results.
We make this determination in a manner consistent with how the operating segments are managed. Based on this analysis, we
have identified two reporting units which are our reportable segments: CLC and SLS.
Goodwill is tested for impairment on an annual basis and between annual tests in certain circumstances, and written down
when impaired (see Note 8 "Goodwill and Intangible Assets" in the Notes to Consolidated Financial Statements). We generally
perform our annual impairment tests during the fourth quarter of each fiscal year using the opening balance sheet as of the first
day of the fourth fiscal quarter, with any resulting impairment recorded in the fourth quarter of the fiscal year.
In September 2011, the FASB amended its guidance to simplify testing goodwill for impairment, allowing an entity to
first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment
test. If an entity determines as a result of the qualitative assessment that it is more likely than not (> 50% likelihood) that the
fair value of a reporting unit is less than its carrying amount, then the quantitative test is required. Otherwise, no further testing
is required. We adopted this accounting guidance in the first quarter of fiscal 2012.
For fiscal 2010, we performed our annual goodwill impairment testing during the fourth quarter of fiscal 2010 using the
opening balance sheet as of the first day of the fourth fiscal quarter and noted no impairment. Such analysis requires significant
judgments and estimates to be made by management in particular related to the forecast. The assumed growth rates and gross
margins as well as period expenses were determined based on internally developed forecasts considering our future plans. The
assumptions used were management's best estimates based on projected results and market conditions as of the date of testing.
Utilizing the Income Approach, we noted no impairment. Based on our evaluation, the fair values of each of the two operating
segments significantly exceeded their carrying value. In order to test the sensitivity of these fair values, management further
reviewed other scenarios relative to these assumptions to see if the resulting impact on fair values would have resulted in a
different conclusion for the CLC and SLS reporting units. Sensitivity was applied to the discount rate used in the Income
approach for both the CLC and SLS reporting units. The discount rate for the CLC and SLS reporting units could have been
increased by more than 25% and still resulted in no impairment. Based on the outcome of this testing and sensitivity analysis,
we decided it would not be necessary to utilize all three testing methods for this annual test.
47
Under the goodwill standards in effect for fiscal 2011, a company could carry forward the detailed determination of a
reporting unit from one year to the next if certain criteria have been met. Those criteria include: the assets and liabilities that
make up the reporting unit have not changed significantly since the most recent fair value determination, the most recent fair
value determination resulted in an amount that exceeded the carrying amount of the reporting unit by a substantial margin, and
based on an analysis of events that have occurred and circumstances that have changed since the most recent fair value
determination, the likelihood that a current fair value determination would be less than the current carrying amount of the
reporting unit is remote.
Based on our analysis and a review of the criteria, using the opening balance sheet as of the first day of the fourth quarter
of fiscal 2011, we determined that we had met the requirements of the goodwill standard for carrying forward our fair value
determination from fiscal 2010, and did not perform detailed testing of the fair value of our reporting units for fiscal 2011.
Between the completion of that testing and the end of the fourth quarter of fiscal 2011, we noted no indications of impairment
or triggering events to cause us to review goodwill for potential impairment; based on our evaluation, the fair values of each of
the two operating segments significantly exceeded their carrying value as of that date.
In our fiscal 2012 annual testing, we performed a qualitative assessment of the goodwill by reporting unit during the
fourth quarter of fiscal 2012 using the opening balance sheet as of the first day of the fourth quarter and concluded that it was
more likely than not that the fair value of each of the reporting units exceeded its carrying amount. In assessing the qualitative
factors, we considered the impact of these key factors: macroeconomic conditions, fluctuations in foreign currency, market and
industry conditions, our operating and competitive environment, regulatory and political developments, the overall financial
performance of our reporting units including cost factors and budgeted-to-actual revenue results. We also considered market
capitalization and stock price performance. Based on our assessment, goodwill in the reporting units was not impaired as of the
first day of the fourth quarter of fiscal 2012. As such, it was not necessary to perform the two-step goodwill impairment test at
that time.
As no impairment indicators were present during the fourth quarter of fiscal 2012, we believe these values remain
recoverable.
At September 29, 2012, we had $77.7 million of goodwill, $9.5 million of purchased intangible assets and $115.1 million
of property and equipment on our consolidated balance sheet.
It is reasonably possible that the estimates of anticipated future net revenue, the remaining estimated economic life of the
products and technologies, or both, could differ from those used to assess the recoverability of these assets in fiscal 2010. In
addition, if the price of our common stock were to significantly decrease combined with any other adverse change in market
conditions, thus indicating that the underlying fair value of our reporting units or other long-lived assets may have decreased,
we may be required to assess the recoverability of such assets in the period such circumstances are identified. In that event,
additional impairment charges or shortened useful lives of certain long-lived assets may be required.
Inventory Valuation
We record our inventory at the lower of cost (computed on a first-in, first-out basis) or market. We write-down our
inventory to its estimated market value based on assumptions about future demand and market conditions. Inventory write-
downs are generally recorded within guidelines set by management when the inventory for a device exceeds 12 months of its
demand and when individual parts have been in inventory for greater than 12 months. If actual market conditions are less
favorable than those projected by management, additional inventory write-downs may be required which could materially
affect our future results of operations. Due to rapidly changing forecasts and orders, additional write-downs for excess or
obsolete inventory, while not currently expected, could be required in the future. In the event that alternative future uses of
fully written down inventories are identified, we may experience better than normal profit margins when such inventory is sold.
Differences between actual results and previous estimates of excess and obsolete inventory could materially affect our future
results of operations. We write-down our demo inventory by amortizing the cost of demo inventory over a twenty month period
starting from the fourth month after such inventory is placed in service.
Warranty Reserves
We provide warranties on certain of our product sales and allowances for estimated warranty costs are recorded during
the period of sale. The determination of such allowances requires us to make estimates of product return rates and expected
costs to repair or replace the products under warranty. We currently establish warranty reserves based on historical warranty
costs for each product line. The weighted average warranty period covered is approximately 15 months. If actual return rates
and/or repair and replacement costs differ significantly from our estimates, adjustments to cost of sales may be required in
future periods.
Stock-Based Compensation
We account for stock-based compensation using fair value. We estimate the fair value of stock options granted using the
48
Black-Scholes Merton model and estimate the fair value of market-based performance restricted stock units granted using a
Monte Carlo simulation model. We use historical data to estimate pre-vesting option forfeitures and record stock-based
compensation expense only for those awards that are expected to vest. We amortize the fair value of stock options on a straight-
line basis over the requisite service periods of the awards, which are generally the vesting periods. We value service-based
restricted stock units using the intrinsic value method and amortize the value on a straight-line basis over the restriction period.
We value market-based performance restricted stock units using a Monte Carlo simulation model and amortize the value over
the performance period, with no adjustment in future periods, based upon the actual shareholder return over the performance
period.
U.S. Generally Accepted Accounting Principles ("GAAP") requires the use of option pricing models that were not
developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in
estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In
addition, option-pricing models require the input of highly subjective assumptions, including the options expected life, the
expected price volatility of the underlying stock and an estimate of expected forfeitures. Our computation of expected volatility
considers historical volatility and market-based implied volatility. Our estimate of expected forfeitures is based on historical
employee data and could differ from actual forfeitures.
See Note 14 "Employee Stock Option and Benefit Plans" in the notes to the Consolidated Financial Statements under
Item 15 of this annual report for a description of our stock-based employee compensation plans and the assumptions we use to
calculate the fair value of stock-based employee compensation.
Income Taxes
As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax
provision (benefit) in each of the jurisdictions in which we operate. This process involves us estimating our current income tax
provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and
accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated
balance sheets.
We record a valuation allowance to reduce our deferred tax assets to an amount that more likely than not will be realized.
While we have considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need
for the valuation allowance, in the event we were to determine that we would be able to realize our deferred tax assets in the
future in excess of our net recorded amount, an adjustment to the allowance for the deferred tax asset would increase income in
the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our
net deferred tax asset in the future, an adjustment to the valuation allowance for the deferred tax asset would be charged to
income in the period such determination was made.
Federal income taxes have not been provided for on a portion of the unremitted earnings of foreign subsidiaries because
such earnings are intended to be permanently reinvested. The total amount of unremitted earnings of foreign subsidiaries for
which we have not yet recorded federal and state income taxes was approximately $270 million at fiscal 2012 year-end. The
amount of federal and state income taxes that would be payable upon repatriation of such earnings are not practicably
determinable.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk disclosures
We are exposed to market risk related to changes in interest rates and foreign currency exchange rates. We do not use
derivative financial instruments for speculative or trading purposes.
Interest rate sensitivity
A portion of our investment portfolio is composed of fixed income securities. These securities are subject to interest rate
risk and will fall in value if market interest rates increase. If interest rates were to increase immediately (whether due to
changes in overall market rates or credit worthiness of the issuers of our individual securities) and uniformly by 10% from
levels at fiscal 2012 year-end, the fair value of the portfolio, based on quoted market prices in active markets involving similar
assets, would decline by an immaterial amount due to their short-term maturities. We have the ability to generally hold our
fixed income investments until maturity and therefore we would not expect our operating results or cash flows to be affected to
any significant degree by the effect of a sudden change in market interest rates on our securities portfolio. If necessary, we may
sell short-term investments prior to maturity to meet our liquidity needs.
At fiscal 2012 year-end, the fair value of our available-for-sale debt securities was $155.1 million, all of which was
classified as short-term investments. Gross unrealized gains and losses on available-for-sale debt securities were $952,000 and
$(3,000), respectively, at fiscal 2012 year-end. At fiscal 2011 year-end, the fair value of our available-for-sale debt securities
was $46.6 million, all of which was classified as short-term investments. Gross unrealized gains and losses on available-for-
49
sale debt securities were $276,000 and ($27,000), respectively, at fiscal 2011 year-end.
Foreign currency exchange risk
We maintain operations in various countries outside of the United States and have foreign subsidiaries that manufacture
and sell our products in various global markets. The majority of our sales are transacted in U.S. dollars. However, we do
generate revenues in other currencies, primarily the Japanese Yen, the Euro and the Korean Won. As a result, our earnings,
cash flows and cash balances are exposed to fluctuations in foreign currency exchange rates. We attempt to limit these
exposures through financial market instruments. We utilize derivative instruments, primarily forward contracts with maturities
of two months or less, to manage our exposure associated with anticipated cash flows and net asset and liability positions
denominated in foreign currencies. Gains and losses on the forward contracts are mitigated by gains and losses on the
underlying instruments. We do not use derivative financial instruments for trading purposes.
We do not anticipate any material adverse effect on our consolidated financial position, results of operations or cash
flows resulting from the use of these instruments. There can be no assurance that these strategies will be effective or that
transaction losses can be minimized or forecasted accurately. If a financial counterparty to any of our hedging arrangements
experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience
material financial losses. In the current economic environment, the risk of failure of a financial party remains high.
At September 29, 2012, approximately $139.4 million of our cash, cash equivalents and short-term investments were held
outside the U.S. in certain of our foreign operations, $46.1 million of which was denominated in currencies other than the U.S.
dollar. In January 2012, we converted $89.8 million of assets formerly denominated in Euro to U.S. dollars and invested those
funds in U.S. Treasury securities within a European subsidiary whose functional currency is the U.S. dollar. Accordingly, there
is no translation adjustment arising from these U.S. dollar denominated investments.
A hypothetical 10% change in foreign currency rates would not have a material impact on our results of operations, cash
flows or financial position.
The following table provides information about our foreign exchange forward contracts at September 29, 2012. The table
presents the weighted average contractual foreign currency exchange rates, the value of the contracts in U.S. dollars at the
contract exchange rate as of the contract maturity date and fair value. The U.S. notional fair value represents the contracted
amount valued at September 29, 2012 rates.
Forward contracts to sell (buy) foreign currencies for U.S. dollars (in thousands, except contract rates):
Euro
Korean Won
Chinese Renminbi
British Pound Sterling
Japanese Yen
Singapore Dollar
1.2807
1,129.1500
6.3475
1.6020
77.9402
1.2316
Average
Contract Rate
U.S. Notional
Contract Value
$
$
$
$
$
$
(61,799 ) $
39,039 $
8,899 $
8,079 $
2,071 $
1,404 $
U.S. Notional
Fair Value
(62,404)
39,559
8,911
8,177
2,079
1,411
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
See Item 15-(a) for an index to the Consolidated Financial Statements and Supplementary Financial Information, which
are attached hereto and incorporated by reference herein. The financial statements and notes thereto can be found beginning on
page 61 of this annual report.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
Not applicable.
50
ITEM 9A. CONTROLS AND PROCEDURES
Management's Evaluation of Disclosure Controls and Procedures
We have evaluated the effectiveness of the design and operation of our disclosure controls and procedures; as such term
is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this annual
report ("Evaluation Date"). The controls evaluation was done under the supervision and with the participation of management,
including our Chief Executive Officer and Chief Financial Officer. Based on this evaluation, our Chief Executive Officer and
Chief Financial Officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective in
providing reasonable assurance that information required to be disclosed by us in reports that we file or submit under the
Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported within the time periods
specified in the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to our
management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions
regarding required disclosures.
Management's Report on Internal Control Over Financial Reporting
Management, including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and
maintaining adequate internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the Company.
Management assessed the effectiveness of our internal control over financial reporting as of September 29, 2012,
utilizing the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") in
Internal Control-Integrated Framework. Based on the assessment by management, we determined that our internal control over
financial reporting was effective as of September 29, 2012. The effectiveness of our internal control over financial reporting as
of September 29, 2012 has been audited by Deloitte & Touche LLP, our independent registered public accounting firm, as
stated in their report which appears below.
Inherent Limitations Over Internal Controls
Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles. The Company's internal control over financial reporting includes those policies and procedures that:
(i)
(ii)
(iii)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the Company's assets;
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that the Company's receipts and
expenditures are being made only in accordance with authorizations of the Company's management and directors;
and
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the Company's assets that could have a material effect on the financial statements.
Management, including our CEO and CFO, does not expect that the Company's internal controls will prevent or detect all
errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute,
assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that
there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent
limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and
instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject
to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended
September 29, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over
financial reporting.
51
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Coherent, Inc.:
We have audited the internal control over financial reporting of Coherent, Inc. and its subsidiaries (collectively, the
"Company") as of September 29, 2012, based on the criteria established in Internal Control—Integrated Framework issued by
the Committee of Sponsoring Organizations of the Treadway Commission. The Company's management is responsible for
maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over
financial reporting included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our
responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective
internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding
of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design
and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's
principal executive and principal financial officers, or persons performing similar functions, and effected by the company's
board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of
the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that
could have a material effect on the financial statements.
Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future
periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of
September 29, 2012, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States), the consolidated financial statements as of and for the year ended September 29, 2012, of the Company and our report
dated November 28, 2012, expressed an unqualified opinion on those consolidated financial statements and includes an
explanatory paragraph relating to the Company's adoption of new accounting guidance for the presentation of comprehensive
income.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
November 28, 2012
ITEM 9B. OTHER INFORMATION
Not applicable.
52
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
Information regarding: (i) our directors will be set forth under the caption "Proposal One —Election of Directors—
Nominees"; (ii) compliance with Section 16(a) of the Securities Act of 1933 will be set forth under the caption "Section 16(a)
Beneficial Ownership Reporting Compliance"; (iii) the process for stockholders to nominate directors will be set forth under
the caption "Proposal One—Election of Directors—Process for Recommending Candidates for Election to the Board of
Directors"; (iv) our audit committee and audit committee financial expert will be set forth under the caption "Proposal One—
Election of Directors—Board Meetings and Committees—Audit Committee"; in our proxy statement for use in connection
with an upcoming Annual Meeting of Stockholders to be held in 2013 (the "2013 Proxy Statement") and is incorporated herein
by reference or included in a Form 10-K/A as an amendment to this Form 10-K. The 2013 Proxy Statement or Form 10-K/A
will be filed with the SEC within 120 days after the end of our fiscal year.
Business Conduct Policy
We have adopted a worldwide Business Conduct Policy that applies to the members of our Board of Directors, executive
officers and other employees. This policy is posted on our Website at www.coherent.com and may be found as follows:
1.
2.
From our main Web page, first click on "Company" and then on "corporate governance."
Next, click on "Business Conduct Policy."
We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or waiver from,
a provision of this Business Conduct Policy by posting such information on our Website, at the address and location specified
above.
Stockholders may request free printed copies of our worldwide Business Conduct Policy from:
Coherent, Inc.
Attention: Investor Relations
5100 Patrick Henry Drive
Santa Clara, California 95054
Executive Officers
The name, age, position and a brief account of the business experience of our executive officers as of November 28, 2012
are set forth below:
Name
John R. Ambroseo
Helene Simonet
Mark Sobey
Luis Spinelli
Bret M. DiMarco
Paul Sechrist
Office Held
Age
51 President and Chief Executive Officer
60 Executive Vice President and Chief Financial Officer
52 Executive Vice President and General Manager, Specialty Laser Systems
64 Executive Vice President and Chief Technology Officer
44 Executive Vice President, General Counsel and Corporate Secretary
53 Executive Vice President, Worldwide Sales and Service
John R. Ambroseo. Mr. Ambroseo has served as our President and Chief Executive Officer as well as a member of the
Board of Directors since October 2002. Mr. Ambroseo served as our Chief Operating Officer from June 2001 through
September 2002. Mr. Ambroseo served as our Executive Vice President and as President and General Manager of the Coherent
Photonics Group from September 2000 to June 2001. From September 1997 to September 2000, Mr. Ambroseo served as our
Executive Vice President and as President and General Manager of the Coherent Laser Group. From March 1997 to September
1997, Mr. Ambroseo served as our Scientific Business Unit Manager. From August 1988, when Mr. Ambroseo joined us, until
March 1997, he served as a Sales Engineer, Product Marketing Manager, National Sales Manager and Director of European
Operations. Mr. Ambroseo received a Bachelor degree from SUNY-College at Purchase and a PhD in Chemistry from the
University of Pennsylvania.
Helene Simonet. Ms. Simonet has served as our Executive Vice President and Chief Financial Officer since April 2002.
Ms. Simonet served as Vice President of Finance of our former Medical Group and Vice President of Finance, Photonics
Division from December 1999 to April 2002. Prior to joining Coherent, she spent over twenty years in senior finance positions
at Raychem Corporation's Division and Corporate organizations, including Vice President of Finance of the Raynet
Corporation. Ms. Simonet has both Master's and Bachelor degrees from the University of Leuven, Belgium.
53
Mark Sobey. Mr. Sobey was appointed Executive Vice President of Coherent and General Manager of Specialty Laser
Systems (SLS) in April 2010. He has served as Senior Vice President and General Manager for the SLS Business Group, which
primarily serves the Microelectronics and Research markets, since joining Coherent in July 2007. Prior to Coherent, Mr. Sobey
has spent over 20 years in the Laser and Fiber Optics Telecommunications industries, including roles as Senior Vice President
Product Management at Cymer from January 2006 through June 2007 and previously as Senior Vice President Global Sales at
JDS Uniphase through October 2005. He received his PhD in Engineering and BSc in Physics, both from the University of
Strathclyde in Scotland.
Luis Spinelli. Mr. Spinelli has served as our Executive Vice President and Chief Technology Officer since February
2004. Mr. Spinelli joined the Company in May 1985 and has since held various engineering and managerial positions,
including Vice President, Advanced Research from April 2000 to September 2002 and Vice President, Corporate Research
from September 2002 to February 2004. Mr. Spinelli has led the Advanced Research Unit from its inception in 1998, whose
charter is to identify and evaluate new and emerging technologies of interest for us across a range of disciplines in the laser
field. Mr. Spinelli holds a degree in Electrical Engineering from the University of Buenos Aires, Argentina with post-graduate
work at the Massachusetts Institute of Technology.
Bret M. DiMarco. Mr. DiMarco has served as our Executive Vice President and General Counsel since June 2006 and
our Corporate Secretary since February 2007. From February 2003 until May 2006, Mr. DiMarco was a member and from
October 1995 until January 2003 was an associate at Wilson Sonsini Goodrich & Rosati, P.C., a law firm. Mr. DiMarco
received a Bachelor degree from the University of California at Irvine and a Juris Doctorate degree from the Law Center at the
University of Southern California. He is also an adjunct professor of law at the University of California Hastings College of the
Law, teaching corporate law and mergers & acquisitions.
Paul Sechrist. Mr. Paul Sechrist was appointed Executive Vice President, Worldwide Sales and Service in March 2011.
He has over 28 years of experience with Coherent, including roles as Senior Vice President and General Manager of
Commercial Lasers and Components from October 2008 to March 2011, Vice President and General Manager of Specialty
Laser Systems, Santa Clara from March 2008 to October 2008 and Vice President for Components from April 2005 to October
2008. Mr. Sechrist received an AA degree from San Jose City College, with Physics studies at California State University,
Hayward.
ITEM 11. EXECUTIVE COMPENSATION
Information regarding: (i) executive officer and director compensation will be set forth under the captions "Election of
Directors—Director Compensation" and "Executive Officers and Executive Compensation" and (ii) compensation committee
interlocks will be set forth under the caption "Executive Officers and Executive Compensation—Compensation Committee
Interlocks and Insider Participation and Committee Independence" in the 2013 Proxy Statement or included in a Form 10-K/A
as an amendment to our Form 10-K for the fiscal year ended September 29, 2012. The 2013 Proxy Statement or Form 10-K/A
will be filed with the SEC within 120 days after the end of our fiscal year.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
Information regarding: (i) equity compensation plan information will be set forth under the caption "Equity
Compensation Plan Information"; and (ii) security ownership of certain beneficial owners and management will be set forth
under the caption "Security Ownership of Certain Beneficial Owners and Management"; in our 2013 Proxy Statement and is
incorporated herein by reference or included in a Form 10-K/A as an amendment to our Form 10-K for the fiscal year ended
September 29, 2012.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required under this item will be set forth under the caption "Certain Relationships and Related Party
Transactions" in our 2013 Proxy Statement and is incorporated herein by reference or included in a Form 10-K/A as an
amendment to our Form 10-K for the fiscal year ended September 29, 2012.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Principal Accounting Fees and Services
The following table sets forth fees for services provided by Deloitte & Touche LLP, the member firms of Deloitte
Touche Tohmatsu, and their respective affiliates (collectively, "Deloitte") during fiscal years 2012 and 2011:
54
Audit fees(1)
Audit-related fees(2)
Tax fees
All other fees(3)
Total
2012
2011
$ 1,725,000 $ 1,665,000
—
—
2,000
$ 1,899,832 $ 1,667,000
172,632
—
2,200
_____________________________________________
(1) Represents fees for professional services provided in connection with the integrated audit of our annual financial
statements and internal control over financial reporting and review of our quarterly financial statements, advice on
accounting matters that arose during the audit and audit services provided in connection with other statutory or
regulatory filings.
(2) Represents $146,874 in fees for due diligence associated with our acquisition activities in fiscal 2012 and $25,578 for
services related to the review of our XBRL filings.
(3) Represents the annual subscription for access to the Deloitte Accounting Research Tool, which is a searchable on-line
accounting database.
Pre-Approval of Audit and Non-Audit Services
The Audit Committee has determined that the provision of non-audit services by Deloitte is compatible with maintaining
Deloitte's independence. In accordance with its charter, the Audit Committee approves in advance all audit and non-audit
services to be provided by Deloitte. In other cases, the Chairman of the Audit Committee has the delegated authority from the
Committee to pre-approve certain additional services, and such pre-approvals are communicated to the full Committee at its
next meeting. During fiscal year 2012, all services were pre-approved by the Audit Committee in accordance with this policy.
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
PART IV
55
(a)
1.
Index to Consolidated Financial Statements
The following Consolidated Financial Statements of Coherent, Inc. and its subsidiaries are filed as part of this annual
report on Form 10-K:
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets—September 29, 2012 and October 1, 2011
Consolidated Statements of Operations—Years ended September 29, 2012, October 1, 2011 and October 2,
2010
Consolidated Statements of Comprehensive Income—Years ended September 29, 2012, October 1, 2011 and
October 2, 2010
Consolidated Statements of Stockholders' Equity—Years ended September 29, 2012, October 1, 2011 and
October 2, 2010
Consolidated Statements of Cash Flows—Years ended September 29, 2012, October 1, 2011 and October 2,
2010
Notes to Consolidated Financial Statements
Quarterly Financial Information (Unaudited)
60
61
62
63
64
65
67
100
2.
Consolidated Financial Statement Schedules
Financial statement schedules have been omitted because they are either not required, not applicable or the information
required to be set forth therein is included in the Consolidated Financial Statements hereto.
3.
Exhibits
Exhibit
Numbers
3.1* Restated and Amended Certificate of Incorporation. (Previously filed as Exhibit 3.1 to Form 10-K for the fiscal
year ended September 29, 1990)
3.2* Certificate of Amendment of Restated and Amended Certificate of Incorporation of Coherent, Inc. (Previously
filed as Exhibit 3.2 to Form 10-K for the fiscal year ended September 28, 2002)
3.3* Bylaws of Coherent, Inc. (Previously filed as Exhibit 3.3 to Form 10-Q for the fiscal quarter ended June 28,
10.1*‡
2008)
Amended and Restated Employee Stock Purchase Plan. (Previously filed as Exhibit 10.1 to Form S-8 filed on
June 12, 2012)
10.2*‡ Coherent Employee Retirement and Investment Plan. (Previously filed as Exhibit 10.23 to Form 8, Amendment
No. 1 to Annual Report on Form 10-K for the fiscal year ended September 25, 1982)
10.3* 1998 Director Option Plan. (Previously filed as Appendix B to Schedule 14A filed February 28, 2006)
10.4*‡ 2001 Stock Plan (Previously filed as Exhibit 10.1 to Form 10-Q for the quarter ended March 29, 2008)
10.5*‡ Change of Control Severance Plan, as amended and restated effective December 10, 2008. (Previously filed as
Exhibit 10.1 to Form 10-Q for the quarter ended April 4, 2009)
Variable Compensation Plan, as amended. (Previously filed as Exhibit 10.7 to Form 10-K for the fiscal year
10.6*‡
ended October 1, 2011)
Fiscal 2011 Variable Compensation Plan Payout Scale for Named Executive Officers. (Previously filed as
10.7*‡
Exhibit 10.8 to Form 10-K for the fiscal year ended October 1, 2011)
Fiscal 2012 Variable Compensation Plan Payout Scale for Named Executive Officers. (Previously filed as
10.8**‡
10.9*‡ Offer Letter to Bret DiMarco. (Previously filed as Exhibit 10.14 to Form 10-K for the year ended
Exhibit 10.9 to Form 10-K for the fiscal year ended October 1, 2011)
September 30, 2006)
10.10*‡
Supplementary Retirement Plan. (Previously filed as Exhibit 10.5 to Form 10-Q for the quarter ended April 1,
2006)
56
10.11*‡
10.12*‡
10.13*‡
10.14*
10.15*
10.16*
10.17*
10.18*‡
10.19*‡
10.20*‡
10.21*‡
10.22*‡
10.23‡
2005 Deferred Compensation Plan. (Previously filed as Exhibit 10.1 to Form 10-Q for the fiscal quarter ended
December 31, 2011)
Form of 2001 Stock Plan Terms and Conditions of Restricted Stock Units. (Previously filed as Exhibit 10.1 to
Form 8-K filed on November 27, 2009)
Form of 2001 Stock Plan Amended Global Stock Option Agreement. (Previously filed as Exhibit 10.2 to
Form 8-K filed on November 27, 2009)
Amended and Restated Loan Agreement by and between Coherent, Inc. and Union Bank of California, N.A.
dated as of May 30, 2012. (Previously filed as Exhibit 10.1 to Form 8-K filed on June 5, 2012)
Amended and Restated Promissory Note (Base Rate) (Previously filed as Exhibit 10.2 to Form 8-K filed on
June 5, 2012)
Second Lease Amendment by and between Coherent, Inc. and 5200 Patrick Henry Associates LLC dated as of
July 23, 2010. (Previously filed as Exhibit 10.1 to Form 10-Q for the quarter ended July 3, 2010)
Form of Indemnification Agreement (Previously filed as Exhibit 10.18 to Form 10-K for the year ended
October 2, 2010)
2011 Equity Incentive Plan. (incorporated by reference to Exhibit 10.1 to the Company's Registration
Statement on Form S-8 (File No. 333-174019) filed on May 6, 2011)
Form of RSU Agreement for members of the Board of Directors under the Company's 2011 Equity Incentive
Plan. (Previously filed as Exhibit 10.1 to Form 10-Q for the fiscal quarter ended July 2, 2011)
Form of Option Agreement for members of the Board of Directors under the Company's 2011 Equity Incentive
Plan. (Previously filed as Exhibit 10.1 to Form 10-Q for the fiscal quarter ended July 2, 2011)
Form of Performance RSU Agreement under the 2011 Equity Incentive Plan. (Previously filed as Exhibit 10.22
to Form 10-K for the fiscal year ended October 1, 2011)
Form of Time-Based RSU Agreement under the 2011 Equity Incentive Plan. (Previously filed as Exhibit 10.23
to Form 10-K for the fiscal year ended October 1, 2011)
Form of Performance RSU Agreement under the 2011 Equity Incentive Plan (Amended)
Subsidiaries
21.1
23.1 Consent of Independent Registered Public Accounting Firm
24.1 Power of Attorney (see signature page)
31.1
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
32.1
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
__________________________________________
32.2
*
**
‡
These exhibits were previously filed with the Commission as indicated and are incorporated herein by reference.
Portions of this exhibit are redacted and confidential treatment has been requested.
Identifies management contract or compensatory plans or arrangements required to be filed as an exhibit.
57
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
Date: November 28, 2012
COHERENT, INC.
/s/ JOHN R. AMBROSEO
By: John R. Ambroseo
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes
and appoints John R. Ambroseo and Helene Simonet, and each of them individually, as his attorney-in-fact, each with full
power of substitution, for him in any and all capacities to sign any and all amendments to this Report on Form 10-K, and to file
the same with, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, hereby ratifying and confirming all that said attorney-in-fact, or his or her substitute, may do or cause to be done
by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the registrant and in the capacities and on the dates indicated:
/s/ JOHN R. AMBROSEO
John R. Ambroseo
(Director and Principal Executive Officer)
/s/ HELENE SIMONET
Helene Simonet
(Principal Financial and Accounting Officer)
/s/ JAY T. FLATLEY
Jay T. Flatley
(Director)
/s/ SUSAN M. JAMES
Susan M. James
(Director)
/s/ L. WILLIAM KRAUSE
L. William Krause
(Director)
/s/ GARRY W. ROGERSON
Garry W. Rogerson
(Director)
/s/ LAWRENCE TOMLINSON
Lawrence Tomlinson
(Director)
/s/ SANDEEP VIJ
Sandeep Vij
(Director)
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
November 28, 2012
Date
58
STATEMENT OF MANAGEMENT RESPONSIBILITY
Management is responsible for the preparation, integrity, and objectivity of the Consolidated Financial Statements and
other financial information included in the Company's 2012 Annual Report on Form 10-K. The Consolidated Financial
Statements have been prepared in conformity with U.S. generally accepted accounting principles and reflect the effects of
certain estimates and judgments made by management. It is critical for investors and other users of the Consolidated Financial
Statements to have confidence that the financial information that we provide is timely, complete, relevant and accurate
Management, with oversight by the Company's Board of Directors, has established and maintains a corporate culture that
requires that the Company's affairs be conducted to the highest standards of business ethics and conduct. Management also
maintains a system of internal control that is designed to provide reasonable assurance that assets are safeguarded and that
transactions are properly recorded and executed in accordance with management's authorization. This system is regularly
monitored through direct management review, as well as extensive audits conducted by internal auditors throughout the
organization.
Our Consolidated Financial Statements as of and for the year ended September 29, 2012 have been audited by Deloitte &
Touche LLP, an independent registered public accounting firm. Their audit was conducted in accordance with the standards of
the Public Company Accounting Oversight Board (United States) and included an integrated audit under such standards.
The Audit Committee of the Board of Directors meets regularly with management, the internal auditors and the
independent registered public accounting firm to review accounting, reporting, auditing and internal control matters. The Audit
Committee has direct and private access to both internal and external auditors.
See Item 9A for Management's Report on Internal Control Over Financing Reporting.
We are committed to enhancing shareholder value and fully understand and embrace our fiduciary oversight
responsibilities. We are dedicated to ensuring that our high standards of financial accounting and reporting as well as our
underlying system of internal controls are maintained. Our culture demands integrity and we have the highest confidence in our
processes, internal controls, and people, who are objective in their responsibilities and operate under the highest level of ethical
standards.
/s/ JOHN R. AMBROSEO
John R. Ambroseo
President and Chief Executive Officer
/s/ HELENE SIMONET
Helene Simonet
Executive Vice President and Chief Financial Officer
59
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Coherent, Inc.:
We have audited the accompanying consolidated balance sheets of Coherent, Inc. and its subsidiaries (collectively, the
"Company") as of September 29, 2012 and October 1, 2011, and the related consolidated statements of operations,
comprehensive income, stockholders' equity, and cash flows for each of the three years in the period ended September 29,
2012. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to
express an opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of the
Company as of September 29, 2012 and October 1, 2011, and the results of its operations and its cash flows for each of the
three years in the period ended September 29, 2012, in conformity with accounting principles generally accepted in the United
States of America.
As discussed in Note 2 to the consolidated financial statements, the Company has retrospectively adopted new accounting
guidance related to the presentation of comprehensive income.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States), the Company's internal control over financial reporting as of September 29, 2012, based on the criteria established in
Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission
and our report dated November 28, 2012 expressed an unqualified opinion on the Company's internal control over financial
reporting.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
November 28, 2012
60
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except par value)
Current assets:
ASSETS
Cash and cash equivalents
Short-term investments
Accounts receivable—net of allowances of $1,443 in 2012 and $1,439 in 2011
Inventories
Prepaid expenses and other assets
Deferred tax assets
Total current assets
Property and equipment, net
Goodwill
Intangible assets, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term obligations
Accounts payable
Income taxes payable
Other current liabilities
Total current liabilities
Long-term obligations
Other long-term liabilities
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock, par value $.01:
Authorized—500,000 shares;
Outstanding—23,746 shares in 2012 and 23,722 shares in 2011
Additional paid-in capital
Accumulated other comprehensive income
Retained earnings
Total stockholders' equity
Total liabilities and stockholders' equity
See accompanying Notes to Consolidated Financial Statements.
September 29,
2012
October 1,
2011
$
$
$
67,761 $
157,168
144,345
160,113
61,730
23,368
614,485
115,096
77,689
9,473
64,029
880,772 $
17 $
29,088
33,944
90,739
153,788
2
55,326
167,061
53,142
141,037
152,385
44,964
22,057
580,646
104,504
75,954
17,980
64,182
843,266
15
39,841
23,929
98,620
162,405
19
62,841
237
131,708
40,455
499,256
671,656
880,772 $
236
130,250
51,221
436,294
618,001
843,266
$
61
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Net sales
Cost of sales
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Amortization of intangible assets
Total operating expenses
Income from operations
Other income (expense):
Interest and dividend income
Interest expense
Other—net
Total other income (expense), net
Income before income taxes
Provision for income taxes
Net income
Net income per share:
Basic
Diluted
Shares used in computation:
Basic
Diluted
Year Ended
$
September 29,
2012
769,088
453,103
315,985
$
October 1,
2011
802,834 $
452,012
350,822
October 2,
2010
605,067
344,256
260,811
78,260
138,519
10,376
227,155
88,830
311
(86 )
1,567
1,792
90,622
27,660
62,962
2.67
2.62
23,561
24,026
$
$
$
81,232
149,499
8,082
238,813
112,009
909
(147 )
11,058
11,820
123,829
30,591
93,238 $
72,354
123,575
8,002
203,931
56,880
1,871
(256 )
(516
)
1,099
57,979
21,063
36,916
3.74 $
3.66 $
1.49
1.47
24,924
25,464
24,718
25,091
$
$
$
See accompanying Notes to Consolidated Financial Statements.
62
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Net income
Other comprehensive income (loss):
September 29,
2012
Year Ended
October 1,
2011
October 2,
2010
$
62,962
$
93,238 $
36,916
Translation adjustments
Changes in unrealized gains (losses) on available-for-sale
securities, net of taxes
Net loss realized on derivative instruments, net of tax
Other comprehensive income (loss), net of tax (1)
Total comprehensive income
(10,796)
(10,842)
(18,259)
30
—
(10,766)
52,196
$
(21)
—
(10,863)
82,375 $
(11)
85
(18,185)
18,731
$
(1) Tax expense (benefit) of $(166), $(2,283) and $756 was provided on translation adjustments during fiscal 2012, 2011 and
2010, respectively. Tax expense (benefit) on changes in unrealized gains (losses) on available-for-sale securities and on
net loss realized on derivative instruments was insignificant.
63
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
Three Years in the Period Ended September 29, 2012
(In thousands)
Balances, October 3, 2009
Common stock issued under stock plans, net of shares withheld for
employee taxes
Repurchases of common stock
Stock-based compensation
Net income
Other comprehensive loss, net of tax
Balances, October 2, 2010
Common stock issued under stock plans, net of shares withheld for
employee taxes
Tax benefit from employee stock options
Repurchases of common stock
Stock-based compensation
Net income
Other comprehensive income, net of tax
Balances, October 1, 2011
Common stock issued under stock plans, net of shares withheld for
employee taxes
Tax benefit from employee stock options
Repurchases of common stock
Stock-based compensation
Net income
Other comprehensive income, net of tax
Balances, September 29, 2012
Common
Stock
Shares
24,455
Common
Stock
Par
Value
244
$
Add.
Paid-in
Capital
188,918
$
Accum.
Other
Comp.
Income
80,269
$
Retained
Earnings
$ 306,140
Total
$
575,571
1,295
(1,196)
—
—
—
13
(12)
—
—
—
32,214
(43,323)
8,269
—
—
24,554
$
245
$
186,078
$
1,233
—
(2,065)
—
—
—
11
—
31,403
290
(20)
(100,617)
—
—
—
13,096
—
—
23,722
$
236
$
130,250
$
567
—
(543)
—
—
—
6
—
(5)
—
—
—
8,745
1,264
(24,994)
16,443
—
—
23,746
$
237
$
131,708
$
—
—
—
—
(18,185)
62,084
—
—
—
36,916
32,227
(43,335)
8,269
36,916
—
(18,185)
$ 343,056
$
591,463
—
—
—
—
—
(10,863)
51,221
—
—
—
—
—
(10,766)
40,455
—
—
—
—
93,238
31,414
290
(100,637)
13,096
93,238
—
(10,863)
$ 436,294
$
618,001
—
—
—
—
62,962
8,751
1,264
(24,999)
16,443
62,962
—
(10,766)
$ 499,256
$
671,656
See accompanying Notes to Consolidated Financial Statements
64
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of intangible assets
Write-off of Hypertronics intangibles
Stock-based compensation
Excess tax benefit from stock-based compensation arrangements
Non-cash translation adjustment related to Finland dissolution
Deferred income taxes
Loss on disposal of property and equipment
Other non-cash (income) expense
Changes in assets and liabilities, net of effect of acquisitions:
Accounts receivable
Inventories
Prepaid expenses and other assets
Other assets
Accounts payable
Income taxes payable/receivable
Other current liabilities
Other long-term liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from dispositions of property and equipment
Purchases of available-for-sale securities
Proceeds from sales and maturities of available-for-sale securities
Acquisition of businesses, net of cash acquired
Investment in SiOnyx
Change in restricted cash
Other-net
Net cash used in investing activities
(continued)
September 29,
2012
Year Ended
October 1,
2011
October 2,
2010
$
62,962
$
93,238
$
36,916
23,243
6,406
4,142
16,315
(1,264)
—
(4,763)
235
(427)
(5,146)
(9,767)
(5,294)
147
(10,443)
(6,922)
(5,360)
707
64,771
20,539
8,082
—
12,963
(5,111)
(6,511)
22,089
300
(232)
(26,185)
(38,570)
(8,098)
(1,194)
(161)
4,272
8,712
2,543
86,676
(36,051)
280
(244,186)
140,700
(3,687)
—
—
—
(142,944)
(37,117)
355
(230,992)
195,570
(14,108)
—
625
—
(85,667)
21,657
8,002
—
8,286
(934)
—
13,287
334
4,420
(33,674)
(14,607)
(9,247)
67
15,122
6,454
22,838
(108)
78,813
(15,139)
2,144
(108,688)
133,087
(20,745)
(2,000)
(625)
38
(11,928)
65
COHERENT, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(In thousands)
September 29,
2012
Year Ended
October 1,
2011
October 2,
2010
Cash flows from financing activities:
Short-term borrowings
Repayments of short-term borrowings
Repayments of capital lease obligations
Repurchase of common stock
Issuance of common stock under employee stock option and purchase plans
Excess tax benefits from stock-based compensation arrangements
Net settlement of restricted common stock
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest
Income taxes
Cash received during the year for:
Income taxes
Noncash investing and financing activities:
Unpaid property and equipment purchases
Assets acquired under capital leases
$
$
$
$
$
$
$
$
9,262
(9,262)
(15)
(24,999)
13,288
1,264
(4,537)
(14,999)
(6,128)
(99,300)
167,061
67,761
$
2,344
(2,344)
(18)
(100,637)
34,720
5,111
(3,306)
(64,130)
(15,198)
(78,319)
245,380
167,061
86
49,755
$
$
108
17,291
11,855
$
5,250
$
$
$
$
$
1,031
—
$
$
1,334
$
— $
—
—
(19)
(43,335)
33,438
934
(1,211)
(10,193)
(11,262)
45,430
199,950
245,380
223
12,642
9,213
2,076
43
(concluded)
See accompanying Notes to Consolidated Financial Statements
66
COHERENT, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. DESCRIPTION OF BUSINESS
Founded in 1966, Coherent, Inc. provides photonics-based solutions in a broad range of commercial and scientific
research applications. We design, manufacture, service and market lasers, laser tools and related accessories for a diverse group
of customers. Headquartered in Santa Clara, California, the Company has worldwide operations including research and
development, manufacturing, sales, service and support capabilities.
2. SIGNIFICANT ACCOUNTING POLICIES
Fiscal Year
Our fiscal year ends on the Saturday closest to September 30. Fiscal years 2012, 2011 and 2010 ended on September 29,
2012, October 1, 2011 and October 2, 2010, respectively, and are referred to in these financial statements as fiscal 2012, fiscal
2011, and fiscal 2010 for convenience. All fiscal years include 52 weeks. Accordingly, the financial statements of these
subsidiaries as of that date and for the years then ended have been used for our consolidated financial statements. Management
believes that the impact of the use of different year-ends is immaterial to our consolidated financial statements taken as a
whole.
Use of Estimates
The preparation of consolidated financial statements in conformity with Generally Accepted Accounting Principles
("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation
The consolidated financial statements include the accounts of Coherent, Inc. and its majority-owned subsidiaries
(collectively, "the Company", "we", "our", or "Coherent"). Intercompany balances and transactions have been eliminated.
Investments in business entities in which we do not have control, but have the ability to exercise significant influence over
operating and financial policies (generally 20%-50% ownership) are accounted for by the equity method. We currently do not
have any investments accounted for by the equity method.
Fair Value of Financial Instruments
The carrying amounts of certain of our financial instruments including cash and cash equivalents, accounts receivable,
accounts payable and accrued liabilities approximate fair value due to their short maturities. Short-term investments are
comprised of available-for-sale securities, which are carried at fair value. Other non-current assets include trading securities
and life insurance contracts related to our deferred compensation plans; trading securities are carried at fair value and life
insurance contracts are carried at cash surrender values, which due to their ability to be converted to cash at that amount,
approximate their fair values. The recorded carrying amount of our long-term obligations approximates fair value at fiscal 2012
and 2011 year-ends. Foreign exchange contracts are stated at fair value based on prevailing financial market information.
Cash Equivalents
All highly liquid investments with maturities of three months or less at the time of purchase are classified as cash
equivalents.
Concentration of Credit Risk
Financial instruments that may potentially subject us to concentrations of credit risk consist principally of cash
equivalents, short-term investments and accounts receivable. At fiscal 2012 year-end, the majority of our short-term
investments are in US Treasury and federal agency obligations and corporate notes and obligations. Cash equivalents and short-
term investments are maintained with several financial institutions and may exceed the amount of insurance provided on such
balances. At September 29, 2012, we held cash and cash equivalents and short-term investments outside the U.S. in certain of
our foreign operations totaling approximately $139.4 million, $46.1 million of which was denominated in currencies other than
the U.S. dollar. The majority of our accounts receivable are derived from sales to customers for commercial applications. We
perform ongoing credit evaluations of our customers' financial condition and limit the amount of credit extended when deemed
necessary but generally require no collateral. We maintain reserves for potential credit losses. Our products are broadly
distributed and there were two customers who accounted for 14.9% and 14.8% of accounts receivable at fiscal 2012 year-end.
No customers accounted for more than 10% of accounts receivable at fiscal 2011 year-end.
67
Accounts Receivable Allowances
Accounts receivable allowances reflect our best estimate of probable losses inherent in our accounts receivable balances.
We regularly review allowances by considering factors such as historical experience, credit quality, the age of the accounts
receivable balances and current economic conditions that may affect a customer's ability to pay.
Activity in accounts receivable allowance is as follows (in thousands):
Beginning balance
Additions charged to expenses
Accruals resulting from acquisitions
Deductions from reserves
Ending balance
Inventories
Fiscal year-end
2012
2011
2010
$
$
1,439
1,362
—
(1,358)
1,443
$
$
1,655 $
1,329
184
(1,729 )
1,439 $
2,147
349
33
(874)
1,655
Inventories are stated at the lower of cost (first-in, first-out) or market. Inventories are as follows (in thousands):
Purchased parts and assemblies
Work-in-process
Finished goods
Property and Equipment
Fiscal year-end
2012
46,526
60,171
53,416
160,113
$
$
$
$
2011
44,824
52,457
55,104
152,385
Property and equipment are stated at cost and are depreciated or amortized using the straight-line method. Cost,
accumulated depreciation and amortization, and estimated useful lives are as follows (dollars in thousands):
Land
Buildings and improvements
Equipment, furniture and fixtures
Leasehold improvements
Accumulated depreciation and amortization
Property and equipment, net
Asset Retirement Obligations
Fiscal year-end
2012
6,251
67,916
205,479
28,162
307,808
(192,712)
115,096
$
$
2011
6,288
62,296
194,566
24,794
287,944
(183,440)
104,504
$
$
Useful Life
5-40 years
3-10 years
Lesser of useful life or terms of leases
The fair value of a liability for an asset retirement obligation is recognized in the period in which it is incurred if a
reasonable estimate of fair value can be made. The fair value of the liability is added to the carrying amount of the associated
asset and this additional carrying amount is depreciated over the life of the asset. All of our existing asset retirement obligations
are associated with commitments to return the property to its original condition upon lease termination at various sites and costs
to clean up and dispose of certain fixed assets at our Sunnyvale, California site. We estimated that as of fiscal 2012 year-end,
gross expected future cash flows of $2.3 million would be required to fulfill these obligations.
68
The following table reconciles changes in our asset retirement liability for fiscal 2012 and 2011 (in thousands):
Asset retirement liability as of October 2, 2010
Payment of asset retirement obligations
Adjustment to asset retirement obligations recognized
Accretion recognized
Changes due to foreign currency exchange
Asset retirement liability as of October 1, 2011
Payment of asset retirement obligations
Adjustment to asset retirement obligations recognized
Accretion recognized
Changes due to foreign currency exchange
Asset retirement liability as of September 29, 2012
$
$
1,737
(328)
318
98
53
1,878
—
69
113
(31)
2,029
At September 29, 2012 and October 1, 2011, the asset retirement liability is included in other long-term liabilities on our
consolidated balance sheets.
Long-lived Assets
We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business
circumstances or our planned use of long-lived assets indicate that their carrying amounts may not be fully recoverable or that
their useful lives are no longer appropriate. Reviews are performed to determine whether the carrying values of long-lived
assets are impaired based on a comparison to the undiscounted expected future net cash flows. If the comparison indicates that
impairment exists, long-lived assets that are classified as held and used are written down to their respective fair values. When
long-lived assets are classified as held for sale, they are written down to their respective fair values less costs to sell. Significant
management judgment is required in the forecast of future operating results that is used in the preparation of expected
undiscounted cash flows. For fiscal years 2012, 2011 and 2010, there were no significant asset impairments recorded.
Goodwill
Goodwill is tested for impairment on an annual basis and between annual tests in certain circumstances, and written down
when impaired (see Note 8. "Goodwill and Intangible Assets"). In testing for impairment, we have the option to first assess
qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of a
reporting unit is less than its carrying amount. We elected to perform this qualitative testing in fiscal 2012, and noted no
impairment. If this had not been the case, we would have needed to perform a more detailed two-step goodwill impairment test
as was done in prior year which is used to identify potential goodwill impairments and to measure the amount of goodwill
impairment losses to be recognized, if any. In a step 2 calculation, goodwill is tested for impairment by comparing the
respective fair value with the respective carrying value of the reporting unit. Fair value is then determined using the Income
Approach (discounted cash flow approach) valuation methodology. Absent any impairment indicators, we perform our annual
impairment tests during the fourth quarter of each fiscal year using opening balance sheet as of the first day of the fourth fiscal
quarter, with any resulting impairment recorded in the fourth quarter of the fiscal year.
Intangible Assets
Intangible assets, including acquired existing technology, patents, customer lists, trade name, non-compete agreements
and production know-how, are amortized on a straight-line basis over estimated useful lives of one year to fifteen years.
Warranty Reserves
We provide warranties on certain of our product sales and reserves for estimated warranty costs are recorded during the
period of sale. The determination of such reserves requires us to make estimates of product return rates and expected costs to
repair or replace the products under warranty. We currently establish warranty reserves based on historical warranty costs for
each product line. The weighted average warranty period covered is approximately 15 months. If actual return rates and/or
repair and replacement costs differ significantly from our estimates, adjustments to cost of sales may be required in future
periods.
69
Components of the reserve for warranty costs during fiscal 2012, 2011 and 2010 were as follows (in thousands):
Beginning balance
Additions related to current period sales
Warranty costs incurred in the current period
Accruals resulting from acquisitions
Adjustments to accruals related to foreign exchange and other
Ending balance
Revenue Recognition
2012
16,704
29,425
(28,263)
—
(424)
17,442
$
$
$
$
Fiscal
2011
13,499 $
27,900
(24,671 )
178
(202 )
16,704 $
2010
10,211
20,466
(17,450)
160
112
13,499
In October 2009, the Financial Accounting Standards Board (“FASB”) issued a new accounting standard for multiple
deliverable revenue arrangements. The new standard changes the requirements for establishing separate units of accounting in a
multiple element arrangement and requires the allocation of arrangement consideration to each deliverable to be based on the
relative selling price. The FASB also issued a new accounting standard for certain revenue arrangements that include software
elements. This new standard excludes software that is contained on a tangible product from the scope of software revenue
guidance if the software is essential to the tangible product's functionality. We prospectively adopted both these standards in
the first quarter of fiscal 2011. The impact of adopting these standards was not material to net sales or our consolidated
financial statements for fiscal 2011. The new accounting standards for revenue recognition if applied in the same manner to
fiscal 2010 would not have had a material impact on net sales or to our consolidated financial statements for that fiscal year.
Under these standards, when a sales arrangement contains multiple elements, such as products and/or services, we
allocate revenue to each element based on a selling price hierarchy. Using the selling price hierarchy, we determine the selling
price of each deliverable using vendor specific objective evidence (“VSOE”), if it exists, and otherwise third-party evidence
(“TPE”). If neither VSOE nor TPE of selling price exists, we use estimated selling price (“ESP”). We generally expect that we
will not be able to establish TPE due to the nature of the markets in which we compete, and, as such, we typically will
determine selling price using VSOE or if not available, ESP.
Our basis for establishing VSOE of a deliverable's selling price consists of standalone sales transactions when the same or
similar product or service is sold separately. However, when services are never sold separately, such as product installation
services, VSOE is based on the product's estimated installation hours based on historical experience multiplied by the standard
service billing rate. In determining VSOE, we require that a substantial majority of the selling price for a product or service fall
within a reasonably narrow price range, as defined by us. We also consider the geographies in which the products or services
are sold, major product and service groups, and other environmental variables in determining VSOE. Absent the existence of
VSOE and TPE, our determination of a deliverable's ESP involves evaluating several factors based on the specific facts and
circumstances of these arrangements, which include pricing strategy and policies driven by geographies, market conditions,
competitive landscape, correlation between proportionate selling price and list price established by management having the
relevant authority, and other environmental variables in which the deliverable is sold.
For multiple element arrangements which include extended maintenance contracts, we allocate and defer the amount of
consideration equal to the separately stated price and recognize revenue on a straight-line basis over the contract period.
We recognize revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement
exists, the product has been delivered or the service has been rendered, the price is fixed or determinable and collection is
reasonably assured. Revenue from product sales is recorded when all of the foregoing conditions are met and risk of loss and
title passes to the customer. Sales to customers are generally not subject to any price protection or return rights.
The vast majority of our sales are made to original equipment manufacturers ("OEMs"), distributors, resellers and end-
users in the non-scientific market. Sales made to these customers do not require installation of the products by us and are not
subject to other post-delivery obligations, except in occasional instances where we have agreed to perform installation or
provide training. In those instances, we defer revenue related to installation services or training until these services have been
rendered. We allocate revenue from multiple element arrangements to the various elements based upon relative fair values.
Our sales to distributors, resellers and end-user customers typically do not have customer acceptance provisions and only
70
certain of our sales to OEM customers and integrators have customer acceptance provisions. Customer acceptance is generally
limited to performance under our published product specifications. For the few product sales that have customer acceptance
provisions because of higher than published specifications, (1) the products are tested and accepted by the customer at our site
or by the customer's acceptance of the results of our testing program prior to shipment to the customer, or (2) the revenue is
deferred until customer acceptance occurs.
Sales to end-users in the scientific market typically require installation and, thus, involve post-delivery obligations;
however, our post-delivery installation obligations are not essential to the functionality of our products. We defer revenue
related to installation services until completion of these services.
For most products, training is not provided; therefore, no post-delivery training obligation exists. However, when training
is provided to our customers, it is typically priced separately and is recognized as revenue as these services are provided.
We record taxes collected on revenue-producing activities on a net basis.
Research and Development
Research and development expenses include salaries, contractor and consultant fees, supplies and materials, as well as
costs related to other overhead such as depreciation, facilities, utilities and other departmental expenses. The costs we incur
with respect to internally developed technology and engineering services are included in research and development expenses as
incurred as they do not directly relate to any particular licensee, license agreement or license fee.
We treat third party and government funding of our research and development activity, where we are the primary
beneficiary of such work conducted, as a credit to research and development cost. Amounts offset against research and
development costs were not material in any of the periods presented.
Foreign Currency Translation
The functional currencies of our foreign subsidiaries are generally their respective local currencies. Accordingly, gains
and losses from the translation of the financial statements of the foreign subsidiaries are reported as a separate component of
accumulated other comprehensive income ("OCI"). Foreign currency transaction gains and losses are included in earnings.
Derivatives
U.S. GAAP requires that all derivatives, whether designated in hedging relationships or not, be recorded on the balance
sheet at fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the
hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the
effective portions of the changes in the fair value of the derivative are recorded in OCI and are recognized in the income
statement when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges are
recognized in other income (expense).
Our objective of holding derivatives is to minimize the risks of foreign currency fluctuation by using the most effective
methods to eliminate or reduce the impact of these exposures. Principal currencies hedged include the Euro, Korean Won,
Japanese Yen, British Pound, Chinese Renminbi and Singapore dollar.
Forwards not designated as hedging instruments are also used to hedge the impact of the variability in exchange rates on
accounts receivable and collections denominated in certain foreign currencies. Our forward contracts have maturities of two
months or less and changes in fair value of these derivatives are recognized in other income (expense).
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions
and other events and circumstances from non-owner sources and is presented in our Consolidated Statements of
Comprehensive Income and in Note 15, "Accumulated Other Comprehensive Income (Loss)."
71
Earnings Per Share
Basic earnings per share is computed based on the weighted average number of shares outstanding during the period,
excluding unvested restricted stock. Diluted earnings per share is computed based on the weighted average number of shares
outstanding during the period increased by the effect of dilutive employee stock awards, including stock options, restricted
stock awards and stock purchase contracts, using the treasury stock method.
The following table presents information necessary to calculate basic and diluted earnings (loss) per share (in thousands,
except per share data):
Weighted average shares outstanding—basic (1)
Dilutive effect of employee awards
Weighted average shares outstanding—diluted
Net income
Net income—basic
Net income—diluted
_______________________________________
(1)
Net of unvested restricted stock
2012
23,561
465
24,026
62,962
2.67
2.62
$
$
$
$
$
$
Fiscal
2011
24,924
540
25,464
93,238 $
3.74 $
3.66 $
2010
24,718
373
25,091
36,916
1.49
1.47
A total of 99,912; 2,416 and 1,221,143 potentially dilutive securities have been excluded from the dilutive share
calculation for fiscal 2012, 2011 and 2010, respectively, as their effect was anti-dilutive.
Stock-Based Compensation
We account for stock-based compensation using the fair value of the awards granted. We estimate the fair value of stock
options granted using the Black-Scholes Merton model. We value restricted stock units using the intrinsic value method. We
use a Monte Carlo model to estimate the fair value of market-based performance restricted stock units. We use historical data to
estimate pre-vesting option and restricted stock unit forfeitures and record stock-based compensation expense only for those
options and awards that are expected to vest. We amortize the fair value of stock options and awards on a straight-line basis
over the requisite service periods of the awards, which are generally the vesting periods. See Note 14 "Employee Stock Option
and Benefit Plans" for a description of our stock-based employee compensation plans and the assumptions we use to calculate
the fair value of stock-based employee compensation.
Shipping and Handling Costs
We record costs related to shipping and handling of revenue in cost of sales for all periods presented.
Advertising Costs
Advertising costs are expensed as incurred and were $3.5 million, $4.1 million and $2.6 million in fiscal 2012, fiscal
2011 and fiscal 2010, respectively.
Income Taxes
As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax
provision (benefit) in each of the jurisdictions in which we operate. This process involves us estimating our current income tax
provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and
accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated
balance sheets.
We account for uncertain tax issues pursuant to ASC 740-10 (formerly FASB Financial Interpretation No. 48,
“Accounting for Uncertainty in Income Taxes”), which creates a single model to address accounting for uncertainty in tax
positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the
financial statements. This standard provides a two-step approach for evaluating tax positions. The first step, recognition, occurs
when a company concludes (based solely on the technical aspects of the matter) that a tax provision is more likely than not to
72
be sustained upon examination by a taxing authority. The second step, measurement, is only considered after step one has been
satisfied and measures any tax benefit at the largest amount that is deemed more likely than not to be realized upon ultimate
settlement of the uncertainty. These determinations involve significant judgment by management. Tax positions that fail to
qualify for initial recognition are recognized in the first subsequent interim period that they meet the more likely than not
standard or when they are resolved through negotiation or litigation with factual interpretation, judgment and certainty. Tax
laws and regulations themselves are complex and are subject to change as a result of changes in fiscal policy, changes in
legislation, evolution of regulations and court filings. Therefore, the actual liability for U.S. or foreign taxes may be materially
different from our estimates, which could result in the need to record additional tax liabilities or potentially to reverse
previously recorded tax liabilities.
We record a valuation allowance to reduce our deferred tax assets to an amount that more likely than not will be realized.
While we have considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need
for the valuation allowance, in the event we were to determine that we would be able to realize our deferred tax assets in the
future in excess of our net recorded amount, an adjustment to the allowance for the deferred tax asset would increase income in
the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our
net deferred tax asset in the future, an adjustment to the allowance for the deferred tax asset would be charged to income in the
period such determination was made.
Federal income taxes have not been provided for on a portion of the unremitted earnings of foreign subsidiaries because
such earnings are intended to be permanently reinvested. The total amount of unremitted earnings and accumulated translation
adjustments of foreign subsidiaries for which we have not yet recorded federal and state income taxes was approximately $270
million and $40 million respectively, at fiscal 2012 year-end. The amount of federal and state income taxes that would be
payable upon repatriation of such earnings are not practicably determinable.
Adoption of New Accounting Pronouncement and Update to Significant Accounting Policies
In May 2011, the Financial Accounting Standards Board (“FASB”) issued additional guidance on fair value
measurements that clarified the application of existing guidance and disclosure requirements, changed certain fair value
measurement principles and required additional disclosures about fair value measurements. We adopted this standard on a
prospective basis in the second quarter of fiscal 2012. The adoption of this accounting standard did not have an impact on our
consolidated financial position, results of operations and cash flows.
In June 2011, the FASB issued a final standard requiring the presentation of net income and other comprehensive income
in either a single continuous statement or in two separate, but consecutive, statements of net income and other comprehensive
income. The new standard eliminated the option previously elected by the Company to present items of other comprehensive
income in the annual statement of changes in stockholders' equity. The new requirements did not change the components of
comprehensive income recognized in net income or other comprehensive income, or when an item of other comprehensive
income must be reclassified to net income. Earnings per share computations do not change. We adopted this standard on a full
retrospective basis, as required, in the second quarter of fiscal 2012. As this standard relates only to the presentation of other
comprehensive income, the adoption of this accounting standard did not have an impact on our consolidated financial position,
results of operations and cash flows.
In September 2011, the FASB amended existing guidance related to goodwill and other intangible assets by giving an
entity the option to first assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more
than 50 percent) that the fair value of a reporting unit is less than its carrying amount. The qualitative factors are consistent with
the existing guidance which requires goodwill of a reporting unit to be tested for impairment between annual tests if an event
occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying
amount. If this is the case, companies will need to perform a more detailed two-step goodwill impairment test which is used to
identify potential goodwill impairments and to measure the amount of goodwill impairment losses to be recognized, if any. We
adopted this authoritative guidance and used this qualitative approach for our annual impairment testing in fiscal 2012, which
we perform annually as of the first day of the fourth quarter.
Recently Issued Accounting Pronouncements
In July 2012, the FASB amended existing guidance related to goodwill and other intangible assets by giving an entity
testing an indefinite-lived intangible asset for impairment the option to first assess qualitative factors to determine whether it is
more likely than not (that is, a likelihood of more than 50 percent) that the fair value of an intangible asset is less than its
carrying amount. If the entity determines, on the basis of qualitative factors, that the fair value of the indefinite-lived intangible
73
asset is not more likely than not impaired, the entity would not need to calculate the fair value of the asset. The guidance does
not revise the requirement to test indefinite-lived intangible assets annually for impairment or to test these assets for
impairment between annual tests if there is a change in events or circumstances. This amended guidance was effective for
annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. We will adopt this
authoritative guidance in the first quarter of fiscal 2013. As of September 29, 2012, we did not have any indefinite-lived
intangible assets recorded in our consolidated balance sheet; accordingly, we do not expect the implementation of this
authoritative guidance to have a material impact on our consolidated financial position, results of operations and cash flows in
connection with our impairment testing.
In December 2011, the FASB issued guidance which requires an entity to disclose information about offsetting and
related arrangements to enable financial statement users to evaluate the effect or potential effect of netting arrangements,
including rights of setoff associated with the entity's recognized financial assets and liabilities, on the entity's financial position.
The new disclosures will enable financial statement users to compare balance sheets prepared under U.S. GAAP and
International Financial Reporting Standards ("IFRS"), which are subject to different offsetting models. The disclosures will be
limited to financial instruments (and derivatives) subject to enforceable master netting arrangements or similar agreements.
Similar agreements include derivative clearing agreements, global master repurchase agreements, and global master securities
lending agreements. Financial instruments and transactions that will be subject to the disclosure requirements may include
derivatives, repurchase and reverse repurchase agreements, and securities lending and borrowing arrangements. An entity
should provide the disclosures required by those amendments retrospectively for all comparative periods presented. The
guidance is effective for us beginning in fiscal 2014. We are currently evaluating the additional disclosures required, if any,
from the adoption of this guidance.
3. RESTRUCTURING ACTIVITIES
During the second quarter of fiscal 2009, we announced our plans to close our facilities in Tampere, Finland and
St. Louis, Missouri. The closure of our St. Louis site was completed in the fourth quarter of fiscal 2009. The closure of our
Finland site was scheduled for completion by the end of fiscal 2010, but we delayed the closure due to increased demand for
products manufactured in Finland. In the second quarter of fiscal 2011, we ceased manufacturing operations in our Finland
facility and recognized a $6.1 million gain, primarily in other income (expense), due to a non-recurring translation adjustment
related to the dissolution of our Finland operations. We exited the facility in the third quarter of fiscal 2011. These closure plans
resulted in charges primarily for employee termination and other exit related costs associated with a plan approved by
management.
During the first quarter of fiscal 2010, we acquired the assets and certain liabilities of StockerYale, Inc's laser module
product line in Montreal, Canada and transitioned those activities to other Coherent facilities in Salem, Massachusetts,
Wilsonville, Oregon and Sunnyvale, California. The transfer was completed in the second quarter of fiscal 2011. These closure
plans resulted in charges primarily for employee termination and other exit related costs associated with a plan approved by
management.
There were no new restructuring charges during fiscal 2012. Restructuring charges during fiscal 2011 and fiscal 2010 are
recorded in cost of sales, research and development and selling, general and administrative expenses in our consolidated
statements of operations.
The following table presents our current liability as accrued on our balance sheets for restructuring charges. The table sets
forth an analysis of the components of the restructuring charges and payments and other deductions made against the accrual
for fiscal 2012, 2011 and 2010 (in thousands):
74
Balances, October 3, 2009
Provision
Payments and other
Balances, October 2, 2010
Provision
Payments and other
Balances, October 1, 2011
Provision
Payments and other
Balances, September 29, 2012
Severance
Related
Facilities
Related
Charges
Other
Restructuring
Costs
Total
$
$
$
488
1,411
(987)
912
218
(1,130)
—
—
—
— $
357 $
3,823
(4,163)
17
—
(17)
—
—
—
— $
$
807
3,134
(2,638)
1,303
680
(1,349)
634
—
(634)
— $
1,652
8,368
(7,788)
2,232
898
(2,496)
634
—
(634)
—
The fiscal 2011 severance related costs were primarily comprised of severance pay, outplacement services, medical and
other related benefits for employees being terminated due to the transition of activities out of Tampere, Finland. At
September 29, 2012, there were no remaining accrued restructuring costs.
The following table presents our restructuring charges incurred by segment:
By Segment
Costs incurred and charged to expense in fiscal 2012
Costs incurred and charged to expense in fiscal 2011
Costs incurred and charged to expense in fiscal 2010
Costs incurred and charged to expense in fiscal 2009
Costs incurred and charged to expense in fiscal 2008
Commercial Lasers
and Components
$
Specialty Laser
Systems
— $
898
8,368
8,674
4,160
— $
—
—
6,763
1,644
Total
—
898
8,368
15,437
5,804
Cumulative costs incurred to date
$
22,100 $
8,407 $
30,507
4. BUSINESS COMBINATIONS
MiDAZ Lasers Ltd
On July 23, 2012, we acquired all of the outstanding shares of MiDAZ Lasers Ltd "Midaz" for approximately $3.8
million, excluding transaction fees. Midaz was a technology-based acquisition. We intend to utilize the acquired technology in
low cost, compact pulsed solid state lasers. Midaz has been included in our Specialty Lasers and Systems segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets
Goodwill
Intangible assets:
Existing technology
Deferred tax liabilities
Liabilities assumed
Total
$
$
187
2,809
1,800
(428)
(582)
3,786
75
Results of operations for the business have been included in our consolidated financial statements subsequent to the date
of acquisition and pro forma results of operations in accordance with authoritative guidance for prior periods have not been
presented because the effect of the acquisition was not material to our prior period consolidated financial results.
None of the goodwill from this purchase is deductible for tax purposes.
The identifiable intangible assets are being amortized over their respective useful life of seven years.
We expensed $0.2 million of acquisition-related costs as selling, general and administrative expenses in our consolidated
statements of operations in the fiscal year ended September 29, 2012.
Hypertronics Pte Ltd
On January 5, 2011, we acquired all of the assets and certain liabilities of Hypertronics Pte Ltd for approximately $14.5
million in cash. Hypertronics designs and manufactures laser-and vision-based tools for flat panel, storage, semiconductor and
solar applications at facilities in Singapore and Malaysia. Hypertronics has been included in our Specialty Lasers and Systems
segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets
Goodwill
Intangible assets:
Existing technology
In-process research and development
Customer lists
Trade name
Non-compete agreements
Liabilities assumed
Total
$
$
4,617
5,807
3,120
570
1,880
410
60
(1,965)
14,499
The goodwill recognized from this acquisition resulted primarily from anticipated revenue growth and synergies of
integrating Hypertronics scan vision technology and system capabilities with our laser technology and global sales, marketing,
distribution and service network. The goodwill was included in our Specialty Lasers and Systems segment.
None of the goodwill from this purchase is deductible for tax purposes.
The identifiable intangible assets are being amortized over their respective useful lives of two to six years.
In-process research and development (“IPR&D”) consisted of seven interrelated projects to be incorporated into one
product and had not yet reached technological feasibility at the time of purchase. Acquired IPR&D assets are initially
recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the
associated research and development efforts. The value assigned to IPR&D was determined by considering the value of the
products under development to the overall development plan, estimating the resulting net cash flows from the projects when
completed and discounting the net cash flows to their present value. During the development period, these assets will not be
amortized as charges to earnings; instead these assets will be subject to periodic impairment testing. Upon successful
completion of the development process for the acquired IPR&D projects, the assets would then be considered finite-lived
intangible assets and amortization of the assets will commence.
During the second quarter of fiscal 2012, we determined that one of the hardware projects classified as IPR&D acquired
from Hypertronics would not be completed. As a result, $0.2 million was expensed in the second fiscal quarter for that project.
During the fourth quarter of fiscal 2012, we decided to no longer pursue orders of Hypertronics' legacy products and thus
determined that an impairment review of the intangible assets was required. As a result of our analysis, we determined that the
76
intangible assets were fully impaired and that the remaining hardware projects classified as IPR&D acquired from Hypertronics
would not be completed. As a result, we recorded a $4.0 million charge in amortization expense in the fourth quarter of fiscal
2012. We also wrote off $0.3 million of inventory unique to these products that were not expected to be resold.
We expensed $0.6 million of acquisition-related costs as selling, general and administrative expenses in our consolidated
statements of operations in the fiscal year ended October 1, 2011.
Results of operations for the business have been included in our consolidated financial statements subsequent to the date
of acquisition and pro forma results of operations in accordance with authoritative guidance for prior periods have not been
presented because the effect of the acquisition was not material to our prior period consolidated financial results.
Beam Dynamics, Inc.
On April 29, 2010, we acquired Beam Dynamics, Inc. for $5.9 million in cash as allocated below and $0.3 million in
deferred compensation related to an employment contract, which was recognized in expense as earned. Beam Dynamics
manufactures flexible laser cutting tools for the materials processing market. Beam Dynamics has been included in our
Commercial Lasers and Components segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets
Goodwill
Intangible assets:
Existing technology
In-process research and development
Customer lists
Trade name
Order backlog
Non-compete agreements
Liabilities assumed
Total
$
$
1,132
3,841
2,130
650
360
140
30
10
(2,371)
5,922
The goodwill recognized from this acquisition resulted primarily from access to anticipated growth in the laser tool
market and was included in our Commercial Lasers and Components ("CLC") segment. None of the goodwill from this
purchase is deductible for tax purposes.
The identifiable intangible assets are being amortized over their respective useful lives of one to six years.
IPR&D consists of three development projects that had not yet reached technological feasibility. Acquired IPR&D assets
are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment
of the associated research and development efforts. The value assigned to IPR&D was determined by considering the value of
the products under development to the overall development plan, estimating the resulting net cash flows from the projects when
completed and discounting the net cash flows to their present value. During the development period, these assets have not been
amortized as charges to earnings; instead these assets have been subject to periodic impairment testing. The development
process for the acquired IPR&D projects was completed and amortization of the assets began in the fourth quarter of fiscal
2012.
We expensed $0.2 million of acquisition-related costs as selling, general and administrative expenses in our consolidated
statements of operations for our fiscal year 2010.
During the third quarter of fiscal 2011, we paid out $0.6 million that had been held in an escrow account to be applied
towards any remaining closing costs for the acquisition and payments to the shareholders. The amount was previously included
in current restricted cash on our consolidated balance sheet.
77
Results of operations for the business have been included in our consolidated financial statements subsequent to the date
of acquisition and pro forma results of operations in accordance with authoritative guidance for prior periods have not been
presented because the effect of the acquisition was not material to our prior period consolidated financial results.
StockerYale, Inc.
On October 13, 2009, we acquired all the assets and certain liabilities of StockerYale, Inc. ("StockerYale")'s laser module
product line in Montreal and its specialty fiber product line in Salem, New Hampshire for $15.0 million in cash. StockerYale
designs, develops and manufactures low power laser modules, light emitting diode (LED) systems and specialty optical fiber
products. These assets and liabilities have been included in our Commercial Lasers and Components segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets
Goodwill
Intangible assets:
Existing technology
Production know-how
Customer lists
Non-compete agreements
Order backlog
Liabilities assumed
Total
$
$
9,770
2,580
610
910
3,170
60
600
(2,700)
15,000
The goodwill recognized from this acquisition resulted primarily from anticipated increases in market share and synergies
of combining these entities and was included in our CLC segment. None of the goodwill from this purchase is deductible for
tax purposes.
The identifiable intangible assets are being amortized over their respective useful lives of one to seven years.
We expensed $0.2 million of acquisition-related costs incurred as selling, general and administrative expenses in our
consolidated statements of operations for our fiscal year 2010.
Results of operations for the acquired product lines have been included in our consolidated financial statements
subsequent to the date of acquisition and pro forma results of operations in accordance with authoritative guidance for prior
periods have not been presented because the effect of the acquisition was not material to our prior period consolidated financial
results.
5. FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
We measure our cash equivalents and marketable securities at fair value. The fair values of our financial assets and
liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active
markets. Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical
assets. Level 2 valuations are obtained from quoted market prices in active markets involving similar assets; these instruments,
which mature within one year and are issued by counterparties with high credit ratings, include U.S. Treasury and international
government obligations, investment-grade corporate bonds, certificates of deposit and commercial paper. Level 3 valuations
would be based on unobservable inputs to a valuation model and include our own data about assumptions market participants
would use in pricing the asset or liability based on the best information available under the circumstances; as of September 29,
2012 and October 1, 2011, we did not have any assets or liabilities valued based on Level 3 valuations.
78
Financial assets and liabilities measured at fair value as of September 29, 2012 are summarized below (in thousands):
Money market fund deposits(1)
Certificates of deposit(2)(7)
U.S. and international government obligations(3)(7)
Corporate notes and obligations(4)(7)
Commercial paper(3)(7)
Foreign currency contracts(5)(8)
Mutual funds—Deferred comp and supplemental plan(6)(9)
Quoted Prices in
Active Markets
for Identical
Assets
Significant
Other
Observable
Inputs
Total Fair
Value
$
$
(Level 1)
10,340
—
—
—
—
—
6,400
(Level 2)
$
—
31,253
110,967
43,406
2,000
(21)
—
10,340
31,253
110,967
43,406
2,000
(21)
6,400
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Included in cash and cash equivalents on the Consolidated Balance Sheet. The carrying amounts approximate fair
value due to the short-term maturities of the cash equivalents.
Includes $29,234 recorded in cash and cash equivalents and $2,019 recorded in short-term investments on the
Consolidated Balance Sheet.
Included in short-term investments on the Consolidated Balance Sheet.
Includes $1,223 recorded in cash and cash equivalents and $42,183 recorded in short-term investments on the
Consolidated Balance Sheet.
Includes $626 recorded in prepaid expenses and other assets and $645 recorded in other current liabilities on the
Consolidated Balance Sheet (see Note 7).
Includes $2,891 recorded in prepaid expenses and other assets and $3,509 recorded in other assets on the Consolidated
Balance Sheet (see Note 14).
Valuations are based upon quoted market prices in active markets involving similar assets. The market inputs used to
value these instruments generally consist of market yields, reported trades, broker/dealer quotes or alternative pricing
sources with reasonable levels of price transparency. Pricing sources include industry standard data providers, security
master files from large financial institutions, and other third party sources which are input into a distribution-curve-
based algorithm to determine a daily market value. This creates a “consensus price” or a weighted average price for
each security.
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-
counter environment with a relatively high level of price transparency. The market participants usually are large
commercial banks. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing
intervals from public data sources and do not involve management judgment.
The fair value of mutual funds is determined based on quoted market prices. Securities traded on a national exchange
are stated at the last reported sales price on the day of valuation; other securities traded in over-the-counter market and
listed securities for which no sale was reported on that date are stated as the last quoted bid price.
Financial assets and liabilities measured at fair value as of October 1, 2011 are summarized below (in thousands):
79
Money market fund deposits(1)
Certificates of deposit(2)(7)
U.S. and international government obligations(3)(7)
Corporate notes and obligations(4)(7)
Foreign currency contracts(5)(8)
Mutual funds—Deferred comp and supplemental plans(6)(9)
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
$
$
8,135
—
—
—
—
7,830
$
—
65,941
62,079
48,967
181
—
Total Fair
Value
8,135
65,941
62,079
48,967
181
7,830
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Included in cash and cash equivalents on the Consolidated Balance Sheet. The carrying amounts approximate fair
value due to the short-term maturities of the cash equivalents.
Includes $59,431 recorded in cash and cash equivalents and $6,510 recorded in short-term investments on the
Consolidated Balance Sheet.
Includes $60,978 recorded in cash and cash equivalents and $1,101 recorded in short-term investments on the
Consolidated Balance Sheet.
Includes $3,436 recorded in cash and cash equivalents and $45,531 recorded in short-term investments on the
Consolidated Balance Sheet.
Includes $578 recorded in prepaid expenses and other assets and $397 recorded in other current liabilities on the
Consolidated Balance Sheet (see Note 7).
Includes $2,844 recorded in prepaid expenses and other assets and $4,986 recorded in other assets on the Consolidated
Balance Sheet (see Note 14).
Valuations are based upon quoted market prices in active markets involving similar assets. The market inputs used to
value these instruments generally consist of market yields, reported trades, broker/dealer quotes or alternative pricing
sources with reasonable levels of price transparency. Pricing sources include industry standard data providers, security
master files from large financial institutions, and other third party sources which are input into a distribution-curve-
based algorithm to determine a daily market value. This creates a “consensus price” or a weighted average price for
each security.
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-
counter environment with a relatively high level of price transparency. The market participants usually are large
commercial banks. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing
intervals from public data sources and do not involve management judgment.
The fair value of mutual funds is determined based on quoted market prices. Securities traded on a national exchange
are stated at the last reported sales price on the day of valuation; other securities traded in over-the-counter market and
listed securities for which no sale was reported on that date are stated as the last quoted bid price.
6. SHORT-TERM INVESTMENTS
We consider all highly liquid investments with maturities of three months or less at the time of purchase to be cash
equivalents. Investments classified as available-for-sale are reported at fair value with unrealized gains and losses, net of related
income taxes, recorded as a separate component of other comprehensive income ("OCI") in stockholders' equity until realized.
Interest and amortization of premiums and discounts for debt securities are included in interest income. Gains and losses on
securities sold are determined based on the specific identification method and are included in other income (expense).
80
Cash, cash equivalents and short-term investments consist of the following (in thousands):
Fiscal 2012 Year-end
Cash and cash equivalents
Short-term investments:
Available-for-sale securities:
Commercial paper
Certificates of deposit
U.S. Treasury and agency obligations
International government obligations
Corporate notes and obligations
Total short-term investments
Cash and cash equivalents
Short-term investments:
Available-for-sale securities:
Certificates of deposit
International government obligations
Corporate notes and obligations
Total short-term investments
Cost Basis
67,752
2,000
2,017
108,284
2,004
41,912
156,217
Cost Basis
166,931
6,500
1,101
45,282
52,883
$
$
$
$
$
$
$
$
$
$
$
$
Unrealized Gains
9
$
— $
2
666
14
272
954
$
Unrealized Losses
— $
— $
—
(2)
—
(1)
(3) $
Fiscal 2011 Year-end
Unrealized Gains
131
10
1
275
286
$
$
$
Unrealized Losses
(1) $
— $
(1)
(26)
(27) $
Fair Value
67,761
2,000
2,019
108,948
2,018
42,183
157,168
Fair Value
167,061
6,510
1,101
45,531
53,142
The amortized cost and estimated fair value of available-for-sale investments in debt securities at fiscal 2012 and
2011 year-ends, classified as short-term investments on our consolidated balance sheets, were as follows (in thousands):
Fiscal Year-end
2012
2011
Investments in available-for-sale debt securities due
in less than 1 year
$
154,200
$
155,149
$
46,383
$
46,632
Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value
During fiscal 2012, we received proceeds totaling $77.9 million from the sale of available-for-sale securities and realized
gross gains of less than $0.1 million. During fiscal 2011, we received proceeds totaling $172.6 million from the sale of
available-for-sale securities and realized gross gains of less than $0.1 million.
At September 29, 2012, gross unrealized losses on our investments with unrealized losses that are not deemed to be other-
than-temporarily impaired were $3,000 on corporate notes and obligations, U.S. Treasury and agency obligations and
international government obligations of $49.9 million.
7. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
All derivatives, whether designated in hedging relationships or not, are recorded on the balance sheet at fair value. We
enter into foreign exchange forwards to minimize the risks of foreign currency fluctuation of specific assets and liabilities on
the balance sheet; these are not designated as hedging instruments. Our derivative contracts do not contain any credit risk
related contingent features and do not require collateral or other security to be furnished by us or the counterparties.
We maintain operations in various countries outside of the United States and have foreign subsidiaries that manufacture
and sell our products in various global markets. The majority of our sales are transacted in U.S. dollars. However, we do
generate revenues in other currencies, primarily the Japanese Yen, the Euro and the Korean Won. As a result, our earnings, cash
flows and cash balances are exposed to fluctuations in foreign currency exchange rates. We attempt to limit these exposures
81
through financial market instruments. We utilize derivative instruments, primarily forward contracts with maturities of two
months or less, to manage our exposure associated with anticipated cash flows and net asset and liability positions denominated
in foreign currencies. Gains and losses on the forward contracts are mitigated by gains and losses on the underlying
instruments. We do not use derivative financial instruments for speculative or trading purposes. If a financial counterparty to
any of our hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign
currency hedge, we may experience material financial losses.
For derivative instruments that are not designated as hedging instruments, gains and losses are recognized in other income
(expense).
The outstanding notional contract and fair value amounts of hedge contracts, with maximum maturity of two months are
as follows (in thousands):
Euro currency hedge contracts:
Purchase
Korean WON currency hedge contracts:
Sell
Other foreign currency hedge contracts:
Purchase
Sell
Other, Net
U.S. Notional Contract Value
U.S. Notional Fair Value
September 29,
2012
October 1, 2011
September 29,
2012
October 1, 2011
61,779
$
42,488
$
62,404
$
42,103
(39,039) $
(7,044) $
(39,559) $
(6,591)
— $
(20,452)
(20,452) $
$
2,351
(9,739)
(7,388) $
— $
(20,578)
(20,578) $
2,355
(9,630)
(7,275)
$
$
$
$
The fair value of our derivative instruments are included in prepaid expenses and other assets and in other current
liabilities in our Consolidated Balance Sheets (see Note 5); such amounts were not material as of September 29, 2012 and
October 1, 2011.
The amount of non-designated derivative instruments' loss in the Consolidated Statements of Operations, included in
other income (expense) for the fiscal year ended September 29, 2012 and October 1, 2011 is as follows (in thousands):
Derivatives not designated as hedging instruments
Foreign exchange contracts
8. GOODWILL AND INTANGIBLE ASSETS
Amount of Gain or (Loss)
Recognized
in Income on Derivatives
Fiscal Year Ended
September 29, 2012
Fiscal Year Ended
October 1, 2011
$
(2,729) $
(14)
Goodwill is tested for impairment on an annual basis and between annual tests if events or circumstances indicate that an
impairment loss may have occurred, and we write down these assets when impaired. We perform our annual impairment tests
during the fourth quarter of each fiscal year using the opening balance sheet as of the first day of the fourth quarter, with any
resulting impairment recorded in the fourth quarter of the fiscal year.
Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible
assets acquired in each business combination. In September 2011, the FASB amended its guidance to simplify testing goodwill
for impairment, allowing an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step
quantitative goodwill impairment test. If an entity determines as a result of the qualitative assessment that it is more likely than
82
not (> 50% likelihood) that the fair value of a reporting unit is less than its carrying amount, then the quantitative test is
required. Otherwise, no further testing is required. We adopted this accounting guidance for our impairment testing in fiscal
2012.
Coherent has two reporting units: Commercial Lasers and Components and Specialty Laser Systems. The fair value of
each of our reporting units was substantially in excess of its estimated carrying amount as of the most recent quantitative
analysis of goodwill impairment performed using the opening balance sheet as of fourth quarter of fiscal 2010. Under the
goodwill standards in effect for fiscal 2011, we determined that we had met the requirements of the goodwill standard for
carrying forward our fair value determination from fiscal 2010, and did not perform detailed calculation of the fair value of our
reporting units for fiscal 2011, but rather compared the fair values calculated in the prior year to the 2011 carrying values of our
reporting units; based on our evaluation, the fair values of each of the two operating segments significantly exceeded their
carrying value as of that date. Between the completion of that testing and the end of the third quarter of fiscal 2012, we noted
no indications of impairment or triggering events to cause us to review goodwill for potential impairment. There were no
triggering events or changes in circumstances subsequent to that quantitative analysis to indicate that the fair value of either of
Coherent's reporting units would be less than its carrying amount.
In our fiscal 2012 annual testing, we performed a qualitative assessment of the goodwill by reporting unit during the
fourth quarter of fiscal 2012 using the opening balance sheet as of the first day of the fourth quarter and concluded that it was
more likely than not that the fair value of each of the reporting units exceeded its carrying amount. In assessing the qualitative
factors, we considered the impact of these key factors: macroeconomic conditions, fluctuations in foreign currency, market and
industry conditions, our operating and competitive environment, regulatory and political developments, the overall financial
performance of our reporting units including cost factors and budgeted-to-actual revenue results. We also considered market
capitalization and stock price performance. Based on our assessment, goodwill in the reporting units was not impaired as of the
first day of the fourth quarter of fiscal 2012. As such, it was not necessary to perform the two-step goodwill impairment test at
that time.
The changes in the carrying amount of goodwill by segment for fiscal 2012 and 2011 are as follows (in thousands):
Balance as of October 2, 2010
Additions (see Note 4)
Translation adjustments and other
Balance as of October 1, 2011
Additions (see Note 4)
Translation adjustments and other
Balance as of September 29, 2012
Commercial
Lasers and
Components (1)
Specialty
Laser
Systems (2)
$
$
6,364 $
—
1
6,365
—
(2)
6,363 $
64,432 $
5,807
(650)
69,589
2,809
(1,072)
71,326 $
Total
70,796
5,807
(649)
75,954
2,809
(1,074)
77,689
(1) Gross amount of goodwill for our CLC segment was $25.7 million at September 29, 2012 and October 1, 2011. For both periods, the accumulated
impairment loss for the CLC segment was $19.3 million reflecting an impairment charge in fiscal 2009.
(2) The gross amount of goodwill for our SLS segment was $73.7 million and $72.0 million at September 29, 2012 and October 1, 2011, respectively.
For both periods, the accumulated impairment loss for the SLS segment was $2.4 million reflecting an impairment charge in fiscal 2003.
We evaluate long-lived assets and amortizable intangible assets whenever events or changes in business circumstances or
our planned use of assets indicate that their carrying amounts may not be fully recoverable or that their useful lives are no
longer appropriate. Reviews are performed to determine whether the carrying values of assets are impaired based on
comparison to the undiscounted expected future cash flows identifiable to such long-lived and amortizable intangible assets. If
the comparison indicates that impairment exists, the impaired asset is written down to its fair value.
During the second quarter of fiscal 2012, we determined that one of the hardware projects classified as in-process
research and development ("IPR&D") acquired from Hypertronics would not be completed. As a result, $0.2 million was
included in research and development expense in the second fiscal quarter for that project. During the fourth quarter of fiscal
2012, we decided to no longer pursue orders of Hypertronics legacy products and determined that the carrying amounts of the
amortizable intangible assets, including the remaining IPR&D, acquired from Hypertronics may not be recoverable and thus
83
determined that an impairment review of the intangible assets was required. As a result of our analysis, we determined that the
intangible assets were fully impaired and that the remaining hardware projects classified as in-process research and
development ("IPR&D") acquired from Hypertronics would not be completed. As a result, we recorded a $4.0 million charge
in amortization expense in the fourth quarter of fiscal 2012. We also considered the valuation of the goodwill recorded upon the
acquisition of Hypertronics (approximately $5.9 million at September 29, 2012) and determined that the goodwill was not
impaired, and no write-off is warranted, as the goodwill is related to the key strategic purpose of our acquisition - expansion
into the Asian market with the addition of a full manufacturing facility.
The components of our amortizable intangible assets are as follows (in thousands):
Fiscal 2012 Year-end
Fiscal 2011 Year-end
Existing technology
Patents (1)
Customer lists
Trade name
Non-compete agreement
Production know-how
In-process research and development
Total
$
$
Gross
Carrying
Amount
51,346
—
7,849
3,050
689
910
—
63,844
Accumulated
Amortization
$
(44,457) $
—
(5,666)
(2,749)
(661)
(838)
—
(54,371) $
$
Net
6,889
—
2,183
301
28
72
—
9,473
$
$
Gross
Carrying
Amount
Accumulated
Amortization
52,283
7,246
9,807
3,566
837
910
1,217
75,866
$
$
(41,615) $
(7,220)
(5,142)
(2,504)
(784)
(621)
—
(57,886) $
Net
10,668
26
4,665
1,062
53
289
1,217
17,980
(1) For accounting purposes, when an intangible asset is fully amortized, it is removed from the disclosure schedule.
Amortizable intangible assets include intangible assets acquired through business combinations as well as through direct
purchases or licenses. All IPR&D projects outstanding at the end of fiscal 2011 were either written off as discussed above, or
completed during fiscal 2012 and reclassified to "existing technology" intangible assets with finite lives.
The weighted average remaining amortization period for existing technology, customer lists, trade name, non-compete
agreements and production know-how are approximately 4 years, 4 years, 1 year, 2 years and less than 1 year, respectively.
Patents and order backlog are fully amortized. Amortization expense for intangible assets during fiscal years 2012, 2011, and
2010 was $10.4 million, $8.1 million and $8.0 million, respectively, which includes $6.6 million, $5.5 million and $5.5 million,
respectively, for amortization of existing technology and production know-how.
Estimated amortization expense for the next five fiscal years and all years thereafter are as follows (in thousands):
2013
2014
2015
2016
2017
Thereafter
Total
Estimated
Amortization
Expense
3,276
2,251
1,758
1,357
357
474
9,473
$
$
84
9. BALANCE SHEET DETAILS
Prepaid expenses and other assets consist of the following (in thousands):
Prepaid and refundable income taxes
Prepaid expenses and other
Total prepaid expenses and other assets
Other assets consist of the following (in thousands):
Assets related to deferred compensation arrangements (see Note 14)
Deferred tax assets
Other assets
Total other assets
Fiscal Year-end
2012
2011
20,634 $
41,096
61,730 $
9,193
35,771
44,964
Fiscal Year-end
2012
2011
21,990 $
37,160
4,879
64,029 $
22,737
37,156
4,289
64,182
$
$
$
$
On June 8, 2010, we invested $2.0 million in SiOnyx, Inc., a privately-held company focused on shallow junction
photonics, used to enhance the performance of light sensing devices used in consumer, industrial, medical and defense related
applications using black silicon processing. The investment is included in other assets and is being carried on a cost basis.
Other current liabilities consist of the following (in thousands):
Accrued payroll and benefits
Accrued expenses and other
Reserve for warranty
Other taxes payable
Customer deposits
Accrued restructuring charges (Note 3)
Deferred income
Total other current liabilities
Other long-term liabilities consist of the following (in thousands):
Long-term taxes payable
Deferred compensation (see Note 14)
Deferred tax liabilities
Deferred income
Asset retirement obligations liability (see Note 2)
Other long-term liabilities
Total other long-term liabilities
Fiscal Year-end
2012
2011
28,100 $
10,445
17,442
15,457
1,830
—
17,465
90,739 $
39,639
12,473
16,704
11,067
3,210
634
14,893
98,620
Fiscal Year-end
2012
2011
21,281 $
22,816
726
2,191
2,029
6,283
55,326 $
27,775
22,685
2,194
2,636
1,878
5,673
62,841
$
$
$
$
85
10. SHORT-TERM BORROWINGS
We have several lines of credit which allow us to borrow in the applicable local currency. We have a total of $20.2
million of unsecured foreign lines of credit as of September 29, 2012. At September 29, 2012, we had used $1.9 million of
these available foreign lines of credit as guarantees. These credit facilities were used in Europe and Japan during fiscal 2012. In
addition, our domestic line of credit consists of a $50.0 million unsecured revolving credit account with Union Bank of
California. The agreement will expire on May 31, 2014. The line of credit is subject to covenants related to financial ratios and
tangible net worth with which we are currently in compliance. No amounts have been drawn upon our domestic line of credit as
of September 29, 2012.
11. LONG-TERM OBLIGATIONS
The components of long-term obligations are as follows (in thousands):
Capital leases
Current portion
Long-term obligations
12. COMMITMENTS AND CONTINGENCIES
Commitments
We lease several of our facilities under operating leases.
Fiscal Year-end
2012
2011
$
$
19
(17)
2
$
$
34
(15)
19
Future minimum payments under our non-cancelable operating leases at September 29, 2012 are as follows (in
thousands):
Fiscal
2013
2014
2015
2016
2017
Thereafter through 2020
Total
$
$
8,721
7,543
5,754
5,255
5,053
9,727
42,053
Rent expense, exclusive of sublease income, was $10.0 million, $10.1 million and $10.1 million in fiscal 2012, 2011 and
2010, respectively. There was no sublease income for fiscal 2012, and sublease income was less than $0.1 million and $0.1
million for fiscal years 2011 and 2010, respectively.
As of September 29, 2012, we had total purchase commitments for inventory over the next year of approximately $65.5
million and purchase obligations for fixed assets and services of $6.8 million compared to $71.5 million of purchase
commitments for inventory and $8.6 million of purchase obligations for fixed assets and services at October 1, 2011.
Contingencies
We are subject to legal claims and litigation arising in the ordinary course of business, such as employment or intellectual
property claims, including, but not limited to, the matters described below. The outcome of any such matters is currently not
determinable. Although we do not expect that such legal claims and litigation will ultimately have a material adverse effect on
our consolidated financial position or results of operations, an adverse result in one or more matters could negatively affect our
results in the period in which they occur.
Between February 15, 2007 and March 2, 2007, three purported shareholder derivative lawsuits were filed in the United
States District Court for the Northern District of California against certain of the Company's current and former officers and
directors. The Company is named as a nominal defendant. The complaints generally allege that the defendants breached their
86
fiduciary duties and violated the securities laws in connection with the granting of stock options, the accounting treatment for
such grants, the issuance of allegedly misleading public statements and stock sales by certain of the individual defendants. On
May 30, 2007, these lawsuits were consolidated under the caption In re Coherent, Inc. Shareholder Derivative Litigation. On
November 24, 2009, the United States District Court of the Northern District of California entered an Order and Final
Judgment, which approved a negotiated settlement and dismissed the action with prejudice. Following receipt of insurance
proceeds (which included reimbursement for certain legal costs incurred in prior years) and the payment of the plaintiff
attorneys' fees and expenses, we received a net cash benefit of $2.2 million from the settlement on December 11, 2009, which
was recorded in selling general and administrative expenses in the Consolidated Statement of Operations for the first quarter of
fiscal 2010.
13. STOCK REPURCHASES
On April 29, 2010, we announced that the Board of Directors had authorized the repurchase of up to $50.0 million of our
common stock. During fiscal 2010, we repurchased and retired 1,195,829 shares of outstanding common stock at an average
price of $36.21 per share for a total of $43.3 million, excluding expenses.
On January 26, 2011, the Board canceled this program and authorized the repurchase of up to $75.0 million of our
common stock under a new program. The program was authorized for 12 months from the date of authorization.
On February 10, 2011, we announced that the Company would repurchase up to 1,271,100 shares of our common stock
through a modified “Dutch Auction” tender offer. On March 14, 2011, we completed our tender offer, repurchased and retired
454,682 shares of outstanding common stock at a price of $59.00 per share for a total of $26.8 million excluding expenses.
During the third and fourth quarters of fiscal 2011, we repurchased and retired an additional 1,024,409 shares of outstanding
common stock at an average price of $47.03 per share for a total of $48.2 million, excluding expenses.
On August 25, 2011, we announced that the Board of Directors had authorized the repurchase of up to $50.0 million of our
common stock. The program was authorized for 12 months from the date of authorization. During fiscal 2011, we repurchased
and retired 586,200 shares of outstanding common stock at an average price of $42.67 per share for a total of $25.0 million,
excluding expenses.
During fiscal 2012, we repurchased and retired 543,200 shares of outstanding common stock at an average price of
$45.99 per share for a total of $25.0 million, excluding expenses. There are no funds remaining authorized for repurchase at
September 29, 2012 under this repurchase program.
14. EMPLOYEE STOCK AWARD, OPTION AND BENEFIT PLANS
Deferred Compensation Plans
Under our deferred compensation plans ("plans"), eligible employees are permitted to make compensation deferrals up to
established limits set under the plans and accrue income on these deferrals based on reference to changes in available
investment options. While not required by the plan, the Company chooses to invest in insurance contracts and mutual funds in
order to approximate the changes in the liability to the employees. These investments and the liability to the employees were as
follows (in thousands):
Cash surrender value of life insurance contracts
Fair value of mutual funds
Total assets
Total assets, included in:
Prepaid expenses and other assets
Other assets
Total assets
Fiscal Year-end
2012
18,481
6,400
24,881
2,891
21,990
24,881
$
$
$
$
$
$
$
$
2011
17,751
7,830
25,581
2,844
22,737
25,581
87
Total deferred compensation liability, included in:
Other current liabilities
Other long-term liabilities
Total deferred compensation liability
Fiscal Year-end
2012
2011
$
$
2,891
22,816
25,707
$
$
2,844
22,685
25,529
Life insurance premiums loads, policy fees and cost of insurance that are paid from the asset investments and gains and
losses from the asset investments for these plans are recorded as components of other income or expense; such amounts were a
net gain of $1.6 million (including a $0.2 million death benefit) in fiscal year 2012, a net gain of $3.1 million (including a $1.5
million death benefit) in fiscal year 2011 and a net gain of $0.7 million in fiscal year 2010. Changes in the obligation to plan
participants are recorded as a component of operating expenses and cost of sales; such amounts were an expense of $2.3
million in fiscal year 2012, an expense of $2.6 million in fiscal year 2011 and an expense of $1.6 million in fiscal year 2010.
Liabilities associated with participant balances under our deferred compensation plans are affected by individual contributions
and distributions made, as well as gains and losses on the participant's investment allocation election.
Coherent Employee Retirement and Investment Plan
Under the Coherent Employee Retirement and Investment Plan, we match employee contributions to the plan up to a
maximum of 4% of the employee's individual earnings. Employees become eligible for participation on their first day of
employment and for Company matching contributions after completing one year of service. The Company's contributions (net
of forfeitures) during fiscal 2012, 2011, and 2010 were $3.2 million, $3.0 million and $2.6 million, respectively.
Employee Stock Purchase Plan
We have an Employee Stock Purchase Plan ("ESPP") whereby eligible employees may authorize payroll deductions of
up to 10% of their regular base salary to purchase shares at the lower of 85% of the fair market value of the common stock on
the date of commencement of the offering or on the last day of the six-month offering period. During fiscal 2012, 2011 and
2010, a total of 139,012 shares, 144,147 shares and 229,172 shares, respectively, were purchased by and distributed to
employees at an average price of $42.19, $34.47 and $18.50 per share, respectively. At fiscal 2012 year-end, we had 1,087,979
shares of our common stock reserved for future issuance under the plan.
Stock Award and Option Plans
We have a Stock Plan for which employees and non-employee directors are eligible participants. This Plan is the 2011
Equity Incentive Plan (the "2011 Plan") which includes our options, time-based restricted stock units and market-based
performance restricted stock units. In prior years, we have had a Stock Plan for which employees and service providers were
eligible participants and a non-employee Directors' Stock Option Plan for which only non-employee directors were eligible
participants. Those prior Plans have expired, and any future grants will be made from the 2011 Plan. Under the 2011 Plan,
Coherent may grant options and awards (time-based restricted stock units and market-based performance restricted stock units)
to purchase up to 6,882,000 shares of common stock, of which 6,371,431 remain available for grant at fiscal 2012 year end.
Employee options are generally exercisable between two and four years from the grant date at a price equal to the fair
market value of the common stock on the date of the grant and generally vest 25% to 50% annually. The Company settles stock
option exercises with newly issued shares of common stock. Grants to employees generally expire six years from the original
grant date.
Director options are automatically granted to our non-employee directors. Such directors initially receive a stock option
for 24,000 shares exercisable over a three-year period and an award of restricted stock units of 2,000 shares. Beginning with the
annual meeting of stockholders in 2011, the annual grant for non-employee directors became 3,500 shares of restricted stock
units that vest on February 15 of the calendar year following the grant.
Restricted stock awards and restricted stock units are independent of option grants and are typically subject to vesting
restrictions—either time-based or performance-based conditions for vesting. Until restricted stock vests, shares (including those
issuable upon vesting of the applicable restricted stock unit) are subject to forfeiture if employment terminates prior to the
release of restrictions and cannot be transferred.
88
•
•
•
The service based restricted stock awards generally vest three years from the date of grant.
The service based restricted stock unit awards are generally subject to annual vesting over three years from the
date of grant.
The market-based performance restricted stock unit award grants are generally either subject to annual vesting
over three years from the date of grant or subject to a single vest measurement three years from the date of grant,
depending upon achievement of performance measurements ("Performance RSUs") based on the performance of
the Company's Total Shareholder Returns (as defined) compared with the performance of the Russell 2000 Index.
The Company previously granted Performance RSUs during the second quarter of fiscal 2009 which had a single vesting
measurement date of November 14, 2010. These RSUs would have vested anywhere between 0% and 300% of the targeted
amount based upon achievement by the Company of (a) an annual revenue threshold amount and (b) adjusted EBITDA
percentage targets. The Company determined that the performance target had not been met and these awards were canceled in
the first quarter of fiscal 2011 with no shares vesting.
Fair Value of Stock Compensation
We recognize compensation expense for all share-based payment awards based on the fair value of such awards. The
expense is recognized on a straight-line basis over the respective requisite service period of the awards.
Determining Fair Value
Stock Options
Valuation and amortization method—We estimate the fair value of stock options granted using the Black-Scholes-
Merton option-pricing formula and a single option award approach. This fair value is then amortized on a straight-line basis
over the requisite service periods of the awards, which is generally the vesting period.
Expected Term—The expected term represents the period that our stock-based awards are expected to be outstanding and
was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-
based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its
stock-based awards.
Expected Volatility—Our process for computing expected volatility considers both historical volatility and market-based
implied volatility; however our estimate of expected forfeitures is based on historical employee data and could differ from
actual forfeitures.
Risk-Free Interest Rate—The risk-free interest rate used in the Black-Scholes-Merton valuation method is based on the
implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.
Expected Dividend—The expected dividend assumption is based on our current expectations about our anticipated
dividend policy.
The Company did not grant any stock options in fiscal 2012. The fair values of the Company's stock options granted to
employees for fiscal 2011 and 2010, and of shares purchased under the stock purchase plan for fiscal 2012, 2011 and 2010
were estimated using the following weighted-average assumptions:
Expected life in years
Expected volatility
Risk-free interest rate
Expected dividends
Weighted average fair value per share
Employee Stock
Option Plans
Fiscal
2011
2012
6.0
—
36.1%
—
1.1%
—
—
—
— $ 16.26
2010
4.6
33.0%
2.0%
—
$ 8.27
$
Employee Stock
Purchase Plans
Fiscal
2011
0.5
32.8%
0.1%
—
$ 12.50
2012
0.5
47.0 %
0.9 %
—
$13.62
2010
0.5
33.5%
0.2%
—
$ 7.27
89
Time-Based Restricted Stock Units
Time-based restricted stock units are fair valued at the closing market price on the date of grant.
Market-Based Performance Restricted Stock Units
We grant market-based performance restricted stock units to officers and certain employees. The performance stock unit
agreements provide for the award of performance stock units with each unit representing the right to receive one share of
Coherent, Inc. common stock to be issued after the applicable award period. The final number of units awarded for this grant
will be determined as of the vesting dates, based upon our total shareholder return over the performance period compared to the
Russell 2000 Index and could range from a minimum of no units to a maximum of twice the initial award. The weighted
average fair value for these performance units was determined using a Monte Carlo simulation model incorporating the
following weighted average assumptions:
Risk-free interest rate
Volatility
Weighted average fair value
Fiscal
2012
0.39 %
41.8 %
2011
0.65%
38.8%
$ 71.59
$ 49.37
We recognize the estimated cost of these awards, as determined under the simulation model, over the related service
period, with no adjustment in future periods based upon the actual shareholder return over the performance period.
Stock Compensation Expense
The following table shows total stock-based compensation expense included in the Consolidated Statements of
Operations for fiscal 2012, 2011 and 2010 (in thousands):
Cost of sales
Research and development
Selling, general and administrative
Income tax benefit
Fiscal 2012
$
$
1,670 $
1,628
13,015
(4,796)
11,517 $
Fiscal 2011
1,331
1,474
10,158
(3,802)
9,161
Fiscal 2010
949
1,174
6,333
(1,610)
6,846
$
$
Total stock-based compensation cost capitalized as part of inventory during fiscal 2012 was $1.8 million; $1.7 million
was amortized into income during fiscal 2012, which includes amounts capitalized in fiscal 2012 and amounts carried over
from fiscal 2011. Total stock-based compensation cost capitalized as part of inventory during fiscal 2011 was $1.5 million;
$1.3 million was amortized into income during fiscal 2011, which includes amounts capitalized in fiscal 2011 and amounts
carried over from fiscal 2010. Management has made an estimate of expected forfeitures and is recognizing compensation costs
only for those equity awards expected to vest.
At fiscal 2012 year-end, the total compensation cost related to unvested stock-based awards granted to employees under
the Company's stock option and award plans but not yet recognized was approximately $14.9 million, net of estimated
forfeitures of $1.9 million. This cost will be amortized on a straight-line basis over a weighted-average period of approximately
1.2 years and will be adjusted for subsequent changes in estimated forfeitures.
At fiscal 2012 year-end, the total compensation cost related to options to purchase common shares under the ESPP but
not yet recognized was approximately $0.1 million. This cost will be amortized on a straight-line basis over a weighted-average
period of approximately one month.
The stock option exercise tax benefits reported in the statement of cash flows results from the excess tax benefits arising
from tax deductions in excess of the stock-based compensation cost recognized, determined on a grant-by-grant basis. During
fiscal 2012, fiscal 2011, and fiscal 2010 we recorded approximately $1.3 million, $5.1 million and $0.9 million, respectively, of
excess tax benefits as cash flows from financing activities.
90
During fiscal 2010, we recorded cash-based compensation expense of $0.3 million for cash payments to employees for
options that were not able to be exercised due to the internal stock option investigation.
Stock Options & Awards Activity
The following is a summary of option activity for our Stock Option Plans for fiscal 2012, 2011 and 2010 (in thousands,
except per share amounts and remaining contractual term in years):
Outstanding at October 3, 2009
Granted
Exercised
Forfeitures
Expirations
Outstanding at October 2, 2010
Granted
Exercised
Forfeitures
Expirations
Outstanding at October 1, 2011
Granted
Exercised
Forfeitures
Expirations
Outstanding at September 29, 2012
Vested and expected to vest at September 29, 2012
Exercisable at September 29, 2012
Weighted
Average
Exercise Price
Per Share
Weighted
Average
Remaining
Contractual
Term in Years
Aggregate
Intrinsic
Value
Number of
Shares
2,494
476
(1,004)
(38)
(35)
1,893
24
(975)
(21)
(4)
917
—
(269)
(1)
(6)
641
639
488
$
$
$
$
$
$
29.44
26.59
29.09
24.66
31.95
28.96
44.74
30.51
24.97
33.95
27.80
—
27.56
26.16
32.10
27.86
27.82
27.77
4.0
$
21,279
4.2
$
13,952
3.5
3.5
3.2
$
$
$
9,823
9,814
7,503
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the
quoted price of our common stock for in-the-money options. During fiscal 2012, 2011 and 2010, the aggregate intrinsic value
of options exercised under the Company's stock option plans were $6.8 million, $18.6 million and $6.0 million, respectively,
determined as of the date of option exercise.
91
The following table summarizes information about stock options outstanding at fiscal 2012 year-end:
Range of Exercise Prices
$15.21 - $23.16
$26.16 - $26.16
$27.93- $32.00
$32.95- $32.95
$35.36 - $44.74
$15.21 - $44.74
Options Outstanding
Options Exercisable
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Remaining
Contractual
Life (Years)
22.31
26.16
30.26
32.95
44.36
27.86
3.08
4.14
6.63
1.01
8.81
3.52
Weighted
Average
Exercise
Price per
Share
22.31
26.16
30.26
32.95
44.74
27.77
Number of
Shares
144,141
143,726
42,000
149,960
8,000
487,827
$
$
Number of
Shares
144,141
280,050
42,000
149,960
25,000
641,151
$
$
The following table summarizes our restricted stock award and restricted stock unit activity for fiscal 2012, 2011 and
2010 (in thousands, except per share amounts):
Time Based Restricted
Stock Units
Market-Based
Performance Restricted
Stock Units
Nonvested stock at October 3, 2009
Granted
Vested
Forfeited
Nonvested stock at October 2, 2010
Granted
Vested
Forfeited
Nonvested stock at October 1, 2011
Granted
Vested
Forfeited
Nonvested stock at September 29, 2012
Number of
Shares(1)
357
245
(104)
(17)
481
191
(183)
(85)
404
250
(206)
(8)
440
$
Weighted
Average
Grant Date
Fair Value
25.66
$
26.73
25.87
23.87
26.22
45.44
26.17
29.20
34.71
53.59
32.66
49.07
47.81
$
$
Number of
Shares(2)
$
Weighted
Average
Grant Date
Fair Value
—
—
—
—
$
—
$ 49.77
—
—
$ 49.77
63.85
53.18
—
$ 57.55
—
—
—
—
—
101
—
—
101
95
(44 )
—
152
__________________________________________
(1)
(2)
Service-based restricted stock vested during each fiscal year
Performance-based awards and units included at 100% of target goal; under the terms of the awards, the recipient may
earn between 0% and 200% of the award.
Restricted Stock Units are converted into the right to receive common stock upon vesting; prior to issuance, the Company
permits the holders to satisfy their tax withholding requirements by net settlement, whereby the Company withholds a portion
of the shares to cover the applicable taxes based on the fair market value of the Company's stock at the vesting date. The
number of shares withheld to cover tax payments was 90,000 in fiscal 2012, 70,000 in fiscal 2011 and 41,000 in fiscal 2010;
tax payments made were $4.5 million, $3.3 million and $1.2 million, respectively.
At fiscal 2012 year-end, 6,371,431 options or restricted stock units were available for future grant under all plans. At
fiscal 2012 year-end, all outstanding stock options have been issued under plans approved by our shareholders.
92
15. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Accumulated other comprehensive income (net of tax) at fiscal 2012 and fiscal 2011 year-ends are substantially
comprised of accumulated translation adjustments of $40.4 million and $51.2 million, respectively.
16. OTHER INCOME (EXPENSE), NET
Other income (expense) includes other-net which is comprised of the following (in thousands):
Foreign exchange gain (loss)
Translation adjustment related to dissolution of Finland (1)
Gain (loss) on deferred compensation investments, net (Note 14)
Other—net
Other income (expense), net
_______________________________________________
2012
(451) $
—
1,644
374
1,567 $
$
$
Fiscal
2011
1,457 $
6,511
3,149
(59)
11,058 $
2010
(1,417)
—
756
145
(516)
(1)
In the second quarter of fiscal 2011, the Company had substantially completed the liquidation of its Finland operations
and recognized in other income the accumulated translation gains for this subsidiary previously recorded in
accumulated other comprehensive income (loss) on the consolidated balance sheet.
17. INCOME TAXES
The provision for (benefit from) income taxes on income (loss) before income taxes consists of the following (in
thousands):
Currently payable:
Deferred:
Federal
State
Foreign
Federal
State
Foreign
Provision for income taxes
2012
Fiscal
2011
2010
$
$
(7,856) $
(103)
38,259
30,300
3,763
289
(6,692)
(2,640)
27,660
$
(14,408) $
677
31,098
17,367
10,325
2,358
541
13,224
30,591
$
(7,776)
(551)
17,967
9,640
10,897
1,418
(892)
11,423
21,063
93
The components of income (loss) before income taxes consist of (in thousands):
United States
Foreign
Income before income taxes
2012
(9,212) $
99,834
90,622
$
$
$
Fiscal
2011
32,993 $
90,836
123,829 $
2010
9,004
48,975
57,979
The reconciliation of the income tax expense at the U.S. Federal statutory rate (35% in fiscal years 2012, 2011 and 2010)
to actual income tax expense is as follows (in thousands):
Federal statutory tax expense
Valuation allowance
Foreign taxes at rates less than U.S. rates, net
Currency translation adjustments recognized
Stock-based compensation
State income taxes, net of federal income tax benefit
Research and development credit
Deferred compensation
Release of unrecognized tax benefits
Release of interest accrued for unrecognized tax benefits
Other
Provision for income taxes
Effective tax rate
2012
31,718
(141)
(1,938)
—
1,176
204
(532)
(325)
(12)
(1,372)
(1,118)
27,660
$
$
$
$
Fiscal
2011
43,340
1,456
(2,818)
(2,424)
885
2,409
(2,752)
(759)
(7,090)
(2,672)
1,016
30,591
$
$
2010
20,293
569
(202)
(490)
1,313
1,104
(824)
(210)
(84)
(1,241)
835
21,063
30.5%
24.7%
36.3%
94
The significant components of deferred tax assets and liabilities were (in thousands):
Deferred tax assets:
Reserves and accruals not currently deductible
Operating loss carryforwards and tax credits
Capital loss carryforwards
Deferred service revenue
Depreciation and amortization
Inventory capitalization
Stock-based compensation
Competent authority offset to transfer pricing tax reserves
Accumulated translation adjustment
Other
Valuation allowance
Deferred tax liabilities:
Gain on issuance of stock by subsidiary
Depreciation and amortization
Accumulated translation adjustment
Other
Net deferred tax assets
Fiscal year-end
2012
2011
$
$
25,217 $
62,720
301
2,135
2,590
1,629
6,503
7,901
—
—
108,996
(9,087 )
99,909
20,296
9,004
796
10,510
40,606
59,303 $
26,580
55,950
409
2,018
1,604
1,795
6,162
9,513
507
137
104,675
(8,831)
95,844
21,131
9,149
—
11,188
41,468
54,376
In determining our fiscal 2012, 2011 and 2010 tax provisions under ASC Subtopic 740, "Income Taxes", we calculated
the deferred tax assets and liabilities for each separate tax entity. We then considered a number of factors including the positive
and negative evidence regarding the realization of our deferred tax assets to determine whether a valuation allowance should be
recognized with respect to our deferred tax assets. We determined that a valuation allowance was appropriate for a portion of
the deferred tax assets of our California research and development tax credits, foreign tax attributes and net operating losses
and capital loss carryforwards at fiscal 2012, 2011 and 2010 year-ends.
During fiscal 2012, we increased our valuation allowance on deferred tax assets to $9.1 million, primarily due to the
reduced ability to utilize California research and development tax credits and offset by the net increased ability to utilize
foreign tax attributes and net operating losses.
The net deferred tax asset is classified on the consolidated balance sheets as follows (in thousands):
Current deferred income tax assets
Current deferred income tax liabilities
Non-current deferred income tax assets
Non-current deferred income tax liabilities
Net deferred tax assets
Fiscal year-end
2012
2011
$
$
23,368 $
(499 )
37,160
(726 )
59,303 $
22,057
(2,643)
37,156
(2,194)
54,376
95
We have various tax attribute carryforwards which include the following:
•
•
•
•
Foreign net operating loss carryforwards are $16.8 million, of which $14.6 million have no expiration date and of
which $2.2 million are scheduled to expire beginning in fiscal year 2030. A valuation allowance totaling $6.6
million has been recorded against the foreign net operating loss carryforwards since the recovery of the
carryforwards are uncertain. California net operating loss carryforwards are $11.0 million which are scheduled to
expire in fiscal years 2017 to 2032.
Federal capital loss carryforwards of $0.8 million which are scheduled to expire in fiscal year 2014 to 2015. State
capital loss carryforwards of $0.8 million which are scheduled to expire in fiscal 2014 to 2015. Full valuation
allowances have been recorded against the federal capital loss and the state capital loss carryforwards since the
recovery of the carryforwards are uncertain.
Federal R&D credit carryforwards of $15.4 million which are scheduled to expire in fiscal years 2023 to 2032.
California R&D credit carryforwards of $15.7 million that have no expiration date. A valuation allowance totaling
$5.9 million, net of federal benefit, has been recorded against California R&D credit carryforwards since the
recovery of the carryforwards are uncertain.
Federal foreign tax credit carryforwards of $17.2 million which are scheduled to expire in fiscal years 2016 to
2022.
Included in the net deferred tax asset balance is $0.8 million of deferred tax liabilities related to the currency translation
adjustment. The associated tax expenses are recorded as a part of other comprehensive income.
We are subject to taxation and file income tax returns in the U.S. federal jurisdiction and in many state and foreign
jurisdictions. For U.S. federal income tax purposes, all years prior to 2009 are closed. In our major foreign jurisdictions and our
major state jurisdictions, the years prior to 2006 and 2008, respectively, are closed to examination. Earlier years in our various
jurisdictions may remain open for adjustment to the extent that we have tax attribute carryforwards from those years. We
believe that we have provided adequate reserves for any adjustments that may be determined by the tax authorities.
As of September 29, 2012, the total amount of gross unrecognized tax benefits including gross interest and penalties was
$27.6 million, of which $16.8 million, if recognized, would affect our effective tax rate. As of October 1, 2011, we recorded
gross unrecognized tax benefits including gross interest and penalties in the amount of $33.7 million of which $19.7 million, if
recognized, would affect our effective tax rate. Our total gross unrecognized tax benefit was classified as long-term taxes
payable in the consolidated balance sheets. We include interest and penalties related to unrecognized tax benefits within the
provision for income taxes. As of September 29, 2012, the total amount of gross interest and penalties accrued was $1.6 million
and it is classified as long-term taxes payable in the consolidated balance sheets. As of October 1, 2011, we had accrued $3.4
million for the gross interest and penalties related to the gross unrecognized tax benefits.
Management believes that it has adequately provided for any adjustments that may result from tax examinations. The
Company regularly engages in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions.
It is reasonably possible that certain federal, foreign and state tax matters may be concluded in the next 12 months. Although
the timing of the resolution and/or closure of audits is highly uncertain, it is reasonably possible that the balance of net
unrecognized tax benefits including interest and penalties could be reduced by approximately $0.5 million to $3.0 million in the
next 12 months.
96
A reconciliation of the change in gross unrecognized tax benefits, excluding interest and penalties, is as follows (in
thousands):
Balance as of the beginning of the year
Tax positions related to current year:
Additions
Reductions
Tax positions related to prior year:
Additions
Reductions
Settlements
Lapses in statutes of limitations
Balance as of end of year
Fiscal year-end
2012
2011
2010
$
30,301
$
43,254
$
50,370
615
—
739
—
99
—
—
(5,048)
25,967
$
496
(1,125)
(913)
(12,150)
30,301
$
$
646
—
—
(6,607)
(874)
(281)
43,254
Our unrecognized tax benefits decreased from $30.3 million in fiscal 2011 to $26.0 million in fiscal 2012, excluding
interest and penalties. This reduction is primarily related to the closure of various statutes of limitations.
A summary of the fiscal tax years that remain subject to examination, as of September 29, 2012, for our major tax
jurisdictions is:
United States—Federal
United States—Various States
Netherlands
Germany
Japan
United Kingdom
2009—forward
2008—forward
2006—forward
2006—forward
2006—forward
2011—forward
18. SEGMENT AND GEOGRAPHIC INFORMATION
We are organized into two reportable operating segments: Commercial Lasers and Components ("CLC") and Specialty
Lasers and Systems ("SLS"). This segmentation reflects the go-to-market strategies for various products and markets. While
both segments work to deliver cost-effective solutions, CLC focuses on higher volume products that are offered in set
configurations. The product architectures are designed for easy exchange at the point of use such that product service and
repairs are based upon advanced replacement and depot (i.e., factory) repair. CLC's primary markets include materials
processing, OEM components and instrumentation and microelectronics. SLS develops and manufacturers configurable,
advanced-performance products largely serving the microelectronics, scientific research and government programs and OEM
components and instrumentation markets. The size and complexity of many of our SLS products require service to be
performed at the customer site by factory-trained field service engineers.
We have identified CLC and SLS as operating segments for which discrete financial information is available. Both units
have dedicated engineering, manufacturing, product business management and product line management functions. A small
portion of our outside revenue is attributable to projects and recently developed products for which a segment has not yet been
determined. The associated direct and indirect costs are presented in the category of Corporate and other, along with other
corporate costs as described below.
Our Chief Executive Officer has been identified as the chief operating decision maker (CODM) as he assesses the
performance of the segments and decides how to allocate resources to the segments. Income (loss) from operations is the
measure of profit and loss that our CODM uses to assess performance and make decisions. As assets are not a measure used to
assess the performance of the company by the CODM, asset information is not tracked or compiled by segment and is not
available to be reported in our disclosures. Income (loss) from operations represents the net sales less the cost of sales and
direct operating expenses incurred within the operating segments as well as allocated expenses such as shared sales and
manufacturing costs. We do not allocate to our operating segments certain operating expenses which we manage separately at
the corporate level. These unallocated costs include stock-based compensation and corporate functions (certain research and
97
development, management, finance, legal and human resources) and are included in the results below under Corporate and
other in the reconciliation of operating results. Management does not consider unallocated Corporate and other costs in its
measurement of segment performance.
The following table provides net sales and income (loss) from operations for our operating segments (in thousands):
2012
Fiscal
2011
Net sales:
Commercial Lasers and Components
Specialty Laser Systems
Corporate and other
Total net sales
Income from operations:
Commercial Lasers and Components
Specialty Laser Systems
Corporate and other
Total income from operations
$
$
$
$
220,240
548,848
—
769,088
$
$
$
9,191
118,789
(39,150 )
88,830
$
283,098
519,736
—
802,834
37,709
116,383
(42,083)
112,009
$
$
$
$
2010
208,691
396,276
100
605,067
2,472
85,002
(30,594)
56,880
The following table provides a reconciliation of our total income (loss) from operations to net income (in thousands):
Reconciliation of Income From Operations to Net Income
Total income from operations
Total other income, net
Income before income taxes
Provision for income taxes
Net Income
Geographic Information
2012
88,830
1,792
90,622
27,660
62,962
$
$
$
$
Fiscal
2011
112,009
11,820
123,829
30,591
93,238
$
$
2010
56,880
1,099
57,979
21,063
36,916
Our foreign operations consist primarily of manufacturing facilities in Europe and Asia-Pacific and sales offices in
Europe and Asia-Pacific. Sales, marketing and customer service activities are conducted through sales subsidiaries throughout
the world. Geographic sales information for fiscal 2012, 2011 and 2010 is based on the location of the end customer.
Geographic long-lived asset information presented below is based on the physical location of the assets at the end of each year.
98
Sales to unaffiliated customers are as follows (in thousands):
SALES
United States
Foreign countries:
Japan
South Korea
Germany
Europe, other
Asia-Pacific, other
Rest of World
Total foreign countries sales
Total sales
Fiscal
2012
184,958
$
2011
208,868 $
2010
196,633
$
168,912
130,754
92,162
62,266
80,834
49,202
584,130
769,088
$
166,911
117,918
100,759
79,751
71,813
56,814
593,966
802,834 $
103,009
52,623
88,518
52,066
63,896
48,322
408,434
605,067
$
Long-lived assets, which include all non-current assets other than goodwill, intangibles and deferred taxes, by geographic
region, are as follows (in thousands):
LONG-LIVED ASSETS
United States
Foreign countries:
Germany
Europe, other
Asia-Pacific
Total foreign countries long-lived assets
Total long-lived assets
Major Customers
Fiscal Year-end
2012
2011
$
79,618 $
81,955
43,572
3,106
13,666
60,344
139,962 $
39,832
3,189
4,550
47,571
129,526
$
We had two customers who each accounted for 11% of consolidated revenue during fiscal 2012; both customers
purchased primarily from our SLS segment. There were no major customers over 10% of revenues for fiscal 2011 or 2010.
19. SUBSEQUENT EVENTS
On October 4, 2012, the Board of Directors authorized a buyback program whereby we are authorized to repurchase up to
$25 million of our common stock.
On October 30, 2012, we acquired all of the outstanding shares of Innolight Innovative Laser and Systemtechnik GmbH
for approximately $18.4 million, excluding transaction costs. Innolight provides a core technology building block for an
emerging class of commercial, sub-nanosecond lasers for microelectronics manufacturing and its semiconductor-based
architecture delivers pulsed output that can be amplified by conventional or fiber amplifiers to ultimately deliver infrared, green
or ultraviolet light capable of processing a range of materials.The results of operations for this acquisition will be included in
our consolidated results of operations following the acquisition date. Due to the timing of the acquisition, we have not yet
developed a preliminary purchase price allocation for the transaction.
99
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
Summarized quarterly financial data for the years ended September 29, 2012 and October 1, 2011 are as follows (in
thousands, except per share amounts):
Fiscal 2012:
Net sales
Gross profit
Net income
Net income per basic share
Net income per diluted share
Fiscal 2011:
Net sales
Gross profit
Net loss
Net income per basic share
Net income per diluted share
___________________________________
$
$
$
$
$
$
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
190,767
80,359
17,051
0.73
0.71
183,111
82,394
19,113
0.77
0.76
$
$
$
$
$
$
193,284
77,648
16,155 (1)
0.69
0.67
200,880
88,769
23,723 (3)
0.94
0.92
$
$
$
$
$
$
196,383
80,245
17,208
0.73
0.72
210,882
90,162
19,022
0.76
0.74
$
$
$
$
$
$
188,654
77,733
12,548 (2)
0.53
0.52
207,961
89,497
31,380 (4)
1.27
1.25
(1)
(2)
(3)
(4)
The second quarter of fiscal 2012 includes a $1,647 benefit from the release of tax reserves and related interest as a
result of the closure of open tax years.
The fourth quarter of fiscal 2012 includes a $4,260 after tax charge due to the write-off of previously acquired
intangible assets and inventories and a $2,790 benefit due to decreases in valuation allowances against deferred tax
assets.
The second quarter of fiscal 2011 includes $5,918 of after tax gain from the dissolution of our Finland operations, of
which a charge of $593 is recorded in cost of sales and a benefit of $6,511 is recorded in other income (expense), net
and a $1,549 increase in valuation allowances against deferred tax assets.
The fourth quarter of fiscal 2011 includes a $9,686 benefit from the release of tax reserves and related interest as a
result of an IRS settlement and the closure of open tax years.
100
INDEX TO EXHIBITS
Sequentially
Exhibit
Number
10.23‡
21.1
23.1
24.1
31.1
31.2
32.1
32.2
Exhibit
Form of Performance RSU Agreement under the 2011 Equity Incentive Plan (Amended)
Subsidiaries
Consent of Independent Registered Public Accounting Firm
Power of Attorney (see signature page)
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
_________________________________________________________
‡ Identifies management contract or compensatory plans or arrangements required to be filed as an exhibit.
All other exhibits required to be filed as part of this report have been incorporated by reference. See item 15 for a complete
index of such exhibits.
101
(Th is page intentionally left blank.)
(Th is page intentionally left blank.)
COHR_AR2012_print.indd 6
1/15/13 1:01 PM
COHR_AR2012_print.indd 7
1/15/13 1:01 PM
COHR_AR2012_print.indd 8
1/15/13 1:01 PM